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SOMMARIO 
Scopo della ricerca sviluppata durante questi tre anni di Dottorato è quello di 
spiegare i meccanismi sottesi alla risposta allo stress ossidativo nell'uomo a livello 
integrativo e molecolare. 
Per questo fine, nel primo anno di Dottorato, si è innanzi tutto implementato un 
metodo quantitativo assoluto atto a valutare la produzione dei radicali liberi. 
Come è noto ciò che importa è l’equilibrio tra produzione di Specie Reattive 
dell’Ossigeno (ROS) e la disponibilità di difese antiossidanti. Quando questo 
equilibrio viene meno, si parla di Stress Ossidativo, con conseguenze a carico 
degli acidi nucleici, dei lipidi e delle proteine, compromettendo il metabolismo e la 
vitalità cellulare, fino a indurre apoptosi o necrosi. Questo è un fenomeno 
ricorrente in molte malattie acute e croniche oltre che nel fisiologico processo di 
invecchiamento.  
Allo scopo si è utilizzata la tecnica di Risonanza Paramagnetica Elettronica (EPR) 
accoppiata a specifiche sonde molecolari (spin trapping) per sviluppare un metodo 
quantitativo “in vivo” in grado di monitorare la produzione di ROS in campioni 
biologici quale il sangue e sue frazioni.  
Gli inizi del mio periodo di Dottorato sono fortunatamente coincisi con 
l’acquisizione da parte dell’Istituto di Bioimmagini e Fisiologia Molecolare (IBFM) 
del CNR (Lita di Segrate), di uno strumento EPR che risponde alle esigenze di 
maneggevolezza e portabilità (e-scan Bruker BioSpin, Germania), di recente 
immissione sul mercato, che opera in onda continua (CW), nella banda X delle µW, 
in grado di rilevare concentrazioni molto basse (nM) in piccoli campioni (50 µl), 
utilizzando una cavità risonante le cui proprietà ottimizzano il fattore di 
riempimento, conferendo un’elevata sensibilità allo strumento. 
L’attendibilità dell'efficacia del metodo sviluppato è stata verificata con correlazioni 
tra metodi classici enzimatici e misure EPR in vari stati: fisiologici e parafisiologici. 
Trattandosi della messa a punto di un metodo di misura completamente innovativo 
e mancando pertanto dati di letteratura cui fare riferimento, si sono rese 
necessarie molte prove sperimentali da campioni ematici, in un vasto gruppo di 
soggetti, con tantissime acquisizioni modificando e ottimizzando di volta in volta i 
parametri e le condizioni (T, pO2) Questo procedimento è stato lento e laborioso; 
una volta superate le difficoltà tecniche, si è avuto a disposizione un piccolo 
catalogo di misurazioni che è servito ad ottenere i primi dati sperimentali che 
saranno illustrati nei primi paragrafi di questa tesi.  
Si è inoltre cercata una correlazione statistica tra la produzione di ROS 
determinata con tecnica EPR ed i marcatori dello stress ossidativo ottenuti dai vari 
test convenzionali enzimatici riportati in letteratura quali il dosaggio da sostanze 
reattive all'acido tiobarbiturico (TBARS) e carbonili proteici (PC) in grado di 
quantizzare il danno “a posteriori” prodotto dai ROS su lipidi e proteine 
rispettivamente. Una correlazione sistematica tra i dati EPR e i dati enzimatici non 
era certa, in quanto questi ultimi rivelano un danno conclamato. Tuttavia, è stata 
trovata una significativa correlazione (ANOVA, p<0.05) in soggetti a riposo, tra la 
produzione di ROS/TBARS e PC (rispettivamente: r2=0.74 e r2=0.60).  
Per rispondere allo scopo della ricerca, abbiamo assunto come modello l’ipossia 
studiata 1) come situazione che induce uno sbilanciamento tra Stress Ossidativo e 
capacità antiossidante e 2) nel tentativo di identificare i possibili meccanismi di 
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ripristino dell’equilibrio.  
Dall'insieme dei dati raccolti, al di là dei risultati specifici, possiamo evincere che 
anche se la misura quantitativa assoluta della produzione di ROS (umol . mim-1) 
non può essere un parametro generalizzato, perché funzione di variabili fisico-
chimiche (pO2, Temperatura, concentrazione della sonda), acquisizione ed 
elaborazione dei parametri vanno comunque prese in considerazione. Dal calcolo 
dei limiti di detenzione (LOD): 30 · 10-3 mM, e quantificazione (LOQ): 100 · 10-3 
mM, lo strumento si è rilevato sensibile e affidabile. 
Allo stesso tempo, va tenuto presente che il dato ottenuto rappresenta la 
produzione di ROS non tamponati dal sistema antiossidante. Per questo, si è 
ritenuto che la misura su campione ematico fosse rappresentativa della risposta 
sistemica integrativa. In particolare, il sangue capillare, oltre alla sua elevata 
sensibilità e riproducibilità (0,5% di differenza tra misure ripetute), ci ha permesso 
di disegnare un protocollo agile mini-invasivo. Da quanto fin qui esposto, possiamo 
ricavare che, al di là della ricerca di un dato assoluto da riportare in letteratura, è 
una valida procedura che ogni soggetto, monitorato nel tempo risulti controllo di se 
stesso, ovvero che a indice della risposta equilibrio/squilibrio vengano quantizzate 
le variazioni.  
Nel tentativo di identificare i possibili meccanismi di ripristino dell’equilibrio dello 
stress ossidativo, gli esperimenti sono stati condotti su: A) soggetti sani, che come 
tali sono caratterizzati da una condizione di equilibrio tra ROS e difese 
antiossidanti, B) soggetti affetti da patologie neurodegenerative, per i quali era 
logico attendersi, come confermato dalla realtà, che fossero caratterizzati da una 
condizione di conclamato squilibrio, rivelabile da un significativo incremento di 
ROS prodotti in condizioni di riposo. 
In soggetti sani, si sono disegnati, messi a punto e applicati differenti protocolli 
sperimentali, per testare l’effetto: a) dell’esercizio fisico (stato ipossico transitorio) 
di breve (hockeisti e nuotatori) e lunga durata (atleti di triathlon); b) 
dell’allenamento (nuotatori); c) dell’ipossia normobarica e ipobarica acuta e 
prolungata (giovani soggetti sedentari); d) dell’assunzione di molecole antiossidanti 
sulla produzione di ROS.  
In patologie neurodegenerative (pazienti affetti da: Neuropatia Diabetica (tipo II 
DN), decadimento cognitivo lieve (MCI) e Sclerosi Laterale Amiotrofica sporadica 
(sSLA)) dopo aver rilevato uno squilibrio in condizioni basali, è stato studiato 
l’effetto dell’esercizio/allenamento (SLA) o dell’assunzione di antiossidanti (tipo II 
DN) sulla possibilità di un potenziale ripristino a valori di equilibrio. Importanti 
risultati sono emersi dall’analisi dei dati registrati nelle varie condizioni sperimentali 
e sono illustrati in questa tesi. ll tema comune di tutti i test, oltre all’evidente studio 
sulla produzione dei ROS, è stato quello dell’ipossia.  
Infatti l’Ipossia, nelle sue varie espressioni (intese come deficienze parziali o totali 
di O2 nel nostro organismo), è stato elemento caratterizzante in tutti i protocolli che 
abbiamo testato.  
I protocolli di studio su pazienti sono tuttora in corso; pertanto i dati illustrati 
devono intendersi come preliminari. Nei soggetti patologici si è costatata una 
differente produzione di ROS in condizioni di riposo, mostrando un valore 
significativamente (p<0,05) più alto nei pazienti affetti da SLA (+20%) rispetto ai 
soggetti sani. L’allenamento, in questi pazienti, sembra giocare un ruolo favorevole 
nel diminuire la produzione di ROS: un decremento del 7% è stato calcolato nei 
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valori a riposo pre e post allenamento. Un sicuro effetto positivo dell’allenamento 
controllato, dopo otto settimane, è stato osservato nei nuotatori (-25%) sulla 
produzione di ROS (2.24 ± 0.14 µmol · min-1). 
Tutti questi esperimenti sono stati condotti e i risultati ottenuti durante il secondo e 
terzo anno della mia Scuola di Dottorato. A parte gli specifici risultati ottenuti dal 
set di dati raccolti, osservazioni generali possono essere riassunte come segue: 
1)	  Non vi è alcun modo per ottenere dati per quantificare il volume totale di ROS 
prodotta da un soggetto in qualsiasi condizione. Il dato EPR ricavato dalle 
misurazioni rappresenta l’eccesso di ROS che il sistema ha prodotto (µmol · min-1) 
in una determinata condizione, ed è quindi un tasso di produzione di ROS Inoltre si 
è scelto di effettuare la misura da sangue invece che da campioni di tessuto in 
modo da ottenere dati il più possibile sistematici. In particolare, il sangue capillare 
(rispetto al sangue venoso o plasma) ha dato la possibilità di sviluppare un metodo 
di misurazione affidabile, relativamente semplice e mini-invasivo. Tuttavia quando 
si passa da misurazioni di sangue capillare a venoso, bisogna prendere in 
considerazione la differente pO2. (la produzione di ROS in sangue venoso è stata 
trovata circa il 18% inferiore a quella nel sangue capillare: 1.79 ± 0.12 vs 1.48 ± 
0.29 µmol·min-1 rispettivamente).  
2)	   I dati non possono essere presi come parametri generali, poiché dipendono 
strettamente da variabili fisico-chimiche (T, pO2) Da tutti questi punti, si può 
evincere che, al di là della ricerca di un dato assoluto da riportare in letteratura, è 
una valida procedura che ogni soggetto, monitorato nel tempo risulti controllo di se 
stesso, ovvero che a indice della risposta equilibrio/squilibrio  vengano quantizzate 
le variazioni. 
3) Tuttavia si è consapevoli che il dato fornito da EPR deve essere integrato con 
dati sistemici quali: analisi ematochimiche di laboratorio (ematocrito, ferro, 
colesterolo, piastrine, neutrofili, linfociti, monociti), saturazione dell’ossigeno, 
cinetica degli scambi gassosi (VO2max).  
Si ritiene che il metodo possa trovare applicazione i) medicina dello sport offrendo 
un valido aiuto nei centri sportivi per monitorare l’efficacia dell’allenamento e gli 
eventuali effetti dello stress provocato ed eventualmente migliorare i protocolli; ii) 
alla medicina di montagna per lo studio delle patologie da alta quota, poiché 
l’ipossia è il primo e più delicato problema dell’altitudine sin dalla quota media 
(1800m); iii) ai centri clinici/diagnostici per monitorare gli effetti delle 
terapie/trattamenti sulla progressione di patologia.  
Seconda parte della mia attività di ricerca, è stato lo studio in vitro dell’ipossia da 
un punto di vista molecolare mediante misurazioni spettroscopiche EPR. Partendo 
da una visione molecolare, l’ipossia orchestra una moltitudine di processi e di 
pathway molecolari. Nel tradizionale meccanismo dell’ipossia si ha la presenza di 
una proteina eme in grado di rilevare il legame reversibile di O2 il quale causa un 
cambiamento allosterico nell’emo-proteina: da inattivo (forma ossigenata) ad attivo 
(forma de-ossigenata). Quindi l'attività di una proteina emo è determinata dalla 
presenza o assenza dell’ossigeno legato. 
Nella presente ricerca, la rilevanza di stati ipossici, dal punto di vista molecolare, 
atti ad essere rilevati sia in condizioni fisiologiche che patologiche è stato attribuito 
all’Ossido Nitrico (NO) e al ruolo della Mioglobina (Mb). E’ noto, infatti, che l’NO è 
un radicale libero particolarmente espresso in condizioni ipossiche in quanto è in 
grado di regolare la vasodilatazione, quindi aumenta l’afflusso di sangue e al 
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tempo stesso può essere però dannoso andando ad inibire la catena respiratoria a 
livello del complesso IV. 
In letteratura sono riportate cinque isoforme di Mb umana (Mb I-V) presenti nel 
muscolo scheletrico in percentuali diverse (Mb I: 75%; Mb II: 20%; Mb III-V: 5%) le 
cui funzioni non sono ancora state chiarite. Prendendo a riferimento Mb II, queste 
proteine differiscono solo per un singolo residuo aminoacidico: E54K (Mb I), 
K133N(Mb III), R139Q (Mb IV) a R139W (Mb V).  
Inoltre popolazioni tibetane, native dell’alta quota, presentano come risposta 
all’ipossia alte capacità antiossidanti, alto flusso ematico sistemico, metabolismo 
ed efficienza meccanica migliore, alti livelli di metaboliti circolanti biologicamente 
attivi all’NO e sono caratterizzate da un significativo aumento della concentrazione 
di Mb a livello muscolare con particolare riferimento all’ isoforma 54E (Mb II). 
Il presente studio, grazie all’analisi combinata EPR e simulazioni di Dinamica 
Molecolare (MD), contribuisce ulteriormente a sottolineare il ruolo importante 
svolto dalla Mb in condizioni di ipossia; inoltre segna un primo passo verso 
l'identificazione dei diversi ruoli svolti dalle isoforme della Mb 
Importanti risultati funzionali si sono ottenuti dallo studio EPR: l’NO ha capacità di 
legame significativamente maggiore con l’isoforma 54E rispetto all’isoforma 54K; 
questa è più circoscritta alla struttura dello stato de-ossigenato e la capacità di 
legame diventa significativamente inferiore (p<0.01) e quasi identica per le due 
proteine in presenza di O2 anche a differenti livelli di pO2 (40 e 100 mmHg).  
Concludendo, osservazioni e prospettive future possono essere condensate nella 
convinzione, che confidiamo saranno condivise e verificate anche dal lettore, della 
validità del nuovo del metodo sviluppato e dei dati raccolti.  
Alcuni risultati, in particolar modo quelli concernenti gli stati patologici, sono da 
considerarsi preliminari; tuttavia la strada da percorrere è estremamente 
interessante e richiede ulteriori indagini. 
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ABSTRACT 
The aim of the research developed in the time course of the three years of my 
Doctoral course in Molecular Medicine was to shed light into the mechanisms 
involved in Oxidative Stress responses in man at both integrative and molecular 
levels. To reach this general and high-level purpose we firstly focused our attention 
towards developing a method capable of returning an absolute quantitative 
estimation of Free Radicals production level. This particular aim was the subject of 
the first year of my researching activity. As a matter of fact, as is well known, in any 
physiological and/or pathological condition a subject could be involved, ‘oxidative 
stress’ results from the imbalance between Reactive Oxygen Species (ROS) 
production and his antioxidant capacity. Electron Paramagnetic Technique (EPR) 
resulted the method of choice since, as is well known, it is the only technique 
capable of returning, in a non-invasive way, the ‘intrinsic’ quantitative information 
(the signal is proportional to the number of excited electron spins). 
 Indeed the beginning of my Doctoral period fortunately coincided with the 
acquisition by the Molecular Bioimaging and Physiology (IBFM) Institute of CNR 
(Lita Segrate) of an EPR instrument (e-scan Bruker BioSpin, Germany) of recent 
design, responding to the innovative characteristics of easy portability and handling. 
The spectrometer operates at the common X-Band microwave frequency and 
deals with very low concentration levels (nM) even in small sample volumes (50 µl).  
Aware of the novelty of the method, we first looked for a correlation between the 
attained EPR experimental data and those returned when adopting the classical 
enzymatic methods (e.g. ThioBarbituric Acid Reactive Substances (TBARS) and 
Protein Carbonyls (PC) data collected from the same subject). Indeed, a 
correlation could not, by principle, be expected, since, compared to the EPR data, 
enzymatic methods give a quantitative “a posteriori” evaluation of the damage 
produced by ROS, on lipids and cellular proteins. As a matter of fact, a positive 
correlation (ANOVA, p<0.05) was found between EPR ROS production data and 
TBARS (r2 ~ 0.7) as well as PC concentration (r2 ~ 0.6), which was found in resting 
subjects.  
Then, in order to achieve the overall objective of the research, we assumed 
‘hypoxia’ as the ‘particular’ condition to be investigated, since it was viewed as a 
peculiar state capable of: 1) producing un imbalance between oxidative stress and 
anti-oxidant capacity; 2) offering the possibility of the identification of mechanisms 
involved in the perturbed balance restoring.  
To attain this ‘secondary’ aim, the experiments were carried out on: A) healthy 
subjects, that as such, were expected to start from a balance equilibrium condition; 
B) subjects affected by neurodegenerative pathologies, for whom, on the contrary, 
a sure imbalance condition was expected, that would be confirmed by a significant 
increment of ROS production, even at rest. 
However a fully innovative method had been developed, so that we lacked of 
referring literature data: a series of preliminary measurements on a homogeneous 
group of healthy subjects had to be firstly carried out, not only to optimize the 
acquisition and environmental conditions (T, pO2 that have to be carefully defined 
since they greatly affect EPR data), but also to reach reliable resting physiological 
values and range of variability. A great reproducibility of the data (µmol . min-1) was 
found on blood capillary samples taken from the same healthy subject six hours 
apart (r² = 0.99, ~ 0.5% discrepancy) and was calculated; limit of detection (LOD) 
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and quantification (LOQ) of 30 · 10-3 mM and 100 · 10-3 mM were calculated 
respectively.  
In healthy subjects, the experimental protocols were designed in order to study the 
effects of: a) exercise (as inducing a transitory hypoxic state) of both short (in 
hockey players, swimmers) and long duration (in triathletes); b) training (as 
inducing a balance restore, in swimmers); c) hypoxia, both hypo- and normobaric 
(to study the effect of the assumed model condition itself, in young sedentary 
subjects); d) antioxidant molecules administration as an external way helping to 
restore the balance. 
In neurodegenerative pathologies (patients affected by: type II Diabetic Neuropathy  
(type II DN), Mild Cognitive Impairment (MCI) and sporadic Amyotrophic Lateral 
Sclerosis (sALS)) after checking the expected unbalance throughout a significant 
increase of ROS production (sALS versus healthy subjects: +20%, p<0.05) under 
resting conditions, the effect of training on the possibility of approaching a normal 
ROS production level was investigated. The collected data thus far, that have to be 
nevertheless considered as preliminary results, of the training effect in sALS 
patients showed a beneficial effects; an decrease ROS production resting value 
(about -7%) was calculated after twelve weeks of training by the patients. in 
swimmers a significantly lower (about -25%) basal ROS production value (2.24 ± 
0.14 µmol · min-1) after eight weeks training period was calculated. 
All these experiments were carried out and results obtained during my second and 
third year of my Doctoral School. Besides and beyond the specific results obtained 
from the collected data set, pointed out throughout my thesis, general observations 
can be summarized as follows:   
1) There is no way to obtain data quantifying the total amount of ROS 
produced by a subject under any condition. Rather, EPR data return amount of 
ROS there were not scavenged by the antioxidant system. In other words, under a 
given condition, they represent the excess of the ROS produced in a given time, 
that is ROS production rate (µmol · min-1). Moreover we chose to carry out the 
measurement on blood instead of tissue samples to obtain most possible 
integrative data. In particular capillary blood (with respect to venous blood or 
plasma) gave us the opportunity of developing a mini-invasive, reliable and easy 
measurement method. Nevertheless when going from capillary to venous data, the 
different blood pO2 must be taken into account. (ROS production in venous was 
found about 18% lower than in capillary blood: e.g. 1.79 ± 0.12 vs 1.48 ± 0.29 µmol 
· min-1 respectively). 
2) The obtained data cannot be taken as general parameters, since they 
strictly depend on the physic-chemical variables (T, pO2) assumed for the 
measurement that must be taken into great account. From all these considerations, 
we can therefore conclude that beyond the possibility of obtaining absolute data to 
report for the first time in literature, this method was found as quite a sensitive and 
reliable mean to monitor the changes of each subject during time progression, 
therefore making each subject the control. 
3) Despite the reliability and high reproducibility of the afore-developed 
method, we are anyway aware that EPR data have to be compared and integrated 
by collecting systemic data: hematochemical parameters (e.g. hematocrit, iron, 
cholesterol, platelets, neutrophils, lymphocytes, monocytes), oxygen saturation, 
maximal oxygen consumption (VO2max). 
Finally we are confident that our method will be in the near future considered 
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suitable to be applied into different medical fields: i) sport medicine, as an effective 
available help in sports centers to set up and adjusts training protocols by 
monitoring training effects on oxidative stress. ii) mountain medicine,  in studying 
pathologies induced by hypoxia following high altitude acute and chronic staying; 
iii) clinic and diagnostic centers, helping in monitoring progression of pathologies 
and/or effects of therapies. 
On the other side, second part of my researching activity, the study of hypoxia 
throughout EPR measurements, was carried out in vitro at a molecular level. In fact, 
hypoxia orchestrates a multitude of processes of molecular pathway responses. 
Nevertheless the traditional mechanism of sensing hypoxia involves the presence 
of a heme protein so that hypoxia can be detected by a reversible binding of O2 at 
the heme site, which causes an allosteric shift in the hemoprotein from inactive 
(oxyform) to active (deoxy) form. The activity of a hemoprotein is therefore 
determined by the presence or absence of bound oxygen.  
Among heme proteins, the relevance of hypoxic states, suitable to be encountered 
in both physiological and pathological conditions was, in the present research, 
made in conjunction with the supporting role recently attributed to deoxy-Myoglobin 
(Mb) as a ROS scavenger, with particular attention to a peculiar reactive species 
molecule, that is nitric oxide (NO). NO is a highly diffusive and reactive molecule, 
produced, in the cells, by the NO synthases enzymes (NOS), using L-arginine and 
O2 as substrates.  Under normoxic conditions, if NO concentration becomes too 
high, oxy-Mb is able to scavenge and oxidize it into NO3-, maintaining 
mitochondrial O2 consumption, thus cellular respiration, at the optimum. On the 
contrary, under hypoxia, the low O2 availability leads to NOS inactivation (being 
substrate limited). The NO produced by Mb down-regulates mitochondria O2 
consumption, contributing to elongate the intracellular oxygen gradient and limiting 
the formation of deleterious reactive oxygen species. In addition, Mb-produced NO 
might contribute to hypoxic vasodilatation. Thus, Mb’s nitrite reductase activity 
(very low pO2 level) might participate both in the modulation of tissue mitochondrial 
respiration and in the limitation of ischemia-reperfusion injury, under hypoxic.  
The relevance of hypoxic states, in conjunction with the supporting role recently 
attributed to deoxy-Myoglobin throughout its scavenging and vasodilatory 
properties was the rational basis for this study.  
As regard as Mb, in human’s skeletal muscle, up to five different Mb isoforms are 
reported in the literature (Mb I-V). Also different Mb percentages are present in the 
muscle: Mb I 75%, Mb II 29%, Mb III-V 5%. 
Taking Mb-II as a reference, these proteins differ only for one external amino acid 
and, namely, they can be seen as the E54K (Mb I), K133N (Mb III), R139Q (Mb IV) 
and R139W (Mb V) mutants, whose specific functions, if any, are completely 
unknown. In addition, these general observations were supported by specific 
findings on populations born and living in extreme hypoxic conditions possibly 
explaining their better metabolic and mechanic efficiency by the increase of Mb 
concentration, with particular reference to the 54E isoform (Mb II). Throughout a 
combined EPR and MD simulations analysis, the present study aimed to give 
experimental evidenced able to further underline the relevant role played by Mb 
under hypoxic conditions, then marking a first step towards the identification of 
different roles played by Mb isoforms, whose presence, among mammals, is a 
distinct feature of human Mb.  
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Functional results obtained by the EPR study showed up not only a significantly 
greater NO binding capacity (more than double; p<0.01) of the 54E with respect to 
the 54K isoform was calculated from the EPR spectra integrated areas but even 
more circumscribed this property to the deoxygenate state, the binding capacity 
becoming significantly lower and almost the same for the two proteins in the 
presence of O2 at the two analyzed pO2 levels  (40 and 100 mmHg). This novel 
and quite intriguing result was supported by structural considerations emerged by 
the MD simulation analysis and in turn mutually supported by structural EPR 
results.  
Concluding remarks and future perspectives can be summarized in our firm belief, 
which we are confident will be verified and accorded by the reader as well, of the 
novelty of the developed method and of the reported data. Indeed some of them, 
especially when concerning pathological subjects, have to considered ‘in fieri’, 
nevertheless the road to take is extremely interesting, and calls for further 
investigations. 
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1 INTRODUCTION 
Setting the scene: How did redox biology begin? 
Nowadays the redox biology is probably the most rapidly expanding field in 
biology; indeed the number of conferences, books, journals and special issues in 
this area, books are increasing significantly [1]. All animals need O2 for an efficient 
production of energy by mitochondria. This need for O2 obscures the fact that it is a 
toxic mutagenic gas; aerobes survive only because they have evolved antioxidant 
defenses [2]. Thus antioxidants and free radicals permeate the whole of life, 
creating the field of redox biology. Free radicals are not all bad as well as 
antioxidants are not all not good. Life is a balance between the two: antioxidants 
serve to keep down the levels of free radicals, allowing them to perform useful 
biological functions without too much damage [2]. This is true in humans as in 
plants. Yet some damage is inevitable, requiring repair systems to maintain cell 
viability.  
 
 
 
1.1 Free radicals: what’s about? Where they come from? 
1.1.1 Discovery of Free Radicals 
In the late 1950 terms like Free Radicals (FR) and antioxidants, were almost 
unknown in biological and clinical sciences, the presence of radicals in biological 
materials being demonstrated only in 1954. For the first time in 1956, Denham 
Harman, has established a link between the toxic effects of high levels of oxygen in 
aerobic organisms and ionizing radiation, suggesting the idea that oxygen toxicity 
was due to formation of FR [3]. 
Free Radicals are highly reactive molecules or fragments of them carrying one or 
more unpaired electrons in the outer shell. 
In Table 1 the classification of FR (oxygen radicals, non-oxygen radicals and 
nitrogen radicals), symbol and intracellular half life (s) [4]. Among them reactive 
oxygen species (ROS) can be classified into two groups of compounds, radicals 
and non-radicals. The specimens in Table 1 belong to the radical group, often 
incorrectly called Free-Radicals (the term is not accurate, because, due to the 
presence of the e-, a radical can be always considered ‘free’) and are capable of 
independent existence. The occurrence of one unpaired electron results in high 
reactivity by their tendency to give or subtract electrons to attain stability.  
By contrast, a large variety of substances belong to the non-radical compounds 
group, some of which, although not radical by definition, are extremely reactive. 
Among them, produced in high concentrations in living cells, hypo-chlorous acid 
(HClO), hydrogen peroxide (H2O2), organic peroxides, aldehydes, ozone (O3), and 
O2 can be found. Indeed, by definition, the oxygen molecule itself can be 
considered a bi-radical, because it contains two unpaired electrons in two different 
orbitals. Nevertheless, ROS are paramagnetic oxygen molecules, produced in cells 
as by-products of oxidation–reduction (REDOX) reactions, which can in turn be 
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stabilized by subtracting electrons to neighboring molecules (e.g. lipids, proteins, 
DNA).  
 
Name Symbol Half life t1/2 (s) 
OXYGEN RADICALS 
Oxygen (bi-radical) O2•• 10-6 
Superoxide O2•- 10-4 
Hydroxyl OH• 10-9 
Peroxyl RO2• 0.1 
Alkoxyl RO• 10-6 
Nitric oxide NO• 0.4 
NON RADICALS OXYGEN 
Singlet O2 10-3 
Hydrogen peroxide H2O2 1 
Ozone O3 
sec/min/h/day 
(T° dependent) 
NITROGEN REACTIVE SPECIES 
Nitrogen dioxide NO 2• s 
Nitrate NO 3• s 
 
 
Table 1: Radicals and non-radicals oxygen and nitrogen metabolites 
 
 
1.1.2 Exogenous and endogenous sources 
Cells are exposed to a large variety of ROS from both exogenous and endogenous 
sources. Exogenous sources of ROS can be identified in UV and γ radiations, 
microbes, allergens, car exhausts, certain foods, tobacco smoke, air pollutants, 
drugs and alcohol when assumed in a great amount. Nevertheless, despite the 
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extremely strong exposure of whole our organism to ROS coming from exogenous 
sources, endogenous ROS play the most important and extensive role, since, in 
the time course of our life, each body cell is continuously exposed to them. The 
major responsible of ROS production are mitochondria [5]; enzymes are another 
endogenous source of ROS. While most enzymes produce ROS as by-products of 
their activity (xanthine oxidase is a clear example) some of them are designed to 
produce ROS: nitric oxide synthase (NOS) yields NO radicals; Nicotinamide 
Adenine Dinucleotide Phosphate (NADPH) oxidase complex utilizes electrons to 
produce superoxide radicals from the oxygen molecule.  
 
 
1.1.3 Balance/Unbalance of ROS  
At appropriate concentration, ROS are known to act as important signaling 
molecules. Free radicals and reactive species are essential to wellbeing, having 
various regulatory roles in cells. For example, ROS are produced by immune cells 
(neutrophils and macrophages) during the process of respiratory burst in order to 
eliminate antigens [6]. They also serve as stimulating signals of several genes 
encoding transcription factors, differentiation, and development as well as 
stimulating cell-cell adhesion, cell signaling, vasoregulation, fibroblast proliferation 
and antioxidant enzymes increasing expression. The latter example is observed in 
subjects performing chronic exercise and will be further discussed (see below in 
the text). At the same time, antioxidant enzymes are essential functional cell 
regulators of metabolic pathways.  
Moreover the effects of ROS are dose dependent. In plants, for an example, ROS 
are used to facilitate an array of essential biological processes, as growth and 
development, seed germination and stress acclimation [7]. 
By contrast, “Oxidative Stress” term indicates a range of deleterious states, 
resulting from an imbalance between antioxidant defense systems and ROS, 
towards these latter, produced in a great extent. This state is associated with 
damage to proteins, lipids and DNA together with functional impairment of 
metabolic processes as the mitochondrial respiratory chain [8, 9]. Indeed, a) the 
oxidative attack on proteins results in site-specific amino acid modification, 
fragmentation of the peptide chain, aggregation of cross linked reaction products, 
altered electrical charges and increased susceptibility to proteolysis [10]; b) the 
lipid peroxidation is a complex process involving the interaction of oxygen-derived 
free radicals with polyunsaturated fatty acids, resulting in a variety of highly 
reactive electrophilic aldehydes [11]; and finally c) DNA, causing deletions, 
mutations and other lethal genetic effects. Characterization DNA damage has 
indicated that both sugar and base moieties are susceptible to have been oxidized, 
causing base degradation, tandem lesions, single and double strand breakage and 
protein cross links [12]. 
 
 
1.1.4 Mitochondria: primary site for ROS production 
As mentioned above, the mitochondria are a primary site for ROS production under 
physiologic condition [5]. The mitochondria are present in every eukaryotic cell. 
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The electron transport chain for generation of adenosine tri-phosphate (ATP) in the 
inner membrane of mitochondria permanently generate superoxide ion (O2•-). It is 
estimated that 1-2% or even 4% of oxygen consumption undergoes transformation 
to O2•-. [13]. The mitochondrial respiratory chain transfers electrons to molecular 
oxygen, permanently producing ROS as a by-product of oxidative phosphorylation 
(OXPHOS). Some oxygen consumed by mitochondria is only partially reduced to 
superoxide radical (O2•-), which can then be converted to hydrogen peroxide 
(H2O2) by superoxide dismutase (SOD), and then further to water by catalase 
(CAT) or to the very reactive hydroxyl radical in the presence of transition metals 
(e.g. Fe2+). Five enzyme complexes are localized on the inner mitochondrial 
membrane. Complexes I–IV (the electron transport chain) are involved in 
transporting electrons through a series of proteins via REDOX reactions, with the 
final destination being an oxygen molecule.  
Under normal situation, this oxygen is then converted to water in complex IV, and 
the energy stored in the proton gradient is used to drive ATP production in complex 
V. However, during this process, it would occur an inadequate coupling of the 
electron transfer between the complexes I and III: complex I (namely, the iron-
sulfur clusters) releases the reactive oxygen species (superoxide anion) only 
towards the mitochondrial matrix, whereas complex III (the ubiquinol oxidation site) 
releases superoxide into both matrix and outside the inner membrane. So a small 
percentage of the oxygen consumed by the mitochondria at complex IV is 
converted to ROS rather than water. Thus, paradoxically, the most fundamental of 
processes in enabling eukaryote life (OXPHOS) is also one of the chief culprits of 
ROS production. Summarizing, many reports have demonstrated that 
mitochondrial superoxide production is mostly a result of incomplete reduction of 
oxygen at sites of respiratory complexes I and III, which therefore can be 
considered as the main sources for mitochondrial ROS (see Figure 1) [14, 15]. 
 
 
 
 
Figure 1: Mitochondrial sites of superoxide production. Electrons are transferred 
from complexes I, II, and III to IV. Inadequate coupling of electron transfer can 
cause leakage, generating superoxide anions at different complex levels.            
[by Handy DE, Loscalzo J.- 14]. 
 
 
oxidase and NOX4 through a flavin-dependent two-electron
reduction of molecular oxygen (38, 118, 211).
Owing to its anionic charge, O!"2 does not readily traverse
intracellular compartments, although studies with isolated
mitochondria provide evidence that superoxide leaks from
mitochondria via the voltage-dependent anion channel
(VDAC) (168). More recent data from mutant yeast strains
lacking VDAC indicate that the translocase of the outer
membrane complex participat s in super xi e release from
mitochondria in the absence of VDAC (55). Together, these
studies suggest that although most of superoxide’s effects are
localized to its sites of production, transmembrane proteins
can mediate O!"2 release frommitochondria. There ave been
no reliable estimates of the extent to which O!"2 leak con-
tributes to cytosolic oxidant levels compared to the direct re-
lease of hydrogen peroxide from mitochondria; however, in
contrast to O!"2 , the neutrally charged and less reactive hy-
drogen peroxide has a longer half-life and can readily diffuse
across membranes (450). Given these and other properties,
hydrogen peroxide plays an ess ntial role in redox signaling.
For example, it coordinates cellular responses to oxidant
production, in part, by the reversible oxidation of protein
thiols (see below). In excess, however, hydrogen peroxide can
overoxidize protein thiols, react with free metals to form !OH,
cause lipid peroxidation, and contribute to cellular xidative
stress (127, 324).
B. Mitochondrial generation of ROS
As discussed in more detail below, mitochondrial re-
sponses to ROS can increase mitoc ondrial production of
ROS, in pa t, by increasing electron leak. Within mitochon-
dria, the components of the ETC reside on the inner mem-
brane (Fig. 1). During respiration, electrons are transferred to
molecular oxygen via the four complexes of the ETC to gen-
erate water while pumping protons (H + ) into the intermem-
brane space at complex I (NADH dehydrogenase), co plex
III (cytochrome c reductase), and complex IV (cytochrome c
oxidase). This gradient of H + is the major contributor to the
mitochondrial inner membrane potential (DC); the return flux
of protons into the matrix through the ATP synthase complex
(proton motive force) powers the synthesis of ATP from ADP
and inorganic phosphate. During respiration, *1%–2% of
molecular oxyg n is converte to O!"2 due to electron leak at
either complex I or complex III (223, 349). According to ther-
modynamic calculations, many of the complexes in the ETC
are capable of converting molecular oxygen to O!"2 ; however,
the efficiency of the transfer of electrons in the respiratory
chain reduces the leak at most sites [(403) and references
therein]. Some estimates indicate that 70%–80% of mito-
chondrial O!"2 arises fr m the Q cycle (ubiquinol, QH2, to
ubiquinone, Q) as part of the electron transfer to cytochrome c
catalyzed by complex III (70). During this cycle, O!"2 can be
released into the mitochondrial matrix or intermembrane
space owing to the bifacial localization of complex III Q-
binding sites within the inner membrane. Other reports sug-
gest that the majority of mito hondrial O!"2 comes from
complex I during oxidation of NADH to NAD + . The actual
role of complex I or III in O!"2 flux may depend on multiple
factors, including cell type and metabolic state. For example,
excess NAD + reduction (increased NADH/NAD + ratio) en-
hances O!"2 generation from complex I via NADH-ubiqui-
none reductase activity (413). Electrons ente the ETC as
NADH in complex I, wh re it is reduced by NADH-ubiqui-
none reductase, which transfers electrons from a flavin com-
plex to several iron–sulfur (Fe-S) centers and then to
coenzyme Q10 (ubiquinone Q). Each of these steps in electron
transport within complex I has been suggested to play a role
in O!"2 generation; thus, the flavin mononucleotide site, Fe-S
clusters, and the complex I-associated ubiquinones may all
contribute to electron leak (149, 172, 196, 227, 229, 233). Blocks
in respiration (downstream of complex I) can lead to excess
reduction of the electron carriers in complex I, causing elec-
tron leak, and enhanced production of O!"2 . Although com-
plex II (succinate d hydrogenase) does not generate O!"2 ,
reverse flow of electrons from complex II to complex I may
I
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III IVQ
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FIG. 1. Mitochondrial sites of superoxide production.Mitochondrial electron transport complexes (I–IV) are located on the
inner mitochondrial membrane. The electron transport in mitochondria starts with the extraction of electrons from NADH
(complex I) or FADH2 (complex II) generated in the tricarboxylic acid (TCA) cycle. Electrons are transferred along the path
shown in the figure, resulting in the reduction of O2 to water at complex IV. During this process, protons (H
+ ) are pumped by
complexes I, III, and IV into the intermembrane space to form an electrochemical gradient (H + potential or Dw) at the inner
mitochondrial membrane. ATP synthase utilizes the stored energy of this proton gradient to drive the formation of ATP
(proton motive force) from ADP and inorganic phosphate (Pi). Electron leak during respiration leads to the formation of
superoxide anion (O!"2 ) due to the incomplete reduction of O2 at complex I and complex III (223, 349). O
!"
2 formed at
complex I is released into the mitochondrial matrix, whereas O!"2 formed at complex III can be released either to the matrix or
to the intermembrane space, depending on the disposition of complex III from which it forms.
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For the complex and fundamental role of mitochondria, it is very important to 
maintain the functional integrity of mitochondria. Because of pivotal role for cellular 
survival, mitochondrial dysfunction is associated at neurological diseases (e.g. 
Parkinson’s disease (PD), Huntington’s disease (HD), Alzheimer’s disease (AD), 
Amyotrophic Lateral Sclerosis (ALS) and various peripheral neuropathies) as well 
as the normal aging process [17]. Also, several non-mitochondrial sources of ROS 
are present in the cell, such as membrane-bound NADPH oxidase [18]. NADPH 
oxidase plays an important role in pathological states of reperfusion, hypertension 
and atherosclerosis. However it is involved in defense against pathogens too.  
 
 
 
 
 
 
 
Figure 2: Mitochondrial signaling by ROS, adapted from Bellance et al, 2009 [16]. 
The mitochondrion is implicated in the generation of Reactive Oxygen Species 
(ROS) and Reactive Nitrogen Species (RNS). In most cells, the mitochondrial 
respiratory chain is recognized as the major site of ROS production in the form of 
superoxide, hydrogen peroxide and the hydroxyl free radical. These molecules can 
be considered as positive products that contribute to cell signaling. However, 
excessive amounts of ROS are deleterious for the cell, contributing to a variety of 
pathological processes. ROS generation can result in the set up of a vicious cycle 
of oxidative damage causing a progressive alteration of DNA and mitochondrial 
function that in turn leads to energy deprivation, redox imbalance and cell 
dysfunction. 
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Due to the potential role that reactive species and free radicals have in lipid, 
protein, and DNA damage, it is not surprising that a network of antioxidant defense 
mechanism is present in the body. In general, antioxidants are often reducing 
agents, which exist both intracellularly and extracellularly and have the capacity to 
react with free radicals and reactive species, minimizing their actions and, thus, 
delaying or preventing oxidative stress. 
Antioxidants can be both synthesized in vivo and absorbed through diet. They can 
be divided into two groups: enzymatic and non-enzymatic. The main enzymatic 
antioxidants include superoxide dismutase (SOD), glutathione peroxidase (GPX), 
and catalase (CAT). Each of these enzymes is responsible for the reduction of a 
different ROS, and they are located in different cellular compartments. 
One of the primary enzymatic ROS scavenging mechanisms involves dismutating 
superoxide to hydrogen peroxide (H2O2), via the SOD. The H2O2 is subsequently 
detoxified via other enzymatic reactions (see Figure 2) [14].  
The non-enzymatic antioxidant group includes glutathione, vitamin C, vitamin E, 
carotenoids, uric acid, and others. Similarly to the enzymatic antioxidants, these 
are present in different cellular compartments and elicit distinct antioxidant 
properties, which maximize their effectiveness. [19]. Reduced glutathione (GSH) is 
a water-soluble low-molecular-weight tripeptide that exerts various essential 
functions in the body, amongst these a major antioxidant role. Further, there is an 
evidence that bilirubin can act as antioxidant to help neutralize certain free radicals 
[20]. The delicate balance between advantageous and detrimental ROS effects 
plays a great physio-pathological importance. The redox state of a cell is kept 
within a narrow range under normal conditions, similar to the manner in which a 
biological system regulates its pH. 
 
 
1.1.5 ROS and disease 
When ROS overwhelm the cellular antioxidant defense system, whether through 
an increase in ROS levels or a decrease in the cellular antioxidant capacity the 
delicate balance oxidant/antioxidant is broken. In this case, as shown until now, not 
only mitochondrial dysfunction caused by the attack of ROS induces many 
neurological diseases, but the high levels of ROS result in number of other 
degenerative processes affecting a wide variety of physiological functions.  
So ROS are involved in the pathogenesis of diseases states such as 
atherosclerosis, diabetes, ischemia/reperfusion injury, inflammatory diseases 
(rheumatoid arthritis, inflammatory bowel diseases and pancreatitis), cancer, 
neurodegenerative diseases (Parkinson, Amyotrophic Lateral Sclerosis, Alzheimer, 
[21], cardiovascular and/or respiratory insufficiency, etc. [22-24]. These diseases 
have as a common thread tissue hypoxia and/or structural alterations, dysfunction 
of mitochondria and consequently the increased ROS production.  
 
 
1.1.6 ROS and physical exercise 
The physical exercise is perhaps one of the most characteristic examples 
demonstrating that ROS are not necessarily harmful, considering that the well-
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known benefits of regular exercise on muscle function and health accompanied by 
repeated episodes of oxidative stress [25]. But this is true? This is one of the 
questions that we tried to answer in these three years of work. We are aware that 
the exercise is associated with a dramatic increase in oxygen uptake by the whole 
body and particularly by skeletal muscle [26]. Sen [27] reported an increase of 10–
15-fold in the rate of whole body oxygen consumption and an increase of more 
than 100-fold in the oxygen flux in active muscles during whole-body aerobic 
exercise, so resulting in increased ROS formation shifting the cellular environment 
from a reduced to an oxidized state independently of physical activity (aerobic, 
anaerobic or resistance types of activities) [28].  
The most of the oxygen consumed by the body is utilized in the mitochondria for 
substrate metabolism and ATP production. An increased ATP demand 
accompanying exercise increases both aerobic and/or anaerobic metabolism [29].  
So many factors might contribute to the oxidative stress induced by exercise and a 
variety of factors can influence the oxidative rate, such as the muscle groups 
recruited, the modes of contraction, the exercise intensity, the exercise duration, 
and the exercising population. Recent reports have indicated the potential role that 
blood may play at rest or during exercise on ROS production. Some important 
factors, that contribute to the oxidative stress during the exercise, are easily visible 
in the blood: increased in blood temperature, decrease in blood pH, decrease in 
blood oxygen partial pressure and increase in the concentration of blood lactate 
[25]. The whole blood or parts of it (plasma [30], erythrocytes [31], neutrophils 
[30,32], lymphocytes [33], platelets [34] have reported an increase production of 
various reactive species after exercise. However, the majority of the relevant 
human studies have measured the redox status of the plasma (plasma is about 
55% of the blood volume; its composed mostly water, about 90% and contains 
dissolved protein, glucose, lipids, mineral ion), this is probably for two reasons: the 
assumption that plasma better reflects tissue redox status and the easiness of 
plasma collection.  
Blood is able to produce ROS during exercise, yet it's equally evident that skeletal 
muscle is able to produce reactive species during increased contractile activity. 
Referring to the appropriate level of reactive species, ROS are important signaling 
molecules for muscle contractions. At the molecular level, the exercise active the 
p38γ MAPK (mitogen-activated protein kinase) which promotes PGC-1α activity 
and expression in control of mitochondrial biogenesis and angiogenesis in skeletal 
muscle [35]. The promoting effects of regular exercise on different cellular 
functions include the up-regulation of antioxidant, oxidative damage repairing 
systems, neurogenesis, and induction of trophic factors [35]. 
 
 
1.1.7 Exercise, pathological state and hypoxia. 
The physical exercise and some pathological status can be seen as a typical 
example of an acute, intermittent or long-lasting/chronic hypoxic exposure or 
condition. One model of chronic intermittent hypoxia (common and life-threatening 
condition that occurs in many different diseases) is the hypertension and 
consequent cardio - and cerebrovascular diseases but also metabolic disorders 
such as diabetes [36] and atherosclerosis. Recent studies suggest that hypoxia 
can be one of the underlying mechanisms of the atherogenesis and carcinogenesis. 
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Despite this, most commonly, the term hypoxia brings to mind the mountain and 
the high altitude. Hypoxia exposure can lead to altitude mountain sickness and 
sometime to high-altitude pulmonary or cerebral or edemas when the exposure is 
severe. In fact, there are indirect evidence from cells and tissue experiments that 
acute hypoxia induces accumulation of ROS [37,38]. The increase in accumulation 
of ROS during exposure to hypoxia have important systemic implications [39] and 
more particularly at brain level with damage of vascular endothelium, neurons, glia, 
and down-regulation of Na+-K+-ATPase, Ca2+-ATPase, Na+/Ca2+ exchanger 
activities. [37]. Significantly effects of high altitude exposure have been shown on 
the cell-proliferative activity and expression of pro-inflammatory cytokines with 
evident impairment of leucocyte function [38].  
The evidence of impact of the hypoxia on metabolism appears from muscle 
proteomic analysis in man and animals [40,41]. The transcription factor responding 
to changes of available oxygen in cellular environment of animal and human body 
is the Hypoxia Inducible Factor 1 (HIF-1). HIF-1 is a heterodimetric complex 
consisting of a constitutively expressed β subunit (also known as the aryl 
hydrocarbon receptor nuclear translocation, ARNT) and a hypoxia inducible 
subunit, α subunit. It controls a wide range of genes involved in adaptation to low 
oxygen pressure, indeed is a potent mediator of hypoxic responses by regulating 
both oxygen delivery (angiogenesis and red cells production) and oxygen 
consumption (glycolytic metabolism). HIF-1 activation is regulates through 
mitochondria and NADPH oxidase-mediated ROS production. The specific tissue 
partial O2 pressure  (pO2) that induces a response depends on many variables 
including diffusion distances, blood flow velocity, metabolic rate, myoglobin 
concentrations and the dynamic influence of NO on mitochondrial electron 
transport [42]. 
Thus, hypoxia is involved in physiological, para-physiological, and pathological 
conditions.  
 
 
1.1.8 Myoglobin (Mb), NO and Hypoxia 
Myoglobin (Mb), otherwise named as “muscle Hemoglobin”, is a relatively small 
globular metalloprotein (153 [43] or 154 [44] residues). Historically, Mb was the first 
protein to be solved at atomic level, [45] (Figure 3) and, also because of its size, 
has been often employed as a model system for larger and more complex globular 
proteins (Figure 4) [46-49].  
Indeed, it is widely considered as the ‘hydrogen atom of biology and a paradigm of 
complexity’ [47] to test new models and investigation techniques. For a very long 
time, it has been simply considered an O2 storage/delivery system necessary to 
maintain its physiological concentration gradient across the cell [50]. The general 
consensus about restriction of Mb expression to the skeletal and cardiac muscle of 
mammals, together with the observation that the diving species exhibit a more than 
tenfold higher concentration of Mb, compared with the non-diving ones at sea level, 
strengthened the idea about its role as an O2 repository [46,47,49,51]. 
However, more recent studies revealed its widespread expression in various non-
muscle tissues, as well as in many other living organisms, including fishes, birds, 
reptiles, mollusks, and even bacteria and protozoa [52]. 
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Figure 3: Max Perutz (left) with his model of hemoglobin and John Kendrew with 
his model of myoglobin in 1962 [Photo by Nobel Prize.org]. 
 
 
 
 
 
Figure 4: Model of the Myoglobin molecule, derived from the 6Å Fourier synyhesis. 
The Haem group is a dark grey disk (centre top) [by John Cowdery Kendrew. 
Myoglobin and the structure of proteins. Nobel Lecture, December 11, 1962]. 
  M Y O G L O B I N  A N D  T H E  S T R U C T U R E  O F  P R O T E I N S 683
Fig. 3. Model of the myoglobin molecule, derived fr m the 6Å Fourier synthesis. The
haem group is a dark grey disk (centre top ).
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In particular, an over-expression in response to hypoxia has been reported, [53,54] 
with even possible implications in tumors’ development [55]. Since 1962, U.S. 
Military studies, in human subjects (young native of Cerro de Pasco – 4400m s.l.) 
have suggested that higher concentration of myoglobin seen in the altitude native 
was probably real since the nitrogen content of the muscle, the lean body mass 
and the body water continent were the same in both high altitude and sea level 
subjects. [56]. Anyway, in the literature, a relationship between Mb expression and 
hypoxia started to emerge, leading to the idea that this supposedly well-known 
protein might have alternative/complementary roles, such as NO scavenging [57] 
and NO2- reduction, [58] being regulated by O2 concentration, NO is a highly 
diffusive and reactive molecule, produced, in the cells, by the NO synthases 
enzymes (NOS), using L-arginine and O2 as substrates [59,60]. Among many 
different and fundamental roles as a signaling molecule, NO is a well-known 
inhibitor of the mitochondrial respiratory chain, having the cytochrome-c-oxidase as 
its primary target [61]. Under normoxic conditions, (see equation 1) if NO 
concentration becomes too high, oxy-Mb is able to scavenge and oxidize it to NO3-, 
[62] maintaining mitochondrial O2 consumption, thus cellular respiration, at the 
optimum. 
 
Normoxia (scavenger): MbO2 + NO à metMb + NO3-                                            (1) 
 
On the contrary, under hypoxia (see equation 2), the low O2 availability leads to 
NOS inactivation (being substrate limited).  
 
Hypoxia (producer): DeoxyMb + NO2-+ H+ à MetMb + NO + OH+                         (2) 
 
 
The few O2 would be mostly consumed by the respiratory chain, resulting in a 
dramatic shortening of its concentration gradient through the tissue [61] However, 
in this condition, Mb was found to be able to act as a NO2- reductase [58,62]. The 
NO produced by Mb down-regulates mitochondria O2 consumption, contributing to 
elongate the intracellular oxygen gradient [61] and limiting the formation of 
deleterious reactive oxygen species [63]. In addition, Mb-produced NO might 
contribute to hypoxic vasodilatation [64]. The vasodilatory property of NO2-, at 
physiological concentrations in vivo, has been previously described and associated 
to its conversion to NO by deoxy-hemoglobin [65]. Then, the nitrite reductase 
activity of Mb at very low pO2 levels, as it occurs during exercise or ischemia, has 
been associated to a rapid conversion of tissue nitrite to NO as well [61]. Thus, 
Mb’s nitrite reductase activity might participate both in the modulation of tissue 
mitochondrial respiration and in the limitation of ischemia-reperfusion injury, under 
hypoxic conditions. 
In humans, up to five different Mb isoforms are reported in the literature, Mb-I (75-
80%; pI 8.57), Mb-II (15-20%; pI 7.29), Mb-III, Mb-IV and Mb-V (all together 5%; pI 
6.83) [66,67].  
More recently, three alternatively spliced transcript variants (see Figure 5), 
encoding for the same protein, have been reported. 
[http://www.genecards.org/cgi-bin/carddisp.pl?gene=MB].  
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Taking Mb-II as a reference, these proteins differ only for one external amino acid 
and, namely, they can be seen as the E54K (Mb I) [68], K133N (Mb III) [69], 
R139Q (Mb IV) [70] and R139W (Mb V) [71] mutants, whose specific functions, if 
any, are completely unknown (see Figure 6A). 
In the context of the aforementioned O2 level dependent multiple roles, it is 
interesting to note that, when compared to low-lander populations, high altitude 
natives, like those from Tibet plateaus [54] or Andean slopes, [72] are 
characterized by a higher muscle Mb concentration. In particular, a recent 
proteomic investigation [54] pointed out that the greater concentration of Mb in 
Tibetans natives (+20%) is totally attributable to the increase of the isoform Mb-II. 
Thus, together with the observation that Tibetans are also characterized by 
higherefficiency of locomotion, a relationship between Mb-II over-expression and 
their evolutive adaptation to high altitude was put forward [54,73]. 
 
 
 
 
 
Figure 5: Three alternatively spliced transcript variants in Mb 
[by UniProtKB/Swiss-Prot variant pages]. 
 
 
Looking only two more expressed isoforms, the single-point mutation occurs in the 
CD-region (i.e. from residue 35 to 58, comprising the C- and the D-helix, together 
with the long loop in-between), where the distal histidine (H64) is located (see 
Figure 6B) [75]. 
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Thus, the difference between the human Mb and those from other mammals 
should stem from some other structural/dynamical diversities. It is important to cite 
here as well, that some (quite extensive) mutations of the CD-region were 
investigated on different sperm-whale Mb mutants [79], where, in particular, 
residues 51÷55 (i.e. the entire D-helix) have been deleted, or mutated with 
alanines. It was found that these mutations or the deletion of the D-helix had a little 
effect on both O2 and CO binding, but a deep impact on hemin loss. However, in 
the light of the above cited ref. [62], human Mb reactivity seems to be somewhat 
different from that of other mammals and, moreover, that investigation was not 
performed at various pO2 levels but simply at ambient pressure. On the contrary, 
this might be particularly important, as highlighted in a very recent paper [80], 
where many different mutants of sperm-whale Mb have been compared in terms of 
their O2 storage and O2 transport activity, separately. Important differences 
emerged only at a very low pO2, and some organism-specific differences were also 
remarked, comparing the sperm-whale to the human Mb [80]. In addition, in a 
recent experimental work of some of the authors [81], the two more expressed 
human Mb isoforms have been investigated through NMR spectroscopy. Both 
resulted to be stable in solution and non hemin loss has been observed, together 
with no significant structural differences in the heme region [81]. 
 
 
 
 
 
Figure 6: A) Five different Mb isoform are expressed in humans differing for only 
one external amino acid (in yellow the differences). Taking Mb-II as a reference: 
E54K (Mb-I), K133N (Mb-III), R139Q (Mb-IV) and R139W (Mb-V) mutants, whose 
specific functions, if any, are completely unknown. B) The E54K mutation site, the 
D helix and CD loop are shown. The two most expressed isoform differ only for the 
residue 54, playing a great effect on the surface charge. They are stable in solution 
showing no dramatic differences in their cavity structure. 
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As a matter of fact, such a single external point-mutation causes a significant shift 
of the isoelectric point, but possible allosteric effects on the internal cavities have 
been excluded by NMR, [81] thus addressing further investigations focused on the 
protein surface and the mutation region, by adopting other suitable techniques. 
The computer simulations represented one method that provide an atomic-level 
description about proteins’ thermal motions that may be difficult to obtain with 
experiments [82], together with fundamental information on protein-solvent 
interplay [83]. 
Besides, EPR technique has been widely used for both structural and functional 
studies on different metallo-proteins, mainly Hemoglobin and Myoglobin, and, in 
particular, to identify and characterize the symmetry of the electronic cloud around 
radical species. In addition to the determination of the heme orientation relative to 
the crystallographic axis in the two cases, detailed information about the symmetry 
of the electric field surrounding the heme-iron, as well as conformational changes 
upon ligand binding, were attained [84]. EPR technique was considered particularly 
suitable to investigate NO binding to Mb. Indeed, nitrosyl-heme is characterized by 
an unpaired electron, such that, from the very beginning, NO was used as a spin-
labeled ligand for probing the electronic structure of the heme group and its 
environment, also in the light of the fact that the O2 - Hb/Mb complex is 
diamagnetic, thus EPR invisible [85]. NO binding to the metallo-heme protein’s 
center can be directly measured in vitro and in vivo. In fact, by virtue of differences 
in the line shape and position of the magnetic field (g values) of the EPR 
absorption, spectra are sensitive to conformational changes of the protein’s moiety, 
which, in turn, produce geometrical changes at the metal site. The binding of NO to 
these proteins gives rise to a unique EPR spectrum, with characteristic symmetry 
and hyperfine coupling [86]. 
 
 
1.2 Free radicals: how can we measure them? 
Since the discovery of oxygen in the early 18th century by Antoine Laurent 
Lavoisier, the necessity of controlling oxygen levels has been recognized. An 
elusive molecule, oxygen plays contradictory roles, one essential for life and the 
other as a toxic substance. Sure is that Oxygen is required by prokaryotic and 
eukaryotic cells for energy production, often via the electron transport chain in the 
mitochondria. In a pioneering paper in 1954, Rebeca Gerschman et al. (Figure 7) 
anticipated the toxic effects of elevated oxygen levels on aerobes to those of 
ionizing radiation, and proposed that oxygen toxicity is due to free radical formation 
[87]. 
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Figure 7: The May 7, 1954 Science paper which postulated that oxidizing free 
radicals were involved in oxygen toxicity (@1954, American Association for The 
Advancement of Science). 	  
From this time, the scientists published a series of articles on the role of ROS in 
the pathogenesis of aging [88]. In subsequent years, numerous investigations were 
conducted in which it was shown that ROS play a key role in senescence and 
some of the underlying mechanisms were elucidated. 
Because most radicals are short-lived species, they react quickly with other 
molecules. As already pointed out, the most vulnerable biological targets for 
oxidative damage are proteins, membrane lipids and DNA. Many approaches allow 
evaluation and demonstration of the participation of ROS in biochemical events. 
Indeed, the literature is replete with descriptions of different methodologies and 
approaches for these purposes. ROS are difficult to measure because they are 
produced in low quantities, have a very short half-life and are quite unstable due to 
their interaction with antioxidation enzymes and cellular components like thiol 
residues, molecular oxygen, and metalloproteins.  
Alternative approaches for the direct determination of ROS are developed. 
Techniques for quantification of oxidative damage markers are often called 
fingerprinting methods by which specific end products resulting from the interaction 
of the ROS with biological macromolecules, such as DNA, proteins, lipid [24], and 
low molecular weight antioxidant are measured. The appearance of these end 
products serves as proof of the prior existence of ROS that left their footprints in 
the cell. Some techniques are available today to measure reactive species and 
oxidative damage in biological samples (blood, cellular culture, biological fluid). 
Depending on the type of samples, some methods are preferred over others. The 
currently available methods include assays based on oxidation of chromophores, 
chemiluminescence techniques, Mass Spectrometry (MALDI, MS/MS), 
fluorescence-based assays, immunological assay, enzymatic assays, High 
Performance Liquid Chromatography (HPLC), flow cytometry, and Electron 
R. Gerschman: A personal remembrance 
Reprinted from SOmNCEj May 7, 1954, Vol. 119, No. 3097, pages 623-626. 
Oxygen Poisoning and X-irradiation: 
A Mechanism in Common 
Rebeca Gerschman, Daniel L. Gilbert, Sylvanus W. Nye, Peter Dwyer, 
and Wallace O. Penn 2 
Department o] Physiology and Vital Economics, 
The University o] Rochester School of Medicine and Dentistry, gocheaer, New York 
CONSIDERATION of varioua isolated re- 
ports in the literature has led us to the hy- 
pothesis that oxygen poisoning and radia- 
tion injury have at least one common basis 
of action, possibly through the formation of oxidizing 
free radicals. 
Fig. 2. The May 7, 1954 Science paper which postulated that oxidizing free radicals were involved in oxygen toxicity (@ 1954, 
American Association for The Advancement of Science). Reprinted with permission. 
systems available at that time. The developments of 
recent years have provided a firm foundation for a 
reasonable discussion of the basis of oxygen toxicity." 
It was not until 1969, when McCord and Fridovich ~5 
pointed out the function of superoxide dismutase, that 
the free radical theory of oxygen toxicity began to 
be taken seriously. Without antioxidant mechanisms, 
aerobic life could not exist. In fact, Rebeca mentioned 
that free radicals could be involved in the aging process 
in 1959; 16 however, she never did experiments in this 
field. Harman 17 in 1956, independently, proposed and 
provided experimental evi ence that fre  radicals could 
be involved in this process. I remember that Rebeca 
heard a seminar about a disease which produced blind- 
ness in premature infants. She said that it could come 
from an excess of  oxyg n in the incubators] 8 Arnall 
Patz et al.19 in the USA and Norman Ashton et al. z° 
in England came to the same definitive conclusion, but 
from a different approach. Today, this disease is known 
as ret inopathy o f  prematur i ty ,  21 but at that time, the 
disease was called retrolental  f ibroplasia .  
On a personal basis, Rebeca was very generous and 
was a source of inspiration to me. I remember when 
she had both of us invited to Otto Loewi's residence 
in New York City; Rebeca knew Loewi, a Nobel Prize 
winner, and realized that this event would be a memo- 
rable one for me, a graduate student. He had me read 
some scientific papers and then the three of us dis- 
cussed their significance. 22 Rebeca also invited me to 
have dinner with her teacher, Bernardo Houssay, who 
was also a Nobel Prize winner. 
Rebeca had a dynamic personality. Anyone who 
met her even once never forgot her. She had charisma 
and charm and was full of life. Today, there still exist 
some prejudices against professional women; at the 
height of her scientific career, th se obstacles were 
much more pronounced. She had perseverance and sci- 
entific vision, and she rose above these barriers. 
The last time we collaborated was during the sum- 
mer of 1963-1964 in Montemar, Chile, where we were 
trying to see if there were any effects of pro-oxidants 
on nerve conduction in the squid giant axon. The last 
time I saw her was in 1980, when we discussed her 
chapter on the developme t of the free radical theory. 23 
Rebeca Gerschman accomplished a great deal scien- 
tifically, due in great part to her remarkable intuition. 
However, she never received the recognition in her 
lifetime that she so richly deserved. She died in Buenos 
Aires, Argentina, 10 years ago on April 4, 1986. 
REFERENCES 
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Paramagnetic Resonance spectroscopy (EPR) each with their own benefits and 
limits. Also, there are news questionable spectrophotometric methods, including: d-
ROM (Reactive Oxygen Metabolites) test and its variant the FORT (Free Oxygen 
Radical Test) [89]. The manufacturer claims that these tests can quantify the 
oxidative status by measuring the hydroperoxides of organic compounds. However 
the clinical interest or the relevance biological of these methods remains to be 
investigated and unclear [90]. 
Lastly, a fascinating technique such as L-band EPR with probe and Magnetic 
Resonance Imaging (MRI) spin trapping are under development to measure 
reactive species directly in whole animals, but no probes are currently suitable for 
human use [91,92]. 
Attributable to the methods used in the thesis, are presented below only two types 
of techniques: enzymatic methods and the EPR. 
 
 
1.2.1 Indirect Method 
The enzymatic assay methods are the indirect methods have been developed just 
to measure the ROS-induced damage, basing on the determination of specific end 
products resulting from the interaction of ROS just with these biological 
macromolecules [93,94]. The enzymatic assay methods adopted were 
measurement of damage products of proteins and lipids [95]. Evaluation of protein 
oxidative damage can be accomplished using the carbonyl assay the most 
commonly used marker is protein carbonyl (PC). Carbonyls are produced from the 
attack of ROS on amino-acid residues in proteins [96]. Redox cycling cations such 
as Fe2+ or Cu2+ can bind to cation binding locations on proteins and with the aid of 
further attack by H2O2 or O2 can transform side-chain amine groups on several 
amino acids (i.e., lysine, arginine, proline, or histidine) into carbonyls. 
All cellular membranes are especially vulnerable to oxidation due to their high 
concentrations of unsaturated fatty acid. The damage to lipids, usually called lipid 
peroxidation, occurs in 3 stages. The first stage, initiation, involves the attack of a 
reactive oxygen metabolite capable of abstracting a hydrogen atom from a 
methylene group in the lipid to form a conjugated diene. When oxygen is in 
sufficient concentration in the surroundings, the fatty acid radical will react with it to 
form ROO. during the propagation stage. These radicals themselves are capable of 
abstracting another hydrogen. The propagation stage allows the reaction to 
continue. A single initiation can lead to a chain reaction. The last stage, chain 
termination, occurs following interaction of one ROO. with another radical or 
antioxidants. In the last stage of the peroxidation process, peroxides are 
decomposed to aldehydes like malondialdehyde (MDA), which can be detected by 
thiobarbituric acid that gives a pink color easily measurable. The Thiobarbituric 
Acid Reactive Substances (TBARS) are considered to be a general indicator of 
oxidative stress rather than a specific marker of lipid peroxidation [97]. 
Since the primary substrate for lipid peroxidation is polyunsaturated fatty acids, it 
has been suggested that the amount of substrate available in the sample (i.e., 
levels of triglycerides) may be a major determinant of the amount of TBARS 
produced [97]. 
Indeed, as recently reviewed [98], wide literature data can be found, obtained by 
these methods in human blood (plasma, serum and red cell samples). In particular, 
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in plasma, oxidative damage was related to an increase of protein (e.g. albumin) 
oxidation as well as lipid (e.g. phospholipids, triacylglycerol’s, cholesterol) 
peroxidation. 
Carbonylation of protein often leads to a loss of protein function, which is 
considered a widespread marker of severe oxidative stress, damage and disease 
derived protein dysfunction in various pathophysiologies. Accumulation of protein 
carbonyls has been observed in Alzheimer’s disease, diabetes, inflammatory 
bowel disease, and arthritis [96]. 
Also, increased level of lipid peroxidation products were found in plasma of 
patients with gynecological malignancies, respiratory distress syndrome, breast 
cancer, squamous cell carcinoma, colon cancer and various types of leukemia [99]. 
The methodological description of the enzymatic assay is presented in chapter 2:  
Materials and Methods paragraph 2.5.  
 
 
1.2.2 Direct Method 
However enzymatic assays can be considered ‘a posteriori’ methods with respect 
to Electron Paramagnetic Resonance (EPR), the technique able to provide direct 
detection of the ‘instantaneous’ presence of free radical species in the sample 
[100]. Nevertheless ROS half life (superoxide [O2·-] t1/2 (s): 10-4; Nitric oxide [NO·]: 
0,4s at ambient temperature), is too short if compared to the EPR time scale so 
they are EPR-invisible: only when ‘trapped’ and transformed in a more stable 
radical species they become EPR detectable [101,102]. 
Moreover, in EPR spectra, signal areas are proportional to the number of the 
excited electron spins, leading to absolute concentration levels, when adopting a 
stable radical compound as reference.  
Despite the great interest in measuring ROS in biology and medicine, EPR 
technique has not till now been widely used because of several technical and 
methodological problem.  
However, some works report about ROS identification in healthy subjects and in 
patients affected by various diseases (iron-deficient anemia; chronic gastritis, 
duodenal and gastric ulcers, ischemic heart and hypertension) [101].  
Recently, Spasojevic I. [103] has described the ten most important features of the 
ROS experiments with EPR. That including the detect nanomolar concentrations of 
paramagnetic species, use of spin-probe, trap or label, few minutes for the 
acquisition, small samples (~100 µL), different type of sample fluid (e.g. plasma, 
cerebrospinal fluid, extracellular fluid, saliva, etc.), tissue samples, biopsy 
specimens, cell cultures, and solid samples (bones, tooth enamel); measured can 
be performed at changed temperature, atmosphere, or light regime. Moreover, the 
exact concentration is obtained from intensity/concentration calibration curve, 
which may be prepared by using synthetic paramagnetic compounds; also, the 
author emphasizes the importance of comparing the EPR data with biochemical 
methods, such as enzymatic assay methods, but also NMR, fluorometry, HPLC, 
and others. 
EPR technique is the prince of all the work done, and for this reason, it seems 
appropriate to devote a little 'space. 
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1.2.2.1 EPR History 
EPR was first detected in 1944 by Yevgeny Zavoisky at Kazan state university in 
the Soviet Union. The instrumentation required for EPR was greatly benefited by 
the development of radar during World War II, which required the use of reliable 
and tunable microwave sources. After the war, the necessary components for an 
EPR spectrometer were cheap and available. Initially, the field was advanced with 
the production of home-built EPR spectrometers. In the 1980s, commercially built 
EPR spectrometers became available. The German company Bruker leads the 
field in the production of commercially available EPR spectrometers, as well as 
NMR spectrometers and MRI detectors. Today, EPR spectroscopy is done at a 
wide range of frequencies and fields. In many ways, the physical properties that 
are the basis of EPR theory and methods are analogous to Nuclear Magnetic 
Resonance (NMR). The most obvious difference is the direct probing of electron 
spin properties in EPR as opposed to nuclear spin NMR. EPR is a spectroscopic 
technique, which detects species that have unpaired electrons. These include free 
radicals (FR) many transition metal ions, molecular structures. EPR is a non-
destructive technique and the samples are very sensitive to local environments. 
EPR spectroscopy theory is described in chapter 2: section 2.2. 	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AIM OF THE STUDY 
Aim of the research developed in the time course of the three years of my Doctoral 
course in Molecular Medicine was to shed light into the mechanisms involved in 
oxidative stress responses in man at both integrative and molecular levels. 
Present study was to gain insight into the dual role-played by ROS as A) signaling 
or otherwise B) scavenged specimens developing a quantitative EPR method for 
their absolute ROS concentration assessment.  
A) Signaling molecules were studied in human’s blood. A mini-invasive 
procedure was developed and its reliability tested. 
The method was then applied to environments where: 
i) an increase (exercise, hypoxia) 
ii) a decrease (training, antioxidant supplementation) 
iii) an unbalance (pathologies) 
of ROS level was accepted 
For this reason several groups of selected subjects were selected. Point by point 
will be described the subjects’ characteristics.  
B) Molecules to be scavenged, in particular nitric oxide (NO), were studied in 
vitro. The role played by Myoglobin and in particular by Human Mb isoforms as NO 
scavenger was investigated.  
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2 MATERIAL AND METHODS 
2.1 Metabolic measurements 
2.1.1 Anthropometric  
On all occasions upon arrival at the laboratory, subject body (kg) and height (cm) 
were measured by mean of a balance and a stadiometer respectively.  
The body surface area (BSA) was calculated without direct measurement. We 
have used a Du Bois formula: 
 
BSA = ((0,007184 * ((H0,725 * W0,445))                  (3)
             
where BSA is in m2, W is weight in kg, and H is height in cm. BSA is a better 
indicator of metabolic mass than body weight because it is less affected by 
abnormal adipose mass. 
 
 
2.1.2 Oxygen Saturation (SaO2) 
Arterial hemoglobin oxygen saturation (SaO2) was measured using finger pulse 
Oximetry - Ohmeda TuffSat (GE Healthcare, Helsinki, Finland) or/and Biox 3740 
Pulse Oximeter Ohmeda, (Denver, CO, USA). Care was taken positioning the 
sensor on the end of an index finger. The light emitter portion was placed on the 
fingernail side and the detector on the site opposite to the nail. The pulse oximeter 
shines red and infrared light through the tissue and detects the fluctuating signals 
caused by arterial blood pulses. The accuracy of this measurement has been 
estimated at ± 2%.  
 
 
2.1.3 Gas exchange (VO2 and VCO2) 
VO2max measure the maximum capacity of an individual's body to transport and 
use oxygen during incremental exercise, which reflects the physical fitness of the 
individual. This is reached when oxygen consumption remains at steady state 
despite an increase in workload. VO2 max is expressed either as an absolute rate 
in liters of oxygen per minute (l/min) or as a relative rate in milliliters of oxygen per 
kilogram of bodyweight per minute (ml/kg/min). The subjects performed a grated 
exercise test with increasing oxygen consumption (VO2max) with variation uphill 
and of velocity.  
O2 uptake (VO2) and CO2 output (VCO2), both expressed in STPD (Standard 
Temperature (= 0°C), Pressure (=760mmHg), Dry (=0%) were determined breath 
by breath using a computerized metabolic cart Vmax 29c (SensorMedics, 
Bilthoven, Netherlands). Expiratory flow measurements were performed using 
mass flow sensor, calibrated before each experiment with 3-liter syringe at three 
different flow rates. VO2 and VCO2 were determined by continuously monitoring 
PO2 and PCO2 at the mouth throughout the respiratory cycle and from established 
mass balance equations, after alignment of the expiratory volume and expiratory 
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gases tracing and analog-to-digital conversion.  
Calibration di O2 and CO2 analyzer was performed before each experiment by 
using gas mixtures of known composition. Digital data were transmitted to a 
personal computer and stored on disk. Gas exchange ratio was calculated as 
VCO2/VO2. Gas Exchange Threshold (GET) was determined using Standard 
methods [105]. 
 
 
2.1.4 Near Infra-Red Spectroscopy (NIRS) 
In some experiments, the oxygenation changes in the vastus lateralis muscle were 
evaluated by Near Infra-Red Spectroscopy (NIRS). A portable near infrared single-
distance, continuous-wave photometer (HEO-100, Omron, Japan), which adopts 
an algorithm based on diffusion theory, was utilized. Briefly, the instrument 
provides separate measurements of changes in deoxygenated Hemoglobin (Hb) 
and Myoglobin (Mb) concentrations:  
 
{∆[deoxy(Hb+Mb)]}                    (4) 
 
expressed in arbitrary units [105]. ∆[deoxy(Hb+Mb)], with respect to an initial value 
arbitrarily set equal to zero, were calculated and expressed in arbitrary units. 
∆[deoxy(Hb+Mb)] is the result of the balance between VO2 and O2 delivery in the 
portion of tissue investigated by the NIRS probe and, therefore, is conceptually 
similar to fractional O2 extraction [106,107]. A “physiological calibration” of the 
∆[deoxy(Hb+Mb)] values was performed: data obtained during the exercise 
protocol were expressed as a ratio of the values determined by obtaining a 
maximal deoxygenation of muscle after the exercise period, by pressure cuff 
inflation (at 300–350 mmHg) at the root of the thigh (subjects in the sitting position 
on the cyclo-ergometer) for a few minutes until ∆[deoxy(Hb+Mb)] increase reached 
a plateau. NIRS measurements in muscle tissue [108] have been shown to be well 
correlated with local venous O2 saturation. Average values of ∆[deoxy(Hb+Mb)] 
were calculated during the last 10s of each workload. The resulting 
∆[deoxy(Hb+Mb)] data were expressed as a function of work rate and were fitted 
by a sigmoid function of the type: 
 
 
f(x) = f0 + A/[1+e-(-c+dx)]                    (5) 
 
 
When t0 represents the baseline, A the amplitude and c is a constant dependent 
on d, the slope of the sigmoid.  In this function c/d gives x values corresponding to 
(f0+A)/2, which is the work rate corresponding to half-amplitude. 
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2.2 The theory of EPR spectroscopy 
The basic concepts of EPR are analogous to those of NMR, but it’s electron spins 
that are excited instead of the spin of atom nuclei. Because most stable molecules 
have all their electrons paired, the EPR technique is less widely used than NMR.  
The phenomenon of EPR (see Figure 8) is based on an intrinsic magnetic moment 
of the electron that arises from its spin. In most system, electrons occur in pairs, 
such that the net magnetic moment is zero. However, if an unpaired electron is 
present, its magnetic moment can suitably interact with a magnetic field. This effect 
is called the Zeeman effect.  
Because the electron has a magnetic moment, it acts a compass or a bar magnet 
when it’s placed in a magnetic field. Since energies are quantized, a single 
unpaired electron has only two allowed energy states. It has a state of lower 
energy when the moment of electron, µ, is aligned with the magnetic field and a 
higher energy state when µ is aligned against the magnetic field.  
The two states are designated by the projection of the electron spin, ms, on the 
direction of the magnetic field. Because the electron is a spin 1/2 particle, the 
parallel state has ms=-1/2 and the antiparallel state has ms=+1/2. The difference 
between the energies of these two states, caused by the interaction between the 
electron spin and the magnetic field is shown in equation 6.  
 
 
ΔE = gµBB0Δms = gµBB0                                                      (6) 
 
 
When g is g-factor, µB is the Bohr magneton, which is the natural unit of the 
electron’s magnetic moment, and the change in spin state is Δms = 1. The energy, 
ΔE=hν, that is required to cause a transition between the two spin states is given 
by  
 
 
ΔE = hν = gµBB0    and    µB = ge β 2                                                              
(7) 
 
 
Absorption of energy occurs when the magnetic field “tunes” the two spin states 
such that the energy difference matches the energy of the applied radiation. This 
field is called the “field for resonance”. Because of difficulties in scanning 
microwave frequencies and because of the use of a resonant cavity for signal 
detection, most EPR spectrometers operate at constant microwave frequency and 
scan the magnetic field. The field for resonance is not a unique “fingerprint” for 
identification of a compound because spectra can be acquired at different 
microwave frequencies. The g-factor 
 
                                    
g = hν /µBB0                                                                                                      (8) 
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Figure 8: Schematic description of the basic principles of EPR spectroscopy. A) 
Electron out and in the magnetic field. B) The scheme of the EPR spectrometer (S: 
the source of the oscillating magnetic filed; M: magnets generating static magnetic 
field; s: sample; D: detector; A: absorption line). C) The energy-level scheme of 
unpaired electron showing EPR absorption and corresponding spectrum with one 
line. D) The energy-level scheme of unpaired electron coupled with a nucleus with 
I=1/2, showing two resonant transitions and corresponding spectrum with two lines. 
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paramagnetic species naturally present in biological 
samples can be detected straightforwardly by the means 
of EPR spectroscopy. (B) Short-lived species must !rst be 
“trapped”. Speci!c EPR “silent” compounds—spin-traps 
are added into the sample. "ey react with short-lived 
radicals to form stable EPR active spin-adducts. At this 
point, I would like to explain the ways in which radicals 
may be indicated. Radical notation and nomenclature 
is not strictly regulated e.g., hydroxyl radical may be 
written as OH?, OH?or ?OH. However, the indication of 
a radical by a superscripted dot at the right side of the 
formula is more accepted (e.g., OH?) 33,34. In some special 
cases, a superscripted dot is used at the left side of the 
formula to assign unpaired electron to the speci!c atom 
(e.g., ?CH3), but otherwise staying with a more general 
notation is recommended. (iii) Finally, the investiga-
tions of some speci!c properties, such as membrane #u-
idity, partial oxygen pressure (pO2), or free thiol groups 
(R-SH), requires for synthetic stable paramagnetic 
species (spin-probes or spin-labels) to be applied. "e 
di$erence between spin-probes and spin-labels is that 
the latter bind to speci!c targets (biomolecules), while 
former are not covalently bound.
"e detection of paramagnetic species of interest here 
shares some technical details, which are brie#y outlined. 
"e resonance occurs at a magnetic !eld of about 300 mT, 
if the frequency is 9–10 GHz (X-band EPR). "ese frequen-
cies are in the microwave region, which does not a$ect in 
vitro or ex vivo measurements. However, for in vivo stud-
ies, lower frequencies and magnetic !elds (1–2 GHz and 
~40 mT; L-band EPR) have to be used. "is is due to the 
requirements of adequate penetration of radiation and 
to avoid non-resonant absorption (heating) in aqueous 
biological samples35. It should be stressed that it is com-
mon for EPR scientists to use a smaller unit of magnetic 
!eld (Gauss [G]) instead of SI unit Tesla [T] (1 T = 104 G; 
1 mT = 10 G). "ere are two types of EPR spectrometers: 
CW (continuous wave) and FT (Fourier transform). In 
the former, more common type of spectrometers, reso-
nant conditions are achieved by changing the magnetic 
!eld at a !xed frequency of radiant energy. "e prin-
ciples of FT-EPR are similar to those of nuclear magnetic 
resonance (NMR). "e spin ensemble placed in a !xed 
magnetic !eld is perturbed by a pulse of radiation at or 
close to resonant frequency. "e detector does not iden-
tify absorption lines, but free induction decay (FID) of 
excited electrons. FID is then deconvoluted to EPR spec-
trum by Fourier’s transformation. FT-EPR enables faster 
spectra acquisition, time-resolved spectroscopy, studies 
of molecular motion, and improved imaging29. However, 
it requires specialized and expensive equipment.
"e introduction of EPR spectroscopy in a labora-
tory comes at a capital cost; the sum of which may vary, 
depending on the applications needed. A top scienti!c 
CW X-Band EPR spectrometer costs ~400,000 USD and 
enables in vitro and ex vivo detection of various para-
magnetic species in biochemical systems and biological 
samples, with supreme sensitivity (nanomolar range). 
However, X-Band EPR spectrometer equipped with soft-
ware for automatic data acquisition and analysis, which 
is applicable in routine measurements, may be obtained 
at much lower price of ~70,000 USD. Importantly, the 
costs of maintenance are low. "e period of exploitation 
Figure 2. Schematic description of the basic principles of EPR 
spectroscopy. Panel A: Electrons out and in the magnetic !eld; 
Panel B: "e scheme of EPR spectrometer (S, the source of 
oscillating magnetic !eld; M, magnets generating static magnetic 
!eld; s, sample; D, detector; A, absorption line); Panel C: "e 
energy-level scheme of unpaired electron showing EPR absorption 
and corresponding spectrum with one line; Panel D: "e energy-
level scheme of unpaired electron coupled with a nucleus with 
I = 1/2, showing two resonant transitions and corresponding 
spectrum with two lines.
Figure 3. Schematic description of EPR techniques in redox 
research. Panel A: EPR spectroscopy of intrinsic long-lived 
radicals (LLR?); Panel B: EPR spin-trapping of short-lived radicals 
(SLR?). ST, spin-trap; SA, spin-adduct; Panel C: EPR spin-probing 
and EPR spin-labeling. SP, spin-probes; SL, spin-labels. Dark, 
EPR active; Pale, EPR “silent”. "e circle represents a biological 
system.
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is independent of a microwave frequency, so the g-factor is a better way to 
characterize signals. Those high values of g occur at low magnetic fields and vice 
versa. The g-factor helps to distinguish and identify types of sample. 
Additional information about the species that contains the unpaired electron can be 
obtained from nuclear hyperfine interactions. The nuclei of the atoms in a molecule 
or complex often have magnetic moments, which produce a local magnetic field at 
the electron. The interaction between the electron and the nuclei is called the 
hyperfine interaction. It gives a wealth of information about the sample such as the 
identity and number of atoms that make up a molecule or complex: as well as the 
electron spin density at nuclei that have magnetic moments.  
The magnetic moments of the nucleus acts like a bar magnet and produces a 
magnetic field at the electron, bi. In a general case of interaction with the nucleus 
spin i=1/2 the number of hyperfine components is defined by the following formula:  
 2nI + 1	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (9)	  	  
2.2.1 EPR Instrument 
EPR spectroscopy can be carried out by either 1) varying the magnetic field and 
holding the frequency constant or 2) varying the frequency and holding the 
magnetic field constant (as is the case for NMR spectroscopy).  
frequency constant, opposite of NMR spectrometers. The majority of EPR 
spectrometers are in the range of 8-10 GHz (X-band), though there are 
spectrometers which work at lower and higher fields: 1-2 GHz (L-band) and 2-4 
GHz (S-band), 35 GHz (Q-band) and 95 GHz (W-band). 
EPR spectrometers work by generating microwaves from a source (typically a 
klystron), sending them through an attenuator, and passing them on to the sample, 
which is located in a microwave cavity (Figure 9). Microwaves reflected back from 
the cavity are routed to the detector diode, and the signal comes out as a decrease 
in current at the detector analogous to absorption of microwaves by the sample. 
Now I will explain the proprieties of microwave (EPR) cavities and how changes in 
these proprieties due to absorption result in an EPR signal. Resonators are used to 
amplify weak signals from the sample. There is no loss of generality if descriptions 
are based on a microwave cavity, which is simply a metal box with a rectangular or 
cylindrical shape that resonates with microwaves much as an organ pipe resonates 
with sound waves. Resonance means that the cavity stores the microwave energy. 
Cavities are characterized by their Q or quality factor, which indicates how 
efficiently the cavities stores microwave energy. As Q increases, the sensitivity of 
the spectrometer increases. 
The Q factor is defined as: 
 𝑸 = 𝟐𝝅  (𝒆𝒏𝒆𝒓𝒈𝒚  𝒔𝒕𝒐𝒓𝒆𝒅)𝒆𝒏𝒆𝒓𝒈𝒚  𝒅𝒊𝒔𝒔𝒊𝒑𝒂𝒕𝒆𝒅  𝒑𝒆𝒓  𝒄𝒚𝒄𝒍𝒆                                                                                    (10) 
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where the energy dissipated per cycle is the amount of energy lost during one 
microwave period. Energy can be lost to the side walls of the cavity because the 
microwave generate electrical currents in the side walls of the cavity which in turn 
generates heat. Q factor can be measured easily because there is another way of 
expressing Q:  
 𝑸 = 𝝂𝒓𝒆𝒔∆𝝂                                (11) 
 
where νres is the resonant frequency of the cavity and Δν is the width at half height 
of the resonance. 
 
Microwaves are coupled into the cavity via a hole called an iris. The size of the iris 
controls how much of the microwave power is reflected back from the cavity and 
how much enters the cavity. The iris accomplishes this by carefully matching or 
transforming the impedance (the resistance to the waves) of the cavity and the 
waveguide. An iris screw in front of the iris lets the user adjust the “matching”. 
When the impedances are matched, the resonator is said to be “critically coupled”. 
 
 
 
 
 
Figure 9: Microwave cavities. 
 
 
 6 
A very alike (similar) pattern is observed when one unpaired electron interacts with several 
equivalent (with similar constant of superfine interaction) nuclei with a magnetic moment differing 
from zero, for example, with two protons. Three states corresponding to the orientation of proton 
spins arise in this case: (a) both along field, (b) both against field, and (c) one along field, and the 
other against field. The third variant (c) is twice more probable than variants (a) and (b) since it can 
be performed by two ways. As the result of such a distribution of unpaired electrons, single line will 
split into three lines with an intensities ratio of 1:2:1. In general case, the number of lines is 
2nMN+1 for the number (n) of equivalent nuclei with the spin MN. 
Scheme of an EPR radiospectrometer 
The source of radiation in radiospectrometer is a klystron which represents a radiolamp 
giving monochrome radiation (with) in the cm-wave band. 
Ventil
Attenuator
Microwave
source (clistron)
Amplifier Recorder
Microwave
resonator
Detector
Sample
Double
T bridge
Field modulating coil
Magnet Magnet
 
The cuvette in radiospectrometer 
containing the sample is in a special unit called 
resonator. Its shape and parameters are such that 
standing wave is formed in it. Radiation, having 
passed the sample in the radiospectrometer and 
spectrophotometer, gets onto the detector, the 
detector signal then being amplified and 
recorded on a recorder or computer. The 
radioband radiation is transmitted from the 
source to the sample and then to the detector 
with the use of special rectangle section tubes 
that are called waveguides. 
 
The dim nsions of waveguide sections are determined by transmitting radiation wave-
length. Constant radiation frequency is used in radiospectrometer for EPR spectrum recording, and 
the condition of resonance is achieved by changing the magnitude of magnetic field. 
Amplification of the signal by way of its modulation by high-frequency variable field is one 
more important feature of radiospectrometer. As the result of modulation of the signal, its 
differentiation occurs, and absorption line transforms to its first derivative which is the signal of 
EPR. 
Application of EPR in medical biological investigations 
Natural EPR signals observed in biological systems 
Application of the EPR method in biological investigations is associated with studies on 
paramagnetic centers of two basic types ó free radicals and transit valency metal ions. 
Investigation of free radicals in biological systems is associated with a difficulty that lies in a low 
concentration of free radicals that are formed in the process of cell life-time. Radical concentration 
in normally metabolizing cells is, according to different sources, about 10ó8 to 10-10 M, while 
modern radiospectrometers allow to measure radical concentrations of 10-6 to 10-
7 M. Concentration of free radicals can be increased by inhibition of their death and increase of 
their formation rate. This can be done by way of irradiation (UV- or ionizing radiation) of 
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2.2.2 The Signal Channel 
All individual components of the EPR spectrometer work together to produce a 
spectrum (see below Figure 10).  
 
 
 
 
Figure 10: Block diagram for an EPR spectrometer. 
 
 
EPR spectroscopy uses a technique known as phase sensitive detection to 
enhance the sensitivity of the spectrometer. The signal channel contains the 
required electronics for the phase sensitive detection. The magnetic field strength, 
which the sample sees, is modulated sinusoidally at the modulation frequency. The 
modulation frequency should be less than the line width, since it causes side 
bands at a distance of the modulation frequency.  
With that we get the complete time dependency of the magnetic field:  
 
 𝑩 = 𝑩𝒊𝒏𝒊𝒕𝒊𝒂𝒍 + 𝒄𝒐𝒏𝒔𝒕  . 𝒕 + 𝑩𝒎𝒐𝒅𝒖𝒍𝒂𝒕𝒊𝒐𝒏  . 𝒔𝒊𝒏(𝟐𝝅𝝂𝒎𝒐𝒅𝒖𝒍𝒂𝒕𝒊𝒐𝒏. 𝒕)              (12) 
 
Basic EPR Practice
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voltage drops to zero and the field is “stable” or “locked”. This
occurs at each discrete step of a magnetic field scan.
The Spectrum 2.2.6
We have seen how the individual components of the spectrome-
ter work. Figure 2-19 shows how they work together to produce
a spectrum.
Figure 2-19 Block diagram of an EPR spectrometer.
Magnet
Bridge
Cavity
and
Sample
Signal
Channel
Field
Controller
Spectrum
Y-axis (Intensity)
X-axis (B0)
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If there is an EPR signal, the field modulation quickly sweeps through part of the 
signal and the microwaves reflected from the cavity are amplitude modulated at the 
same frequency.  
For an EPR signal that is approximately linear over an interval as wide as the 
modulation amplitude, the EPR signal is transformed into a sine wave with 
amplitude proportional to the slope of the signal (Figure 11-12). The signal 
channel produces a DC signal proportional to the amplitude of the modulated EPR 
signal. Any signals (such as noise and electrical interference) that do not fulfill 
these requirements are suppressed. To further improve the sensitivity, a time 
constant is used to filter out more of the noise.  
 
 
 
 
 
Figure 11: Field modulation and phase sensitive detection. 	  
Phase sensitive detection with magnetic field modulation can increase the 
sensitivity by several orders of magnitude; however, the user must be careful in 
choosing the appropriate modulation amplitude, frequency and time constant. At 
low modulation amplitudes, as the amplitude of the magnetic field modulation is 
increased, the height of the detected EPR signals increased. If the modulation 
amplitude is too large, the detected EPR signal broadens and becomes distorted 
(Figure 13A). To get the most accurate information about signal line-shape, the 
modulation amplitude should be less than 10% of the distance (in Gauss) between 
the positive and negative peaks in the derivate spectrum. Higher modulation 
amplitudes cause broadening of the signal, the integrated intensity of the signal 
continues to increase linearly with modulation amplitude so if the goal of the 
experiment is primarily spin quantitation, higher modulation amplitude may be used 
to further improve signal-to-noise. Time constants selected by the operator will 
affect the noise in the spectrum. Increased time constant filter out noise by slowing 
down the response time of the detection circuit. As the time constant is increased, 
the noise level decreased. If a time constant is selected that is too long for the rate 
at which the magnetic field is scanned, the signal may be distorted or even missed. 
Figure 13B shows the distortion and disappearance of a signal as the time 
constant is increased. Figure 13C shows an example with very narrow or closely 
spaced EPR signals (~50 mG), the signal is broadened if the modulation frequency 
is too high. The 100 KHz modulation frequency corresponds to 35 mG sidebands 
on the EPR signal. 
Basic EPR Practice
2-18
changes because the absorbing sample changes the impedance of
the cavity. The cavity is therefore no longer critically coupled
and microwave will be reflected back to the bridge, resulting in
an EPR signal.
The Signal Channel 2.2.4
EPR spectroscopists use a technique known as phase sensitive
detection to enhance the sensitivity of the spectrometer. The
advantages include less noise from the detection diode and the
elimination of baseline instabilities due to the drift in DC elec-
tronics. A further advantage is that it encodes the EPR signals to
make it distinguishable from sources of noise or interference
which are almost always present in a laboratory. The signal
channel, a unit which fits in the spectrometer console, contains
the required electronics for the phase sensitive detection.
The detection scheme works as follows. The magnetic field
strength which the sample sees is modulated (varied) sinusoi-
dally at the modulation frequency. If there is an EPR signal, the
field odulation quickly weeps through part of he sig al and
the microwaves reflected from the cavity are amplitude modu-
lated at the same frequency. For an EPR signal which is approxi-
mately linear over an interval as wide as the modulation
amplitude, th  EPR signal is tran formed into a sine wave with
an amplitude proportional to the slope of the signal (See
Figure 2-14.)
Figure 2-14 Field modulation and phase sensitive detec-
tion.
First Derivative
	   27	  
 
 
 
Figure 12: Differential scanning and phase sensitive detection. Show how the 
Gaussian line defined as (𝑩) = 𝒆𝒙𝒑 −𝑩 − 𝜶)/𝜷  is differentially scanned. The 
lower left of figure shows the time dependency of the magnetic field from equation 
12. The field B0 scans the absorption signal like a characteristic curve. The dotted 
lines indicate the	  passage of half a modulation period in the time domain. The 
steeper the slope (first derivative) of the absorption signal, the larger is the energy 
difference between two peeks of the modulation field. At the maximum of the 
absorption curve, this difference is zero. During passage through the maximum, 
the phase of the oscillating signal drawn lightly in the right part of figure with the 
frequency νmodulation	  jumps by 180°C. The oscillating signal is applied to the input of 
the phase sensitive detector (look in amplifier), and the phase sensitive detected 
signal is shown as a thick stretched-out line on the right side of figure. 
 
 
 
Chapter 5, page 11 
Continuous wave -EPR uses differential scanning (like broad-band cw-NMR, which is rarely 
seen today). The magnet power supply contains a setup to sweep a certain field range, so that 
a linearly time-varied external magnetic field B0 = Binitial + const. t results. The external field 
is overlaid with an extra magnetic field with a frequency of, for example, 100 kHz, created by 
a pair of coils located between the pole shoes and the resonator. The amplitude of this extra 
field, BModulation, should be as large as possible for good signal-to-noise ratio, but smaller than 
the line width of the EPR signal to prevent false signals. The modulation frequency should 
also be less than the line width, since it causes side bands at a distance of the modulation 
frequency. 
 
With that we get the complete time dependency of the external magnetic field: 
 
 B0 = Binitial + const.· t + Bmodulation· sin (2SQModulation·t). (5.19) 
 
 
Fig. 5.8 Differential scanning and 
phase sensitive detection. 
 
 
Figure 5.8 shows how a 
Gaussian line defined as 
f(B) = exp {(B  D)/E} is 
differentially scanned. The 
lower left of Fig. 5.8 shows 
the time dependency of the 
magnetic field from 
equ.(5.19). The field B0 scans 
the absorption signal like a 
characteristic curve. The 
dotted lines indicate the 
passage of half a modulation period in the time domain. The steeper the slope (first 
derivative) of the absorption signal, the larger is the energy difference between two peeks of 
the modulation field. At the maximum of the absorption curve, this difference is zero. During 
passage thr ugh the aximum, the phase of the oscillating signal drawn lightly in the right 
part of Fig. 5.8 with the frequency Qmodulation jumps by 180°. The oscillating signal is applied 
to the input of th  phase sensitive detector (look in amplifier), and the phase sensitive detected 
signal is shown as a thick stretched-out line on the right side of Fig. 5.8. 
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To explain the phase sensitive detection, we again refer to Fig. 5.7. The 100 kHz signal 
coming from the detector is passed through a sm ll-band amplifier and fed into the phase 
sensitive detector. This has another input, to which the 100 kHz reference frequency of the 
generator is applied, the same generator which drives the modulation coils. There is also a 
phase shifter not shown which assures that the signal and reference frequencies have the same 
(or opposite) phase. The phase sensitive detector is a multiplier followed by a low pass filter. 
The multiplier multiplies the signal function to the reference function (pure sine wave) and 
integrates with the help of the low-pass filter over an adjustable time period of a few seconds. 
In a mathematical sense, the operation of a phase sensitive detection is equivalent to the 
convolution of functions. From trigonometric identities we know that the product of two sinus 
function leads to two terms which contain the difference and sum of the arguments of the 
functions. The sum is suppressed by the low-pass filter and the phase difference plays an 
important role in the difference. The phase sensitive rectifier therefore creates the thick line 
from the thin one in Fig. 5.8. This curve corresponds exactly to the derivative of the 
absorption curve on the left side, if the modulation amplitude and time constant were 
sufficiently small to prevent signal falsification. 
Spectroscopy   D. Freude Chapter "EPR", version June 2006 
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Figure 13: A) Signal distortions due to excessive field modulation; B) Signal 
distortion and shift due to excessive time constant; C) Loss of resolution due to 
high modulation frequency. 
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2.3 Subjects  	  
ROS production rate (at rest and after exercise/training) was assessed in different 
healthy subjects’ categories:  
• Healthy sedentaries (one hundred; age 45 ± 7; 50 male and 50 females) 
• Healthy sedentary woman (10 females; mean age 48.80 ± 5.32; height 164 
± 3 cm; body mass 56.81 ± 10.35 Kg)  
• Healthy sedentaries (12 females and 10 males, age 66 ± 5.4) 
• Hockey players (18 males, age 19.70 ± 1.16; height 178 ± 4 cm; body 
mass 77.65 ± 6.97 Kg)  
• Swimmers (10 males, age 30 ± 5; height 1.82 ± 4,7; body mass 78.6 ± 
5Kg)  
• Triathletes (28 males, age 42 ± 7.8; height 174.6 ± 5 cm; body mass 70.7 
± 7.2 Kg, years of training 5 ± 1.5). The mean time race was 6.14’.43” in 
short (ShC) and 12.48’.21” in long (Ironman) 
 
Hypoxia effects were tested in thirty-six subjects at different heights on sea level: 
• 4100 m: n=4, (2 males and 2 females, age 23 ± 1.25; height 175 ± 5 cm; 
body mass 75.55 ± 4.95 kg) 
• 3480 m: n= 14, (5 males and 9 females, age 33.30 ± 7.6, height 168 ± 7 
cm; body mass 58.5 ± 12.6 Kg) 
• 1860 m: n= 18 males (age 19.70 ± 1.16, height 178 ± 4 cm; body mass 
77.65 ± 6.97 Kg) 
 
Unbalance ROS production were assessed in patients affected by degenerative 
diseases: 
 
• type II Diabetic Neuropathies  (4 males and 4 females, age 64.5 ± 2.6) 
• Mild Cognitive Impairment (MCI) (17 males and 19 females, age 73 ± 4.2) 
• Sporadic Amyotrophic Lateral Sclerosis (ALS) (16 males and 6 females, 
age 60.7 ± 12) 
 
 
 
A written informed consent was signed by all participants after being informed of all 
risks, discomforts and benefits involved in the study. Procedures were in 
accordance with the Declaration of Helsinki, and institutional review board approval 
was received for this study. 
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2.3.1 Increase ROS production 
 
2.3.1.1 Physical Exercise 
In laboratory (IBFM – CNR Laboratory of Milan), the exercise effects on ROS 
production were tested in: I) hockey players and II) swimmers.  During the physical 
effort electrocardiogram (ECG) was registered to detect possible cardiac 
pathologies. In section 2.1.3 description of gas exchange.  
 
I) Varese hockey team were recruited to participate in the study. The subjects 
visited the laboratory two times. On the first day, blood collection and 
anthropometric measures were collected and an incremental test on treadmill (1% 
of grade) up to voluntary exhaustion to assess gas exchange threshold (GET) and 
peak O2 uptake (VO2 peak) was also performed. After six minutes of warm up 
exercise (according to the subject’s estimated level of physical fitness), the speed 
was increased 1 km . h-1 every minute. On the second visit, at least seven days 
after, the subjects performed a 10 minutes constant-load submaximal exercise 
(CLE) at heavy-intensity and speed corresponding to a VO2 equal to ~50% of the 
difference between GET and VO2 peak. The experimental protocol is shown in 
Figure 14. Voluntary exhaustion was defined as the inability to maintain the 
running frequency, despite vigorous encouragement by the operators, as well as 
by maximal levels of self-perceived exertion using the validated Borg scale (Table 
2) [109]. EPR data were compared with complementary enzymatic assays of PC, 
TBARS. 
 
 
 
 
 
 
 
Figure 14: EPR protocol adopted to measure ROS production rate in Hockey 
players. 
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Level Borg Rating of Perceived Exertion Scale 
0 Nothing 
1 Really easy 
2 Easy 
3 Moderate 
4 Sort of Hard 
5 Hard 
6  
7 Really Hard 
8  
9 Really, Really Hard 
10 Maximal 
  
 
 
Table 2: The Borg Scale: takes into account the fitness level and is a simple 
method of rating perceived exertion 
 
II) Saronno master swimmers were recruited and the subjects visited the 
laboratory two times (pre and post eight weeks training protocol – Figure 15). A 
mechanical arm-ergometer (Monark 891E, Stockholm, Sweden) was utilized. The 
ergometer had an adjustable seat and handlebars, which were set to suit each 
individual subject. All subjects were instructed to remain seated during the test. 
Blood collection and anthropometric measures were collected in every time. In 
these subjects were tested the immediate effects of incremental test (IT) up to 
voluntary exhaustion and the long-term training effects were tested.  
Voluntary exhaustion was defined as the inability to maintain the armful frequency, 
despite vigorous encouragement by the operators, as well as by maximal levels of 
self-perceived exertion using the validated Borg scale (Table 2) [109]. Arm-
ergometer workload was adjusted by manually placing weights on the attached 
basket. Table 3 below shows the characteristics of the swimmers. 
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Figure 15: EPR protocol adopted to measure ROS production rate in swimmers. 
 
 
 
Features of Swimmers (mean ± DS) 
N° = 10, all males 	   PRE	   POST	  
Age (years)	   32.4 ± 5.08	   32.4 ± 5.08	  
Weight (kg)	   78.6 ± 5	   78.8 ± 5.1	  
Height (cm)	   182.2 ± 4.7	   182.2 ± 4.7	  
BMI	   23.7 ± 16.8	   23 ± 3.2	  
Fat Mass	   16.8 ± 3.6	   13 ± 2.9	  
Free Fat Mass	   65.3 ± 2.3	   65.7 ± 2.9	  
BSA	   2.18 ± 0.07	   2.18 ± 0.08	  
BORG 16.8 ± 1.6 17.2 ± 1.3 
VO2max (mL·Kg-1·min-1)	   36.1 ± 4.2	   40.6 ± 5.7	  
 
 
Table 3: Features of the swimmers. The “PRE” indicates the value at baseline 
(before training) and  “POST” indicates the value after training. (BMI: Body Mass 
index; BSA: Body Surface Area; BORG: Rating of Perceived Exertion Scale) 
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2.3.1.2 Long-Duration Exercise 
Long-Duration exercise effects were tested in triathletes during Triathlon 
competition (Elbamen 2012, 8th edition, 30 September 2012).  
Anthropometric measures, SaO2 and blood sample for chemical laboratory 
analysis were collected in two time: at rest (pre competition) and immediately after 
endurance competition; 13 athletes who performed a short-competition (ShC 7.3): 
swim 1.9Km, bike 94Km and run 21,1Km; 15 performed a long-competition 
(Ironman): swim 3.8Km, bike 180Km, run 42.2Km. The protocol adopted to 
measure the ROS production s shown in Figure 16. The characteristics of the 
triathletes are shown in Table 4.   
EPR data were compared with complementary enzymatic assays of TBARS, PC, 
values by blood chemical laboratory test and anthropometrics measures. 
 
 
 
 
 
Figure 16: EPR protocol adopted to measure ROS production rate in Triathletes. 
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Features of Triathletes (mean ± DS) 
N° = 28, all males 
 ShC 7.3  IRONMAN 
 PRE POST  PRE POST 
Age (years) 42.9 ± 8.8 42.9 ± 8.8  41.3 ± 7.1 41.3 ± 7.1 
Weight (kg) 71.2 ± 7.4 69.5 ± 7.7  70.3 ± 5.2 68.4 ± 5 
Height (cm) 174.3 ± 5.6 174.3 ± 5.6  174.9 ± 4.5 174.9 ± 4.5 
PAS (mmHg) 125.5 ± 3.4 122.8 ± 17.7  122.5 ± 17 121.4 ± 12.7 
PAD (mmHg) 72.5 ± 13.5 68.5 ± 8.5  72.5 ± 10.4 71.6 ± 8.5 
BSA 2.02 ± 0.12 1.99 ± 0.13  2.01 ± 0.09 1.99 ± 0.09 
HR 60.5 ±  8.7 85.2 ± 17.2  59.1 ± 16.7 80.8 ± 14.2 
SO2 97.8 ± 0.6 96.6 ± 1.3  97.6 ± 0.9 97.4 ± 1.5 
 
 
Table 4: Features of the Triathletes: PAS: Sistolic Pressure; PAD: Diastolic 
Pressure; BSA: Body Surface Area; HR: Heart Rate; SO2:Oxygen Saturation. 
 
 
 
 
 
2.3.1.3 Acute Normobaric Hypoxia 
Sedentary subjects (n=4, aged 23 ± 1.25 years; height 1.75 ± 0.05 m; body mass 
75.55 ± 4.95 kg) reported to the laboratory early in the morning after a light 
breakfast, and sat comfortably on a chair where remained over the 6 h. The room 
temperature was kept constant at 21°C. Venous and capillary blood samples were 
withdrawn for oxidative markers and ROS determination (0 h). Subsequently, 
subjects started breathing a normobaric hypoxic mixture (12.5% O2 in air, 
simulating about 4100m altitude) obtained by removing a controlled amount of 
oxygen from air (MAG-10, Higher Peak LLC, Winchester, MA, USA). The mixture 
was delivered through a facemask at 30 l min−1. Excess airflow was diverted 
outside the mask to prevent inspired oxygen pressure from increasing above 90 
Torr. Arterialized blood oxygen saturation was monitored by finger pulse oximetry 
(Biox 3740 Pulse Oximeter, Ohmeda, Denver, CO, USA); venous and capillary 
blood samples were withdrawn at different times during the test. At the end of the 
fourth hour subjects were switched to normoxic breathing conditions and blood 
samples withdrawn for up to 2 h.  
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2.3.1.4 Acute Hypobaric Hypoxia 
ROS production was determined in sedentary subjects (aged 33.30 ± 7.6 years; 
height 1.68 ± 0.07 m; body mass 58.5 ± 12.6 kg). Capillary blood samples were 
withdrawn before (at Turin) and during 24 hours sojourn at Plateau Rosà (3480m 
s.l.) (see Figure 17A). 
 
 
 
2.3.1.5 Prolonged Hypobaric Hypoxia 
ROS production at rest was determined in male elite athletes (aged 19.70 ± 1.16 
years; height 1.78 ± 0.04 m; body mass 77.65 ± 6.97 kg) before and 1 week after 
the return at sea level after 2 weeks exposure to moderate altitude (Livigno, 1860m 
s.l.) and 1 week after the return at sl. Data were compared with complementary 
enzymatic assays of TABARS and PC (see Figure 17B).  
 
 
 
	  
 
 
Figure 17: EPR protocol adopted to measure ROS production rate in A) Acute 
Hypobaric Hypoxia; B) Prolonged Hypobaric Hypoxia. 
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2.3.2 Decrease ROS production 
2.3.2.1 Training  
Training effect was tested in master swimmers. Features of athletes are reported 
in Table 3 (see section 2.2.1.1). Training was performed for 8 weeks with a high-
volume/low intensity program.  
Before (PRE) and after (POST) training they were tested by an arm-ergometer 
incremental test (IT). ROS production was analyzed at REST, at the END and after 
10 minutes of passive recovery (RECOVERY). Figure 15 (see section 2.3.1.1) 
show the protocol adopted to measure the ROS production by EPR. 
 
 
 
 
2.3.2.2 Antioxidant Supply  
The effect in acute antioxidant treatment (R-Thioctic acid: 1cp * 1.6g) was studied 
in ten healthy sedentary woman (mean age 48.80 ± 5.32 years; height 1.64 ± 0.03 
m; body mass 56.81 ± 10.35 kg). Time course of ROS production rate was 
calculated at pre (0 minutes) and at 20, 40, 60, 90, 120 and 180 minutes after 
antioxidant supplementation. Control experiments were performed in the same 
subjects without supplementation. 
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2.3.3 Unbalance ROS production 
Unbalanced ROS production in neurodegenerative pathologies (patients affected 
by type II Diabetic Neuropathy (type II DN), Mild Cognitive Impairment (MCI) and 
sporadic Amyotrophic Lateral Sclerosis (sALS)) was checked at baseline. The 
effect of exercise/training and/or the antioxidant supply was investigated.	  
Two projects are currently in progress. 
 
2.3.3.1 type II Diabetic Neuropathy 
i) CNR-IBFM and Istituto Auxologico of Milan collaborations: project to test the 
antioxidant effects on type II diabetic patients (n° = 8) with peripheral neuropathy 
after supplementation R-Thioctic acid: (1cp * 1.6g)*30 days. 
 
In healthy subjects, preliminary test were conducted to get an idea of the kinetics 
of absorption and effect of the integrator. Results have been encouraging (Data not 
shown in this thesis). 
 
[Diabetic neuropathy is the most common cause of neuropathy and clinically 
manifests as diffuse or focal forms. Furthermore, oxidative stress plays a central 
role in the pathogenesis of peripheral neuropathies since it determines a reduced 
supply of metabolites in nerve cells, resulting in cellular necrosis. It therefore 
aggravates the impairment of nerve conduction, worsening symptoms and the 
quality of life of patients. An improvement on the signs of neuropathy is reported in 
the literature, in patients who have been administered the α lipoic-acid (600mg/die), 
which interacts with many enzymes to convert glucose, fatty acids and other 
energy sources in (ATP).  
EPR determination may be useful for the analysis of the effects of antioxidant 
substances (see section 3.1.7.2)]. 
 
The drafting of a project followed these on patients with the approval of the hospital 
Ethics Committee. The protocol study (show in Figure 18) included collected 
venous and capillary blood sample started a couple of months ago. 
 
 
	   38	  
 
 
Figure 18: Protocol adopted to measure ROS production rate in type II Diabetic 
Neuropathic patients after R-Thioctic acid supplementation. 
 
 
 
2.3.3.2 sporadic Amyotrophic Lateral Sclerosis 
ii) CNR-IBFM and Fondazione Maugeri (Veruno – Novara) collaboration: project to 
test the exercise and training effects in sporadic Amyotrophic Lateral Sclerosis  
(sALS) patients (n°=24).  
[ALS is a progressive neurodegenerative disease characterized by loss of motor 
neurons in the anterior horns of spinal cord, brainstem motor nuclei, cerebral 
cortex and ultimately to death due to respiratory failure, usually within 3 to 5 years 
after disease onset. ALS pathogenesis included oxidative stress, endoplasmic 
reticulum stress, excitotoxicity, mitochondrial dysfunction, neural inflammation, 
protein misfolding and accumulation, dysfunctional intracellular trafficking, 
abnormal RNA processing, and noncell-autonomous damage]. 
 
Each subject participated in two visits over a twenty weeks time period. (t0 pre and 
t1 post training). The experiments were conducted in the morning. Figure 19 
shows the experimental protocol. 
The protocol evaluation included: collected venous (at rest and 15 minutes after 
the end of the exercise) (see section 2.5.1) and capillary blood sample (at rest, 
immediately after and 15 minutes after the end of the exercise); Incremental Test 
(IT) with Gas exchange (VO2 and VCO2) (see section 2.1.3) and NIRS analysis of 
oxygenation changes in the vastus lateralis muscle (see section 2.1.4); at the end 
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of exercise, pressure cuff inflation (at 300–350 mmHg) at the root of the thigh for a 
few minutes until ∆[deoxy(Hb+Mb)] increase reached a plateau (see section 2.1.4). 
After a 1-minute unloaded-cycling period, a ramp protocol at a pedaling rate of 
approximately 60 rpm was started. Pedaling frequency was digitally displayed to 
the subjects. Incremental exercise testing was conducted while the subject was 
seated on the electronically braked cycle ergometer (Ergo-Metrics 800S; 
SensorMedics; Yorba Linda, CA, USA) and breathing ambient air through a 
mouthpiece.  
 	  
	  	  	  
Figure 19: EPR protocol adopted to measure ROS production rate in sALS 
patients. 	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2.4 EPR measurements “in Vivo” 
All experiments were carried out by the e-scan EPR instrument (Bruker, Germany) 
operating at the common X-Band microwave frequency (~ 9.8 GHz). The 
instrument is interfaced to a temperature and gas controller Bio III unit (Noxigen 
Science Transfer & Diagnostics GmbH, Germany) allowing to maintain 
temperature at a constant chosen level and to regulate O2, CO2 and or other gas 
partial pressure.  
 
 
2.4.1 Detection of ROS in Human Blood 
2.4.1.1 Fresh Blood 
The experimental protocol adopted for ROS detection is shown in Figure 20. All 
EPR spectra were recorded and processed by using a standardly supplied by 
Bruker software (Win EPR 2.11 version). For EPR experimental procedures, 50 µl 
of capillary blood, collected in heparinized capillary tubes (Cholestech LDX, 
Germany), were analyzed (see Figure 20A). Among spin trapping (otherwise 
labelled probe) molecules, suitable for biological utilization, 1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH, Noxygen Science Transfer 
& Diagnostics, Germany) was adopted (see Figure 21). A 1 mM CMH solution was 
prepared in buffer (Krebs-Hepes buffer (KHB) containing 25 mM deferroxamine 
methane-sulfonate salt (DF) chelating agent and 5 mM sodium diethyldithio-
carbamate trihydrate (DETC)) at pH 7.4. Blood was immediately treated with CMH 
(1:1). 50 µl of the obtained solution was put in the glass EPR capillary tube 
(Noxygen Science Transfer & Diagnostics, Germany), that was placed inside the 
cavity of the e-scan spectrometer (Bruker, Germany) for data acquisition (see 
Figure 20B). Acquisition EPR parameters were: microwave frequency = 9.652 
GHz; modulation frequency: 86 kHz; modulation amplitude: 2.28 G; center field: 
3456.8G, sweep width: 60 G, microwave power: 21.90 mW, number of scans: 10; 
receiver gain: 3.17*101. Sample temperature was firstly stabilized and then kept at 
37°C by the Temperature & Gas Controller “Bio III” unit, interfaced to the 
spectrometer. The actual amount of solution analysed was chosen to fill the entire 
sensitive area of the resonator cavity. An example of the recorded EPR signal 
showing the triplet coming from the interaction of the 14N-OH group of CMH with 
the ROS oxygen unpaired electron (NOH + O2•  → NO• + H2O2 ) is displayed in  
Figure 20C. The radicals generated by the reaction of the probe with the blood 
radicals were acquired and the spectra sequentially recorded for about 5 min 
(Figure 20D) in order to calculate the ROS production rate. The EPR signal is 
proportional to the unpaired electron numbers and could, in turn, be transformed in 
absolute produced micromoles (µmol . min-1): the stable CP• (3-Carboxy-2,2,5,5- 
tetramethyl-1-pyrrolidinyloxy) radical signal was recorded in a separate session 
and used as reference. 
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Figure 20: Step by step sketch of the EPR experimental protocol adopted to 
measure the ROS production rate in fresh blood. 
 
	  
	  
	  
 
 
 
Figure 21: Detection O2 with EPR spectroscopy spin-probe using 1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) molecule. 
 
2.4.1.2 Frozen Blood 
Figure 22 shows the EPR protocol adopted for samples of frozen human blood. 
Approximately 2 ml of venous blood was drawn from an antecubital vein, with 
subjects lying on a bed (see Figure 22A). The samples were collected in 
heparinized vacutainer tubes (Vacutainer, Becton Dickinson, USA).  100µl of 
venous blood was immediately treated with CMH (1:1), as described in the 
previous section 2.4.1.1, and incubated for 15 minutes at 310K (see Figure 22B). 
During sample incubation, two previously filled of buffer containing DF and DETC 
(200µl each) and then in liquid nitrogen (N2) frozen caps were put inside a 1ml 
insulin syringe. After incubation, 200ul of blood sample were inserted into the 
syringe and in turn frozen in liquid N2 (see Figure 22C). EPR measurements were 
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carried out on the so frozen blood samples transferred in an EPR tube held by a 
finger-tip liquid nitrogen dewar (NOX-G.5-LND Noxygen Science Transfer & 
Diagnostics, Germany). Spectra were recorded at 77 K by using an e-Scan 
spectrometer. The EPR signal, generated by the reaction of the spin probe (CMH) 
with whole blood ROS, was then recorded: acquisition parameters: modulation 
amplitude: 5 G; centered field: 2.0023 g, sweep time 10 s, field sweep 60 G, 
microwave power: 1 mW, number of scans: 10; receiver gain: 1*103 (see Figure 
22D). The timing of the procedure is shown in sketches.  
	  
	  
 
 
 
Figure 22: EPR protocol adopted to measure ROS production in frozen samples. 
 
 
 
2.4.1.3 pO2 / NOX calibration 
In order to calculate the real ROS production, a calibrate curve is necessary taking 
in account partial pressure of oxygen (pO2) values. 
Assuming a linear behavior of the EPR signal when changing pO2, the 
paramagnetic oxygen-sensitive probe Oxyethidium was used (NOX-Oxyethidium. 
Noxygen Science Transfer & Diagnostics, Germany). In capillary blood samples, 
prepared by using the protocol described in section 2.4.1.1, a 1µl of NOX (2µM) 
was added and the EPR signal, proportional to the oxygen amount bound to the 
probe, was recorded. Acquisition parameters were: microwave frequency = 9.734 
GHz; modulation frequency: 86 kHz; modulation amplitude: 1.02 G; center field: 
3481.5G, sweep width: 60 G, microwave power: 21.90 mW, number of scans: 10; 
receiver gain: 3.17*101, T= 310K. 
The experiments were carried out by using O2 permeable capillaries (PT Noxygen 
Science Transfer & Diagnostics, Germany) and starting from ambient PO2 (200 
mmHg, maximum signal) and then following N2 until the EPR signal reached its 
minimum due to the radical signal alone, that is without O2 bound (pO2=0). The 
experimental data and the regression line is shown in Figure 23. From the 
obtained data a calibration factor of 0.0917 µmol·min-1 was calculated. In this way 
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we were able to compare data collected under different pO2 conditions, by 
eliminating the effect of changing pO2 on ROS production. Without this correction, 
raw data collected at high altitude result in a lower level with respect to those 
obtained at sea level, even if, on the contrary, at altitude the ROS production 
generally increases, due to an in coming relative hypoxic state. 
 
 
 
 
 
 
Figure 23: Calibration curve pO2/ROS. 
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2.5 Enzymatic assays 
ThioBarbituric Acid Reactive Substances (TBARS) and Protein Carbonyls (PC) 
were used to lipidic peroxidation indices and protein damage respectively. 
 
 
2.5.1 Blood sample 
Approximately 3 ml of venous human blood was drawn from an antecubital vein, 
with subjects lying on a bed. The samples were collected in heparinized vacutainer 
tubes (Vacutainer, Becton Dickinson, USA); plasma was separated by centrifuge 
(5702R, Eppendorf, Germany) at 1000 g for 10 min at 4 °C. All samples were then 
stored in multiple aliquots at -80 °C until assayed. Samples were thawed only once 
before analysis, performed within two weeks from collection.  
 
 
2.5.2 ThioBarbituric 
The measurement of Thiobarbituric acid-reactive substances (TBARS) is a well-
established method to detect lipid peroxidation. We used TBARS assay kit 
(Cayman Chemical, USA) which allows a rapid photometric detection of the 
thiobarbituric acid malondialdehyde (TBAMDA) adduct at 532 nm. Samples were 
read by a microplate reader spectrophotometer (Infinite M200, Tecan, Austria). A 
linear calibration curve was computed from pure MDA-containing reactions. All 
samples were determined in duplicate and the inter-assay coefficient of variation 
was in the range indicated by the manufacturer (about 10%). 
 
 
2.5.3 Protein Carbonyls  
Reactive species produced directly or indirectly through lipid peroxidation 
intermediates also may oxidatively modify proteins. The accumulation of oxidized 
proteins was measured by content of reactive carbonyls. A Protein Carbonyl assay 
kit (Cayman Chemical, USA) was used to evaluate colorimetrically-oxidized 
proteins. The samples were read at 370 nm, by a microplate reader 
spectrophotometer (Infinite M200, Tecan, Austria), as described in detail by the 
manufacturer. Oxidized proteins values obtained were normalized to the total 
protein concentration in the final pellet (absorbance reading at 280 nm), in order to 
consider protein loss during the washing steps, as suggested in the kit's user 
manual. All samples were determined in duplicate and the inter-assay coefficient of 
variation was in the range indicated by the manufacturer. 
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2.6 “In Vitro” Myoglobin 
2.6.1 Proteins preparation  
Both 54K and 54E human Myoglobin (Mbs) were purchased from Asla (Riga, 
Latvia) and provided in the aquomet-form. They have been obtained by site-
directed mutagenesis PCR approach and expressed in Escherichia coli BL21 
(DE3) cells (Novagen). 
 
2.6.2 EPR Sample preparation 
The EPR experiments were carried out on the two proteins in the nitrosyl-Mb form. 
First, in order to avoid side-reactions between either free NO or NO-Mb and the 
oxygen, the starting ferric proteins (0.05 mM, MAHMA-NONOate, Alexis 
Biochemicals corporation) were reduced by addition of freshly prepared 100 mM 
sodium dithionite (SDT, Sigma) under free-O2 condition. The ferrous deoxy-
proteins were then incubated with the NO donor (0.05 mM) for 30 min. 
Second, in order to investigate the NO binding affinity in a condition as physiologic 
as possible, we avoid the addition of any reducing reagents in excess. The two 
human Mb isoforms were incubated in the presence of the NO donor at three 
different O2 concentrations, i.e. pO2 equal to 0, 40 and 160 mmHg. To this aim, 
samples were prepared by dissolving the 54K and 54E isoforms (0.05 mM) in the 
aquomet-form in Krebs-Hepes buffer (20 mM); the pH was then adjusted to 7.4 by 
addition of NaOH.. Proteins were incubated in a temperature and gas treatment 
chamber (BIOV, Noxygen) in the presence of the NO donor (0.05 mM) at the 
chosen pO2 level at 310 K. After 30 min. of incubation, each sample (400 µL) was 
put under liquid nitrogen overnight.  
 
2.6.3 pO2 Calibration 
EPR experiments, as said, were carried out at three different values of pO2 = 0, 40, 
160 mmHg. While zero and ambient levels were easily obtained by incubating the 
Mb samples (in the presence of the NO donor) under 100% N2 gas flow or 
exposed to air, respectively, a pO2 calibration had to be performed, in order to 
establish the incubation time necessary to reach the desired oxygen level in the 
sample. To this aim, the oxyethidium (3,8-diamino-5-oxy-6-hydro-5-ethyl-6-
phenylphenanthridine, Noxygen) radical (4 mM) was dissolved in buffer and put in 
apposite O2 permeable capillaries (40 µL final volume). N2 (100%) was previously 
flowed into the capillaries to completely remove O2 from the solution. At regular 
time intervals, one of the aliquots was taken out of the chamber and put in a glass 
capillary for EPR analysis at 310 K. Experimental data were finally fitted with a 
straight line, going from the maximum EPR signal obtained from the air-exposed 
sample (pO2 = 160 mmHg), until a low intensity residual resonance due to the 
radical’s signal alone (incubation time 0 min.; pO2 = 0). From this calibration curve 
(not shown), the deoxy-Mb samples were, thus, incubated for 30 min at 310 K to 
attain a pO2 level of 40 mmHg. 
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2.6.4 EPR Mb Measurement  
EPR experiments were carried out on frozen samples put in EPR tube, held by a 
finger-tip liquid nitrogen dewar (NOX-G.5-LND Noxygen Science Transfer & 
Diagnostics, Germany). Spectra were recorded at 77 K in E-Scan spectrometer.  
All the spectra were recorded using the same acquisition parameters: 10 scans on 
average, 5.24 s sweep time, 8.16 G modulation amplitude, 86 kHz modulation 
frequency, 42 mW microwave power at a frequency of 9.786 GHz. EPR spectra 
were baseline corrected and the normalized spectral area (a.u.) calculated by 
double integration, using the standard EPR software supplied by Bruker (WinEPR, 
Version 3.1). Five repetitions were performed for each experiment 
 
 
2.7 Statistical Analysis 
 
All EPR spectra were obtained by using software standardly supplied by Bruker 
(version 2.11, Win EPR System). For ROS detection “in vivo”, all spectra were 
collected by adopting the same protocol, as shown in Figure 20 and above 
reported. 
Descriptive statistics such as mean ± SD were used to summarize continuous 
variables. Data were analyzed using parametric statistics following mathematical 
confirmation of a normal distribution using repeated Shapiro-Wilks W test. 
Experimental data were compared by ANOVA variance analysis followed by 
Bonferroni’s multiple comparison test to further check the among groups 
significance (GraphPad Prism 6, Software Inc. San Diego, CA). The relationship 
between selected dependent variables was assessed using Pearson Correlation 
coefficents. P < 0.05 statistical significance level was accepted.  
 
 
Note to the reader: in addition to the data reported in the tables, a ∆% estimation  
[((post value-pre value)/pre value)*100] is reported in the text, which gives often a 
more impressive result. 
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3 RESULTS  
  IN VIVO  3.1
3.1.1 EPR Measurements: Fresh Blood versus Frozen Blood 
In the first point was investigated the EPR signal by fresh blood versus frozen 
blood. As shown in Figure 24A, the two EPR signals of ROS: in green line the 
signal obtained by fresh blood (at 310 K) and in red line by frozen blood in N2 (at 
77 K). Different were the time for preparation of the samples and their acquisition, 
but otherwise is what we measure (Figure 24B). Quantitative detection of ROS 
rate production (µmol . min-1) by fresh blood sample is possible because with the 
acquisition time (until the signal reaches plateau, in about 30 minutes), every 
measured value is available for calculating the kinetics of production. Conversely, 
frozen blood acquisitions provide only a value that reflects the amount of ROS at 
that precise instant. 
 
 
 
 
Figure 24: A) Two typical EPR signals obtained by fresh blood (green) and frozen 
blood (red); B) the plot represents the linear trend of ROS production as a function 
of elapsed time. 
 
Just one of the aims of our research was to obtain a quantitative measure of ROS 
production in blood. To this end, we have set aside the frozen protocol and have 
continued our experiments on fresh blood samples only. 
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3.1.2 Limits of detection and quantification with the selected EPR 
method  
The limits of detection (LOD) and quantification (LOQ) can be estimated using the 
ICH Guidelines [110] that defines these parameters as the analytic concentrations 
at which the signal-noise ratios (SNR) are at least 3:1 and 10:1, respectively, and 
in EPR they depend upon the acquisition parameters, especially on the number of 
scans (NS), that influence linearly the SNR and the experimental time. In the EPR 
spectrum of a solution of ROS at known concentration (6µM) recorded under the 
same acquisition parameters adopted in the present study, the SNR of the line 
belonging to the ROS signal with NS = 10 was found to be 600. Therefore LOD 
and LOQ are immediately calculated as, respectively, 6µM × 3/600 = 30·10−3µM 
and 6µM × 10/600 = 100·10−3µM. 
 
 
3.1.3 Reproducibility measurements 
The high reproducibility of the EPR measurements shows up by the plots reported 
in Figure 25. The data are referred to a couple of EPR measurement data (test I 
(open squares), test II (closed squares)) performed on blood capillary samples 
taken from the same healthy subject six hours apart. The data are expressed as 
arbitrary units (a.u.) and refer to EPR signal double integrals.  The regression lines 
obtained from the collected data show an excellent correlation coefficient (r² = 
0.99) resulting almost super-imposable: test I (slope: 7.98, intercept: 15.49); test II 
(slope: 7.95, intercept: 15.95). The best fitting straight lines (r2 = 0.99) were found 
almost superimposable: about the 0.5% discrepancy in the ROS absolute 
production rate (µmol · min−1) was calculated between the measurements.  
The stacked plot of the recorded EPR spectra during a single experiment is 
displayed at the upper left corner. The spectra are centered at g = 1.997. For each 
spectrum, the greatest signal amplitude difference in the triplet (a.u.) is returned by 
the acquisition routine, resulting in a point of the displayed graph. The ROS 
production rate (a.u.) is estimated by the best fitting line. It can be, in turn, 
converted in the absolute ROS production rate level (µmol · min−1) throughout the 
acquisition of a stable radical compound like CP• (3-Carboxy-2,2,5,5- tetramethyl-
1-pyrrolidinyloxy). 
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Figure 25: The high reproducibility of the EPR measurements is well demonstrated 
by the plots displayed in the figure showing the calculated EPR signal levels 
versus the elapsed time. 
 
3.1.4 Protocol design 
The experimental protocol was developed to measure ROS production in human 
blood and then adopted in all experiments carried out in vivo (see Figure 20 in 
section 2.4.1.1). As mentioned above, our experimental investigations have been 
focused to the study of ROS production in various conditions of hypoxic state: 
exercise, altitude effects and diseases. Now, point by point, will be reported the 
results. 
 
 
3.1.5 Starting measurements  
After checking the reproducibility of the EPR measurement from the collected data 
of different repeated tests in healthy subjects; we assessed the ROS production 
rate in human blood in about one hundred healthy subjects. As shown in the 
Figure 26, different ROS concentrations were obtained when collecting data, on 
the same resting subject, from different blood fractions.  
	   50	  
In peripheral blood ROS production levels were found about 18 ± 4% greater (1.79 
± 0.12 µmol · min-1 vs 1.48 ± 0.29 µmol · min-1) than in venous, owing to the 
different pO2 (100 mmHg vs 75 mmHg respectively). Indeed a greater level was 
found in a sample containing only erythrocytes (2.97 ± 0.3 µmol · min-1). On the 
contrary, significantly lower results (0.15 ± 0.05 µmol · min-1) were found in plasma 
due to red cells absence, the main ROS producing elements in blood (see Figure 
26). The data well demonstrate the crucial role played by some parameters (see 
Figure 27) (e.g. temperature, pO2) on the results, suggesting that great care must 
be taken to keep all parameters at a constant level during the whole experimental 
procedure. 
 
 
 
 
Figure 26: Histogram plot (mean ± SD) of the absolute ROS production rate blood 
concentration (µmol · min-1) obtained from blood samples collected from more than 
100 healthy subjects.                                                                                              
The dependence of the values from the used sample is clearly shown in the figure 
(µmol · min-1): capillary blood (red): 1.79 ± 0.12; venous blood (blue): 1.48 ± 0.29; 
plasma (yellow): 0.16 ± 0.02; erythrocytes (purple): 2.87 ± 0.3. 
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Figure 27:Temperature dependence of ROS production in blood: ROS amplitude 
(a.u.) at 310 K are indicated in red symbols and at 295 K are indicated in grey 
symbols. Temperature dependence of the Krebs-Hepes buffer is displayed in the 
upper left corner: buffer amplitude (a.u) at 310 K are indicated in black symbols 
and at 295 K are indicated in grey symbols. 
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3.1.6 Increase ROS Production 
 
3.1.6.1 Short duration exercise in laboratory 
The exercise effects were studied in young athletes belonging to different 
categories: I) hockey players, II) swimmers.  
 
I) In Hockey player exercise induced EPR detectable enhancement in-vivo ROS 
formation in capillary blood. The results are summarized in Figure 28. The kinetics 
of ROS production estimated by the EPR signal intensity levels variation at REST, 
immediately after Constant-Load submaximal Exercise (CLE) and during the 20 
min of recovery after is shown. Compared with resting data, a statistically 
significant (p<0.05) increase of ROS production immediately at the END of CLE 
was observed (+7%), thereafter the ROS production returned to the pre exercise 
condition. 
 
 
 
 
 
 
Figure 28: Time course of the ROS production rate (umol·min-1) detected by EPR 
technique before (REST), immediately after the CLE (END) and at 10 and 20 
minutes of recovery. Results are expressed as mean ± SD. Changes over time 
were significant at p<0.05 immediately post CLE compared to rest (* symbol). 
 
At the same time, as can be observed in Figure 29A, TBARS concentration 
increased immediately after exercise, significantly (p<0.05) peaked 20 minutes 
after exercise and returned toward baseline levels thereafter. Also PC 
concentration increased immediately after the end of CLE, even if showing a 
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slower rate. Its level became statistically significant (p<0.05) at 20 minutes after 
exercise; nevertheless the highest values were reached at 1 hour after the END of 
the exercise and declined thereafter (see Figure 29B). 
 
 
 
 
Figure 29: Time course of TBARS (A) and PC (B) concentration before (REST), 
immediately after the CLE (END) and at 20 min, 1 and 2 hours of recovery. Results 
are expressed as means ± SD. Changes over time were significant at p<0.05 
compared to rest (* symbol). 
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EPR data were compared to enzymatic measurements carried out on thawed 
plasma samples from the same subjects at rest. A good Correlation was found 
between ROS production and biomarkers of oxidative damage. Table 5 reports the 
mean values of plasma TBARS and PC and the ROS production values of capillary 
blood. A positive relationship was found at rest between ROS production and 
plasma TBARS concentrations (r2 = 0.74, p<0.05) (see Figure 30A) and with 
plasma PC concentrations (r2 = 0.60, p<0.05) (see Figure 30B). At high resting 
ROS production rate levels corresponded greater plasma TBARS and PC 
concentrations. 
 
TBARS (µM) 6.49 ± 1.01 
Protein Carbonyls (nmol • mg-1 protein) 0.94 ± 0.40 
ROS production rate (µmol • min-1) 1.99 ± 0.09 
 
Table 5: Plasma TBARS and PC levels and ROS production rate in capillary blood 
of hockey athletes at rest. Results are presented as mean ± SD 
 
 
 
 
 
Figure 30: TBARS (A) and PC (B) content as determined by enzymatic assays 
methods versus the ROS production rate (µmol · min -1) calculated by EPR data 
(solid symbols). The linear regression lines (solid lines) are reported. The variance 
analysis (Pearson product-moment correlation) indicated a positive association for 
both TBARS and PC (r2 values 0.74 and 0.60, * p<0.05). 
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II) In Master Swimmers a significant increase of the ROS production rate was 
found at the END of exercise: + 16% (see Figure 31) progressively returning to the 
basal level in the time course of recovery. The kinetics of ROS production 
estimated by the EPR signal intensity levels variation at rest, immediately after 
(END) Incremental Test (IT) and during the 10 min of recovery after is shown. 
Compared with resting data, a statistically significant (p<0.05) increase of ROS 
production immediately at the END of IT was observed.  
 
 
 
 
 
 
Figure 31: Time course of the ROS production rate (µmol · min -1) detected by 
EPR technique before (REST), immediately after the IT (END) and at 10 minutes 
of recovery. Results are expressed as mean ± SD. Changes over time were 
significant at p<0.05 immediately post IT compared to rest (* symbol). 
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3.1.6.2  Long-duration Exercise: Triathlon competition 
Short (ShC 7.3) and long (Ironman) Triathlon competition increased ROS 
production rate in capillary blood. Indeed in both athletic groups (ShC 7.3 and 
Ironman) a significant increase of the ROS production at the end of competition: 
+12.5% (p< 0.001) and +14% (p< 0.0001) respectively is shown (see Figure 32).  
According to Figures 33, 34 and in the Table 6 the results show a significant 
(p<0.0001) increase in TBARS levels and PC after competition in both groups 
(ShC 7.3 and Ironman). 
 
 
 
 
 
 
Figure 32: ROS production (µmol · min -1) rate in Ironman Triathletes (long-
competition) are indicated in closed symbols; ShC 7.3 Triathletes (short-
competition) are indicated in open symbols. Results are expressed as mean  ± SD. 
Changes over time were significant at p<0.05 (* symbol) compared to pre 
competition value. 
 
 
EPR data were compared to enzymatic measurements carried out on thawed 
plasma samples from the same subjects at rest. No relationship was found 
between EPR and enzymatic TBARS and PC determinations.  
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Figure 33: TBARS levels in plasma of triathletes (ShC 7.3 and Ironman) before 
(PRE) and after (POST) competition. The values are presented as mean ± SD. 
*p<0.05, significant difference in relation to pre competition. 
 
 
 
 
 
Figure 34: PC concentration in plasma of triathletes (ShC 7.3 and Ironman) before 
(PRE) and after (POST) competition. The values are presented as mean ± SD. 
*p<0.05, significant difference in relation to pre competition.  
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 ShC 7.3 IRONMAN 
 PRE  POST  PRE  POST 
TBARS (µM) 10.8 ± 3.2 15.02 ± 3.8* 10.9 ± 2.48 16.25 ± 4.2* 
Protein Carbonyls 
(nmol • mg-1 
protein) 
1.42 ± 0.45 2.74 ± 0.83* 1.35 ± 0.41 3.08 ± 1.02* 
ROS production 
rate (µmol • min-1) 
1.39 ± 0.10 1.57 ± 0.09* 1.47 ± 0.1 1.68 ± 0.2* 
 
 
Table 6: Plasma TBARS, PC levels and ROS production rate in capillary blood of 
Triathletes pre and post competition. Results are presented as mean ± SD and the 
significant difference was from p<0.05 (* symbol) 
Changes in heart rate, saturation and body mass were found at the end of the 
race:  
• Shc 7.3 significant increase heart rate (p=0.0002; +41%) and significant 
decrease body mass index (p=0.0001; -2.73%), BSA (p=0.0001; -1%), SO2 
(p=0.008; -1.3%).  
• Ironman significant increase heart frequency (p=0.0039; +37%) and 
significant decrease body mass index (p=0.0002; -2.7%) and BSA 
(p=0.0002; -1.2%). (Data not shown) 
In ironman significant linear correlation was found between resting ROS and heart 
frequency pre-competition (r2= 0.46) (Data not shown). 
 
 
Also, chemical laboratory tests showed significant changes before and after 
competition and are summarized in Table 7: 
• Shc 7.3 post competition showed a significant increase: total cholesterol 
(+5%), HDL (+12.5%), sodium (+4%), glucose (+21%), leukocytes 
(+124%), erythrocytes (+4%), hemoglobin (+3.5%) hematocrit (+3%), 
platelets (+12%), neutrophils (+187%), monocytes (+112%), transferrin 
(+11%) and significant decrease: eosinophils (-83%) and corpuscular 
volume (-1%). 
• Ironman post competition showed a significant increase: HDL (+17%), 
leukocytes (+218%), platelets (+19%), neutrophils (+347%), monocytes 
(+229%), Mean Corpuscular Hemoglobin Concentration - MCHC (+2.8), 
ferritin (+21%), transferrin (+6.5%) and significant decrease: LDL (-12.5%), 
iron (-56%), eosinophils (-97%), potassium (-16%), chloride (-4%), 
corpuscular volume (-2.5%). 
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 ShC 7.3 IRONMAN 
 PRE POST PRE POST 
Tot cholesterol 
(mg/dL) 
192.08±19.64 202.08±25.19* 212.79±34.45 207.64±26.35 
LDL (mg/dL) 106.67±19.72 108.69±22.69 117.43±26.7 102.71±20.5* 
HDL(mg/dL) 62.85±12.21 70.77±14.39* 71.50±14.73 83.86±11.49* 
Iron (µg/dL) 105.62±30.34 96.77±33.31 111.93±35.10 48.57±14.09* 
Ferritin (ng/mL) 100±48 106.92±51.86 116.93±76.86 141.79±86.86* 
Transferrin 
(mg/dL) 
283.31±27.4 313.77±51* 275.7±37.4 293.5±37.9* 
K (mEq/L) 6.12±0.6 6.04±0.5 6.15±0.89 5.15±0.48* 
Na (mEq/L) 139.69±2.06 145.08±3.20* 139.71±2.20 140.21±2.72 
Cl (mEq/L) 102.85±2.73 104.92±3.15 101.79±2.72 97.64±3.08* 
Glucose 
(mg/dL) 
81.15±5.52 98.54±20.10* 74.79±13.46 74.50±13.77 
Leukocytes 
(10^9/L) 
6.37±3.17 14.31±3.12* 5.41±0.91 17.25±2.69* 
Erythrocytes 
(10^12/L) 
4.86±0.24 5.04±0.34* 4.69±0.24 4.77±0.30 
Hemoglobin 
(g/dL) 
14.83±0.69 15.36±1.04* 14.20±0.67 14.52±0.87 
Hematocrit (%) 48.32±1.74 45.02±2.56* 42.62±2.13 42.36±2.49 
Platelets 
(10^9/L) 
204.50±30.95 229.91±19.21* 229.77±42.91 273.29±37.14* 
Neutrophils  
(10^9/L) 
3.97±3.05 11.44±3.20* 3.09±0.72 13.85±2.71* 
Lymphocytes 
(10^9/L) 
1.61±0.27 1.75±0.52 1.71±0.41 1.86±0.34 
Monocytes 
(10^9/L) 
0.49±0.26 1.05±0.33* 0.44±0.13 1.46±0.38* 
Eosinophil’s 
(10^9/L) 
0.18±0.12 0.03±0.04* 0.14±0.08 0.00±0.00* 
Basophils 
(10^9/L) 
0.04±0.03 0.04±0.02 0.03±0.01 0.03±0.01 
MCHC (g/dL) 33.83±0.73 34.11±0.63* 33.33±0.66 34.29±0.63 
Corpuscular Vol 
(Φ) 
90.29±3.54 89.39±3.77* 91.15±3.01 88.94±2.81* 
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Table 7: Blood chemical laboratory test results in ShC 7.3 and Ironman pre and 
post competition. Results are presented as mean ± SD. Changes over time were 
significant at p<0.05 immediately after compared to pre (* symbol) competition 
 
 
 
EPR data were compared to chemical laboratory measurements from the same 
subjects in the time course of the same experimental session.  
Pre and post competition, possible relationship between EPR data and laboratory 
measurement was searched: 1) grouping all the athletes (ShC + Ironman) because 
no statistical difference were observed in two groups before completion and 2) 
then maintaining distinct the two groups, inasmuch, workload in two races are 
different. 
 
 
1) A direct correlation between ROS production rate (as determined by EPR 
measurements) and platelets (r2= 0.53), iron (r2= 0.43), HDL (r2= 0.42), corpuscular 
volume (r2= 0.40), Mean Corpuscular Hemoglobin - MCH (r2= 0.44) was observed 
at rest (see Figure 35A-E). A minimal and almost significant correlation was found 
for lymphocytes (r2= 0.23; p=0,05) (see Figure 35F) too. 
 
 
 
 
 
2) In ShC 7.3: ROS production at rest versus pre-competition: significantly 
correlation were found between ROS production rate and MCH (r2= 0.67) and 
corpuscular volume (r2= 0.68). Moreover, notable but no significantly correlations 
were found between ROS production rate and hemoglobin (r2= 0.34), hematocrit 
(r2= 0.38), platelets (r2= 0.48), eosynophils (r2= 0.38), basophils (r2= 0.38) and HDL 
(r2= 0.37) (Data not shown). 
A direct correlation between ROS production rate (as determined by EPR 
measurements) and hemoglobin  (r2= 0.63), MCH (r2= 0.67), and MCHC (r2= 0.61) 
was observed at the end of competition (see Figure 36A-C). Also, good but not 
significantly correlation in hematocrit (r2= 0.54), sodium (r2= 0.45) were found. 
(Data not shown). 
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Figure 35: Correlation between ROS rate production and blood chemical 
laboratory test in triathletes pre-competition. Platelets (A), Iron (B), HDL (C), MCH 
(D), Corpuscular Volume (E) and Lymphocytes (E) content as determined by blood 
chemical laboratory test versus the ROS production rate (µmol · min -1) calculated 
by EPR data (solid symbols). The linear regression lines (solid lines) are reported. 
The variance analysis (Pearson product-moment correlation) indicated a significant 
(* p<0.05) positive association for A,B,C,D,E. A minimal and almost significant 
correlation was found for lymphocytes (F). 
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Figure 36: Correlation between ROS rate production and blood chemical 
laboratory test in triathletes ShC 7.3 post-competition. MCH (A), MCHC (B), 
Haemoglobin (C) content as determined by blood chemical laboratory test versus 
the ROS production rate (µmol · min -1) calculated by EPR data (solid symbols). 
The linear regression lines (solid lines) are reported. The variance analysis 
(Pearson product-moment correlation) indicated a significant (* p<0.05) positive 
association. 
 
 
 
In Ironman, ROS production at rest versus pre-competition: a significant linear 
correlation (p<0.01), especially for Iron (r2= 0.66) was found; increasing the ROS 
production rate, as determined by EPR measurements, hemoglobin (r2= 0.50), 
hematocrit (r2= 0.33) and platelets (r2= 0.50) were found increased too. Data are 
not shown. 
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Lastly the ROS production at rest, were compared to years of training: only in ShC 
7.3 a significant linear correlation was found (r2= 0.60) (see Figure 37).  
 
 
 
 
Figure 37: Correlation between ROS rate production pre competition and years of 
training in triathletes ShC 7.3. The linear regression lines (solid lines) is reported. 
The variance analysis (Pearson product-moment correlation) indicated a significant 
(* p<0.05) positive association. 
 
 
No correlation was found in ShC 7.3 and Ironman between ROS production and 
body weight. 
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3.1.6.3 Hypoxia 
The I) Acute Normobaric, II) Acute Hypobaric and III) Prolonged Hypobaric 
Hypoxia effects were preliminarily studied at different heights on sea level.  
The experiments in Acute Normobaric Hypoxia are still in progress. You will still be 
presented the results so far achieved. 
 
 
I) Acute Normobaric Hypoxia was simulated at 12.5% O2 in air, which 
corresponds to 4500m s.l. Figure 38 show, a fast, initial elevation of ROS 
production, whose size appears to be related to the subjects’ capillary SO2, (Figure 
39) followed, by a return to pre-hypoxia levels at the end of hypoxia exposure (4 
hours). A burst of ROS (+ 38%) is formed in the transition to low intracellular O2 
tension. The Arterialized blood oxygen saturation was relatively constant at 85–
90% (see Figure 39) during simulated hypoxia state. 
 
 
 
 
 
Figure 38:Time course of ROS production rate (umol·min-1) detected by EPR 
technique. Black symbols are values before (0 minutes) and after hypoxia 
exposure (recovery); white symbols are values during hypoxia. Results are 
expressed as mean  ± SD. Changes over time were significant at p<0.05 
compared to pre exposure (* symbol). 
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Figure 39: SO2 during Acute Normobaric Hypoxia and recovery. Black symbols are 
values before hypoxia exposure (0 minutes) and during the recovery; white 
symbols are values during hypoxia. Results are expressed as mean  ± SD. 
Changes over time were significant at p<0.05 compared to pre exposure 
 (* symbol). 
 
 
 
Plasmatic concentrations of TBARS and PC were significantly increased after four 
hours of hypoxia exposure. During Acute Normobaric Hypoxia TBARS underwent 
only a 10% increase at four hours. By contrast, one hour after hypoxia offset the 
plasma concentration of TBARS was significantly (P<0.05) increased returning 
back to pre-hypoxia control value in the subsequent two hours (Figure 40A).  PC 
concentration significantly increased, attaining the highest value (P<0.05) at four 
hours of hypoxia exposure. At hypoxia offset, PC decreased slowly, being still 
higher after two hours than at pre hypoxia exposure (Figure 40B). 
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Figure 40: Histogram plot (mean ± SD) of (A) TBARS (µM) and (B) PC (nmol·mg-1 
protein) obtained from plasma samples collected at 0, 2,4 hours of hypoxia 
exposure and 1,2,4 hours of recovery phase in room air. Changes were significant 
at p<0.05 (* symbol) or p<0.01 (** symbol) compared to pre hypoxia exposure. 
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II) In Acute Hypobaric Hypoxia ROS production significantly increases at six 
hours after arrival at 3480m sl (+42%), and continues to increase at 24 h exposure 
(+47%) as shown in Figure 41A. These data are in agreement with a reduction of 
SO2: -11 and -10% respectively (see Figure 41B). 
 
 
 
 
Figure 41: Histogram plot (mean ± SD) of (A) ROS production rate (µmol · min-1) 
obtained from capillary blood samples collected at 0m s.l. (PRE) to 6 and 24h after 
3480m s.l. exposure in sedentary subjects. (B) the SO2 measured at the same 
time of blood sampling. Changes over time were significant (p<0.05) at 6 and 24h 
compared to PRE (* symbol). 
 
 
 
Frequency of Ventilation (FV) (A) and Heart Rate (HR) (B) were significantly 
increased in Acute Hypobaric Hypoxia (see Figure 42). At 6 and 24 h an elevation 
of FV and HR was observed: FV +43 and +36; HR +30% and +25% respectively. 
 
 
 
 
Figure 42: Histogram plot (mean ± SD) of FV (A) and HR (B) at PRE and 6 and 
24h after 3480m s.l. exposure. Changes over time were significant (p<0.001) at 6 
and 24h compared to PRE (* symbol). 
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No correlation was found between the ROS production and the values FC and HR. 
Data are not shown. 
 
 
 
III) In Prolonged Hypobaric Hypoxia, after two weeks at 1860m s.l, it was found 
a significant increase of ROS production (~ +33%); followed by a return to pre-
hypoxia levels (-3%) after one week to s.l. recovery (POST) (see Figure 43). 
 
 
 
 
 
Figure 43: Histogram plot (mean ± SD) of ROS production rate (µmol · min-1) 
obtained from capillary blood samples collected at 0m s.l. (PRE), after two weeks 
exposure to moderate altitude 1860 m s.l. (Livigno) and return at 0m s.l. (POST) by 
male elite athletes. Changes were significant (p<0.0001) by exposure compared to 
PRE and POST condition (* symbol). 
 
 
At the same time, two weeks exposure to moderate hypoxia induced significant 
changes in oxidative markers concentration: TBARS concentration significantly 
increased (+9%) after two weeks of exposure (Figure 44A) and PC concentration 
significantly decreased (-40%) at return at s.l. (POST) (Figure 44B). 
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Figure 44: Histogram plot (mean ± SD) of (A) TBARS (µM) and (B) PC (nmol·mg-1 
protein) obtained from plasma samples collected at 0m s.l. (PRE), after two weeks 
exposure to moderate altitude 1860 m s.l. (Livigno) and at one week after the 
return at s.l. (POST) by male elite athletes. Changes were significant at p<0.0001 
compared to PRE (* symbol). 
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3.1.7 Decrease ROS production 
3.1.7.1 Training effect 
In section 3.1.6.1 were shown the effects of incremental test to master swimmers. 
These subjects were scheduled over a period of high-volume/low intensity program, 
and then required to undergo another incremental test. Our aim was to investigate 
the training effects.  
Two session were defined: PRE (explained in section 2.3.1.1 and Figure 15) and 
POST the session after training. 
In POST training session, compared with resting data, a statistically significant (p< 
0.001) increase of ROS production immediately at the END of IT was observed, 
thereafter the ROS production returned to the pre exercise condition. 
In swimmers, the training effects (twelve weeks) of moderate daily exercise 
showed a significant (p<0.001) decrease in ROS production (-20%) (see Figure 
45).  
Moreover the variance analysis (Pearson product-moment correlation) indicated an 
inverse correlation (r2 values = 0.58, p<0.05) between ROS rate production and 
VO2 max (see Figure 46). 
 
 
 
 
Figure 45: Time course of ROS production rate (umol·min-1) detected by EPR 
technique before (REST), immediately after the IT (END) and at 10 minutes of 
recovery. Two session of IT are shown. In black line the first session: defined PRE 
(explained in Figure 8) and in grey line the session after POST training. Changes 
were significant at p<0.0001 compared to PRE (*, §symbol). Also, we founds 
significant at p<0,001 differences between rest PRE and rest POST training 
(#symbol). 
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Figure 46: After exercise, correlation between ROS rate production and 
VO2max.The linear regression (solid line) shows an inverse correlation between 
ROS production (umol·min-1), at the end of exercise, and VO2 max (mL·Kg-1·min-1) 
(r2 values = 0.58, P<0.05). The black squares indicate PRE and grey squares 
indicate POST training value. The variance analysis (Pearson product-moment 
correlation) indicated a significant (* p<0.05) positive association. 
 
 
A good training, that is a moderate training, can have a positive effect on ROS 
production, leading to decrease ROS and increase the antioxidant capacity in 
whole body. 
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3.1.7.2 Antioxidant Supply  
Antioxidant supplementation (R(+) Thyoctic acid) induced EPR detectable 
changes in formation of in-vivo ROS in capillary blood (Figure 47). The kinetics of 
ROS production estimated by the EPR signal intensity at rest, immediately and 
during the time period (up to 3 hours) following the R-Thioctic acid administration is 
shown in the Figure 47 together with the data recorded without supplementation at 
the corresponding interval time. The ROS production rate level, subsequent to the 
supply, increased after 20 minutes, then decreased (40 minutes) and kept at a 
lower level with respect to the resting value, reaching its lowest significant (p<0.01) 
level at 90 min, then returning to the baseline. No significant difference was 
observed between experimental baseline and control data recorded without 
supplementation. 
Contrary to the effects of the training, the exogenous administration (R(+) Thyoctic 
acid) has a limited effect in time. 
 
 
 
 
 
 
Figure 47: Time course of ROS production rate (µmol · min−1) calculated by the 
EPR acquisition data without supplementation (red circle) and following antioxidant 
(R-thioctic acid) supply (black square). Results are expressed as mean ± SD. 
Changes over time resulted significant (P<0.01) at 90 min post, compared to pre-
supplementation (*symbol). 
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3.1.8 Under diseases: Unbalance of ROS production rate  
ROS production in pathological subjects was tested. The data obtained on patients 
(at baseline) affected by Type II Diabetic Neuropathic (Type II DN), Mild Cognitive 
Impairment (MCI) and sporadic Amyotrophic Lateral Sclerosis (sALS) were 
compared to the baseline data collected on healthy subjects (Table 8), a significant 
increase (p<0.05) of the ROS production level was found as an effect of both 
neurodegenerative diseases (MCI +2% and sALS +20%) (see Figure 48). 
 
 
 ROS production rate (µmol · min -1) 
Baseline value 
Healthy 1.84 ± 0.09 
Type II DN 1.71 ± 0.2 
MCI 1.87 ± 0.3 
sALS 2.2 ± 0.4 
 
Table 8: ROS production rate at baseline in healthy subjects and patients 
 
 
 
 
 
Figure 48: At baseline: histogram plot (mean ± SD) of the absolute ROS 
production rate (µmol · min-1) obtained by capillary blood collected from healthy 
subjects (black) and patients: type II DN (orange), MCI (green), sALS (blue) 
sALS and MCI patients shown a significant (p<0.05) increase of ROS production 
rate (*symbols). 
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The two studies presented below are in fieri and arised from collaborations: 
i) Study on diabetic neuropathy in patients with Type II diabetes mellitus and 
antioxidant supplementation: IBFM-CNR and Istituto Auxologico of Milan 
ii) Study on sALS patient: IBFM-CNR and Fondazione Maugeri of Veruno (Novara). 
 
 
3.1.8.1 Type 2 Diabetes mellitus Neuropathic patients  
Antioxidant supplementation (R(+) Thyoctic acid) induced EPR detectable 
changes in formation of in-vivo ROS in capillary blood (Figure 49) in type II 
Diabetic Neuropathic patients (Type II DN). 
The ROS production rate, subsequent to the supply of 1,6 g R(+) Thyoctic acid, 
significantly (p<0.01; -7%) decreased after 1 hour (1.71 ± 0.4 vs 1.59 ± 0.3 
µmol·min-1). This acute decremental effect of the supply persisted after 15 days 
(1.56 ± 0.1 µmol·min-1) and 30 days (1.5 ± 0.1 µmol·min-1) of daily supplementation. 
 
 
 
 
 
 
Figure 49: Time course of ROS production rate (µmol · min−1) calculated by the 
EPR acquisition data without supplementation (basal – grey square) and following 
antioxidant (R-thioctic acid) supply (black square). Results are expressed as mean 
± SD. Changes over time resulted significant (P<0.01) at 1h post, compared to pre-
supplementation (*symbol). 
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At the same time, 15 days and 30 days antioxidant supplementation induced 
changes in oxidative markers concentration: TBARS concentration decreased (-
15%) 30 days after (Figure 50A) and particularly PC concentration significantly 
(p<0.01) decreased (-18%) 30 days after (Figure 50B). 
 
 
 
 
 
Figure 50: Time course of TBARS (A) and PC (B) concentration before and after 
(15 and 30 days) antioxidant supplementation. Results are expressed as means ± 
SD. Changes over time were significant at p<0.05 compared to basal value (* 
symbol). 
 
Moreover the variance analysis (Pearson product-moment correlation) indicated a 
good correlation (r2 values = 0.85, p<0.01) between ROS rate production and 
TBARS concentration (Data no shown). 
 
 
 
 
 
 
 
 
basal  15 days 30 days
0
10
20
30
TB
A
R
S 
(µ
M
)
R(+) Thyoctic acid supplementation 
basal 15 days 30 days
0
1
2
3
PC
 (n
m
ol
.m
g-
1  p
ro
te
in
) *
R(+) Thyoctic acid supplementation 
A B
	   76	  
3.1.8.2 sporadic Amyotrophic Lateral Sclerosis 
The exercise and training effects have also been tested in bulbar and spinal sALS 
patients. For exercise effects evaluation ROS production rate (µmol·min-1) was 
tested in capillary blood samples taken at REST, immediately END exercise and 
15 minutes after the end of an incremental test (IT). Venus blood samples were 
taken at rest before and 15 minutes after the end of the IT for the assessment of 
oxidative damage markers too. 
 
Two session were defined: t0 (pre training) and t1 (after 20 weeks of training). 
 
 
Bulbar sALS:  
In patients with bulbar sALS: at t0 a significant decrease (p<0.05) of the ROS 
production rate was found both immediately at the END of IT (-17%) and 15 
minutes after exercise (recovery) (-17%) (see Figure 51A) 
After 20 weeks training protocol (30 min/day cycling exercise) the test was 
repeated. 
At t1 no significantly modification of the ROS production rate was found 
immediately after IT (-4%) and 15 minutes in the recovery (-6.5%). 
At t1 compared with t0, similar ROS production rate at rest was observed (2.36 ± 
0.4 µmol·min-1and 2.31 ±0.3 µmol·min-1). 
At t0 TBARS and PC concentration decreased (-3.5% vs -2.5%) at the “END” of 
the exercise (Figure 52A-B). 
At t1 TBARS and PC concentration increased (+8% vs 22%) at the END of the 
exercise (Figure 52A-B). 
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Figure 51: Exercise and training effects in sALS patients. Time course of ROS 
production rate (umol·min-1) calculated by EPR technique before (REST), 
immediately after the IT (END) and at 15 minutes of recovery in (A) bulbar sASL 
and (B) spinal sALS patients. Two exercise session: t0 before training (black 
square) and t1 after 20 weeks of training (green square in bulbar and blue square 
in spinal sALS patients). Results are expressed as mean ± SD. Changes over time 
were significant at p<0.05 immediately post CLE compared to rest (* symbol). 
 
 
 
 
 
Figure 52: Histogram plot (mean ± SD) of (A) TBARS (µM) and (B) PC (nmol·mg-1 
protein) obtained from plasma samples in bulbar sALS patients. Plasma was 
collected before (REST) and after the end IT (15 minutes) in two session: t0 (pre 
training) and t1 (after 20 weeks of training). 
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Spinal sALS 
In patients with spinal sALS: at t0 a non significant increase (+7%) of the ROS 
production rate was found immediately after exercise followed by a progressive 
returning to the basal level after 15 minutes (+0.5%) (see Figure 51B). 
After 20 weeks of training protocol (30 min/day cycling exercise), the test was 
repeated. 
 
 
 
 	  
Figure 53: Histogram plot (mean ± SD) of (A) TBARS (µM) and (B) PC (nmol·mg-1 
protein) obtained from plasma samples in spinal sALS patients. Plasma was 
collected before (REST) and after the end IT (15 minutes) in two session: t0 (pre 
training) and t1 (after 20 weeks of training). 
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At t1 a non-significant increase (+4%) of the ROS production rate was observed; 
progressively returning to the basal level after 15 minutes (+0.5%). 
Between two REST values (t0: 2.03 ± 0.4 µmol·min-1 and t1: 1.88 ± 0.3 µmol·min-1) 
a decrease of about 7% was found. 
At t0 and t1: TBARS concentration increased (+8%) at the END of the exercise 
(see Figure 53A); PC concentration increased (+14% in t0 and +13% in t1) (see 
Figure 53B). 
 
 
In order to evaluate the training effect on the basal level progression a Control 
group (Ctrl) of patients (sALS), matched for age, sex and degree of pathology, was 
recruited.  
At t0 an increase of ROS production was observed immediately at the end of IT 
and the subsequent returned to the pre exercise condition were analogue to those 
reported above.  
20 weeks after the test was repeated and no significant modification of the ROS 
production rate trend was found (Data not shown). 
The positive training effects are highlighted in Figure 54 and 55. Indeed, at REST, 
after training spinal sALS had shown a decreased of ROS production not 
evidenced in the Ctrl group and in bulbar sALS. This data are also supported by 
the mean values of fractional O2 muscle extraction [∆[deoxy (Hb+Mb)]peak/[∆(deoxy 
(Hb+Mb)]isch ] determined by NIRS. After training, the ability of O2 muscle extraction 
was improved (+85%) in sALS patients versus Ctrl group. 
 
 
 
 
 
Figure 54: Histogram plot (mean ± SD) of the absolute ROS production rate (µmol 
· min-1) obtained at REST by capillary blood collected from sALS patients (three 
group: control, spinal and bulbar sALS) in two session (t0 pre and t1 after 20 
weeks). 
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Figure 55: Histogram plot (mean ± SD) of fractional O2 muscle extraction 
determined by NIRS obtained at REST in control and spinal sALS group. 
In t1 (after 20 weeks) the untrained group (Ctrl) has a significantly (p<0.05) 
worsening O2 muscle extraction (* symbol). 
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3.2  IN VITRO 
3.2.1 Myglobin-NO 
Firstly, since in some of our experiments, incubation with the NO-donor was 
performed starting from the aquomet-Mb, an extremely important preliminary 
investigation had to be carried out, in order to ascertain whether the EPR spectrum 
of the latter might interfere with that of the nitrosyl-form we were interested in. 
The EPR spectra recorded from the two proteins in the aquomet-form, showed the 
characteristic axial symmetry (data not shown). The sample was placed in a 
microwave resonant cavity and irradiated with microwaves of fixed frequency ν in 
the MHz range. The magnetic field H was varied and the absorption spectrum was 
recorded. Resonances are defined by the following relationship: 
 
 g =    !!      . !  [!"#]![!]                                        (13)
                                     
 
where h/β is a constant with a value of 0.714484. The position of the absorption 
bands is therefore given by the spectroscopic splitting factor, i.e. the g factor, 
which is independent of the microwave frequency applied and is suitable to identify 
any given free radical. For one electron in a isotropic environment the absorption 
function is Lorentzian, with a unique g value. The convention in EPR spectroscopy 
is to show the first derivative of the absorption function. On the other hand, in an 
anisotropic environment, unpaired electrons become sensitive to two types of 
symmetry elements, axial and rhombic. In particular, in heme compounds, where 
iron is covalently bound to the four nitrogen atoms of the porphyrin ring, such a 
semi-rigid square and planar arrangement of the nitrogens imposes a tetragonal 
symmetry upon the iron-ligand system (the symmetry around the high spin iron is 
determined by the chemical nature of the ligands surrounding it and by their 
geometrical arrangement). 
As a consequence, constraints on the heme can perturb this tetragonal symmetry. 
If the free radical is in an anisotropic environment with axial symmetry, the EPR 
spectrum is defined by two distinct g values: g|| and g⊥.  
 
In the present study, the very low intensity observed for the latter in the case of 
human Mbs, assured us that, even if the aquomet-form was present, the 
corresponding signal did not perturb the peak due to the nitrosyl-Mb. As said, this 
was an important preliminary check since, after the incubation with the NO donor, 
conversion from aquomet-to nitrosyl-Mb might be lower than 100%, and a residual 
amount of the former might be still present in solution. 
Figure 56 shows the spectra of both the 54K and 54E human Mb isoforms (0.05 
mM), recorded after reduction to the deoxy-form, and subsequent incubation in the 
presence of the NO donor, in the absence of oxygen.  
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Figure 56: EPR spectra of nitrosyl-54K and 54E isoforms. Spectra were recorded 
after reducion to the deoxy-form (0.05 mM) by sodium dithionite addition and 
successive incubation with the NO donor (0.05 mM). Spectra were not normalized 
to allow for a better comparison. Three distinct g values are shown, indicated by 
the arrows. 54K: gx=2.03, gz=2.00, gy=1.99; 54E: gx=2.02, gz=1.99, gy=1.97. The g 
values were calculated by equation (13) from the absorption frequencies displayed 
in the spectra (G) and the microwave irradiation frequency of 9786 MHz. An EPR 
spectrum reported in the literature for the “native” human nitrosyl-Mb is shown in 
the inset and the g factors indicated. 
 
 
 
The peculiar spectral shape, similar in both the proteins, suggested the formation 
of the nitrosyl-Mb form. Three effective g values could be detected in the spectra: 
one peak on each side of the horizontal line were identified as the x and y in-plane 
absorption (gx and gy), whose directions are mutually perpendicular and 
approximately parallel to the heme plane. Their g values were 2.027 and 1.986, 
and 2.025 and 1.971, for the 54K and 54E isoforms respectively. In between, an 
‘inverted S shape’ is displayed, located at g ≈ 2.004 for both the proteins.  
The axial absorption, i.e. the gz factor, showed the hyperfine splitting due to the NO 
nitrogen, and was found at 1.999 and 2.004 for 54K and 54E respectively.  
From the EPR spectrum of the “native” human nitrosyl-Mb, g factors approximately 
equal to 2.08 (gx), 2.01 (gz) and 1.98 (gy) have been previously reported in the 
literature (see the inset in Figure 56). 
As expected, the g factors of the two proteins were found to significantly deviate 
from the free electron spin value (2.0023), indicating that the 3d orbitals of the iron 
ion are strongly involved, as a result of the spin-orbit interaction.  
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Figure 57: EPR spectra of nitrosyl-54K and 54E isoforms. The second derivative 
of the spectra reported in Figure 56 is shown. The difference between the spectra 
is emphasized and, in particular, the z-hyperfine coupling constant of 7G is marked. 
 
 
 
Super-hyperfine interaction with another axially bound 14N nucleus should be 
expected: the sixth ligand of the heme-iron was identified as the unprotonated 
nitrogen belonging to the residue H93 (i.e. the proximal histidine), and the coupling 
constant of the super-hyperfine splitting of resonance lines, due to the covalent 
bond between heme-iron and this residue, estimated to be ~7G (see Figure 57). 
Indeed, in a hexacoordinate nitrosyl-form, a nine-line hyperfine splitting is 
theoretically expected, originated from the interaction of the unpaired electron both 
with the 14NO nitrogen and the 14N nucleus of the axial base located in trans to the 
NO.  
As can be easily observed from the spectra, the two proteins showed a different 
super-hyperfine interaction, with the 54E showing an almost axial symmetry. The 
difference was even more pronounced when spectra were recorded under pO2 = 
40 mmHg starting from the aquomet-form (Figure 58).  
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Figure 58: Second derivative of the EPR spectra of nitrosyl-54K and 54E isoforms, 
starting from the corresponding aquomet-form. Spectra were recorded from the 
aquomet-54K and 54E isoforms (0.05 mM) after incubation with the NO donor 
(0.05 mM), at pO2 = 40 mmHg. Spectra have been not normalized to allow for a 
better comparison. 
 
 
 
The NO binding of the two Mb isoforms is reported in Figure 59 as the intensity of 
the EPR signal due to the nitrosyl-Mb generated (the a.u. were determined by 
double integration of first derivative EPR spectra) as a function of the oxygen 
concentration. A significantly larger NO binding capacity (more than double; p < 
0.01) was determined for 54E under deoxygenated conditions, while the two 
proteins became almost comparable in the presence of oxygen. An exponential 
decay of the bound NO as a function of pO2 (R2 = 0.99) was found by fitting a 
model curve to the experimental data: NO binding rate (amount of NO (a.u) · pO2-1) 
was higher for the 54E than 54K isoform. 
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Figure 59: NO binding affinity of the two human Mb isoforms. Histogram of double 
integrated signals of the EPR spectra due to the nitrosyl-Mb formed starting from 
either 54K or 54E in the aquomet-form (0.05 mM), after incubation with the NO 
donor (0.05 mM) at different pO2 levels. The arbitrary concentrations (a.u.) were 
determined by double integration of first derivative EPR spectra. The exponential 
decay of NO amount bound to each protein as a function of pO2 (r2 = 0.99) is 
characterized by a different rate constant for the two proteins:  54E: 0.037 and 
54K: 0.033 a.u pO2-1. Standard deviation is also reported, which was calculated 
from four independent measurements. 
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4 DISCUSSION 
Aim of our study was to shed light into the mechanisms involved in oxidative stress 
responses in man at both integrative and molecular levels. Our experimental 
investigations have been focused to the study of ROS production under various 
conditions of hypoxic states. 
In healthy subjects, the experimental protocols were designed in order to study the 
effects of: a) exercise (as inducing a transitory hypoxic state) of both short (in 
hockey players, swimmers) and long duration (in triathletes); b) training (as inducer 
of an adaptive antioxidant response in swimmers); c) hypoxia, both hypo and 
normobaric (to study the effect of the assumed model condition itself, in young 
sedentary subjects); d) antioxidant molecules administration as an external way 
helping redox  balance. 
In neurodegenerative pathologies (patients affected by: Mild Cognitive Impairment 
(MCI), Type II Diabetic Neuropathy (Type II DN) and sporadic Amyotrophic Lateral 
Sclerosis (sALS)) after checking the expected unbalance throughout a significant 
increase of ROS under resting conditions, the effect of training on the possibility to 
restore a normal ROS production level was investigate. Now, hereafter you will find 
point by point the discussion to simplify the lecture. 
 
 
EPR, Blood, ROS production and oxidative stress: starting 
considerations 
ROS are highly unstable oxygen molecules characterized by the presence of at 
least one unpaired electron, which can be stabilized by subtracting electrons to 
neighboring molecules. 
Despite the growing interest in the role played by ROS, reliable quantitative 
methods for the assessment of oxidative stress in humans are still lacking. 
Electron Paramagnetic Resonance (EPR) spectroscopy is, without any doubt, the 
only direct away to detect and measure free radicals [111]. 
Nevertheless ROS half-life is too short if compared to the EPR time scale so they 
are EPR-invisible: only when ‘trapped’ and transformed in a more stable radical 
species they become EPR detectable [101,102]. In particular, in EPR spectra, 
signal areas are proportional to the number of the excited electron spins, 
potentially leading to absolute concentration levels, when adopting a stable radical 
compound as reference. 
Moreover our developed method was found suitable to be applied to a lot of 
physiological and pathological subjects and conditions. It must be underlined the 
novelty of the technique so that, as already reported, we completely lacked 
literature data to be taken as reference. 
All together these reasons led biologists to currently use enzymatic assay methods 
to determine the ROS-induced damage by means of bio-molecules such as 
proteins, lipids and DNA and as recently reviewed [1] wide literature data can be 
found using enzymatic methods, in human blood on both plasma serum and red 
cell samples. Blood interacts with all organs and tissues and, consequently, with 
many possible sources of reactive species. In addition, a lot of oxidizable 
substrates are already present in blood so carrying a lot of substances that are 
considered oxidative stress markers (e.g., TBARS, protein carbonyls).  
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Changes in blood concentrations of these markers reflect corresponding changes 
in tissue of interest (mainly skeletal muscle) [112]. As a matter of facts, the vast 
majority of the relevant human studies have measured the redox status by using 
plasma or serum. This choice was a probably adopted after considering that 
plasma reflects tissue redox status together with the ease of plasma collecting 
procedure. However with this latter choice we cannot exclude potential artefacts 
generated by in vitro chemistry during the preparation and incubation phase of the 
spin probe or spin trap used, although this limitation is not exclusive to a particular 
technique since it has interpretive implications for any reactive metabolite 
measured ex vivo, especially human plasma. 
Moreover, due to classic tests have mainly quantified the ROS levels in human 
plasma but not those associated with erythrocytes, these studies have not taken 
into account the role of circulating cells. Ginsburg et al. [113] raised serious doubts 
whether reports on antioxidant quantifications carried out exclusively in plasma can 
be trusted to represent true oxidant-scavenging abilities. 
Indeed red blood cells may exert both antioxidant and pro-oxidant activity. 
Because of the high iron concentration (~20 mM), the red blood cell (RBC) can be 
considered an “iron mine” but, paradoxically, it is also one of the major 
components of blood antioxidant capacity and one of the most resistant to 
oxidative stress cell. A very efficient intracellular reducing machinery, coupled with 
its high cell density makes the erythrocyte an effective “sink” of reactive species. 
Probably not only the blood per se but, more important, the whole organism can 
benefit from RBC scavenging ability. The reverse side of RBC antioxidant power is 
its capability of being, in turn, a source of reactive species. The superoxide radical 
generated within the RBC by deoxygenated or partially oxygenated hemoglobin, 
usually found at low levels and likely under physiologic conditions, does not 
represent a big hazard for the cell. Similarly, the ability of RBC to scavenge or 
generate nanomolar concentrations of NO• can be easily handled by the 
methemoglobin reductase/NADH/glycolysis system. Completely different may be 
the situation when the erythrocyte crosses a tissue where an intense production of 
reactive oxygen/nitrogen species is occurring. Under these conditions, the RBC 
may accumulate oxidative damage, in turn reflecting the oxidative stress of other 
tissues and organs. For this reason, oxidative status of RBCs is potential candidate 
for monitoring the overall oxidative-stress status.  
During exercise, since reactive species are generated by both blood and muscle, it 
is reasonable to assume that there is a bidirectional movement of reactive species 
from the muscle to the blood, and vice versa, until equilibrium is reached. The 
same may hold true for exchanges among blood constituents, namely, plasma, 
erythrocytes, leukocytes and platelets [1], once that certain basic assumptions are 
met: reactive species with adequate half-life have the ability to cross membranes 
and generate reactive species at the vicinity of the compartments considered.  
As a matter of facts with respect to spin-trapping EPR, enzymatic assays are ‘a 
posteriori’ methods  
 
 
Fresh versus Frozen Blood samples: Protocol Design 
Based on all these considerations and aiming at reducing the invasiveness of the 
method and hence increase its clinical and diagnostic potential, herein, we 
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investigated the application of the radical-probe approach to the measurement of 
oxidative stress status in peripheral blood. 
Moreover fresh, rather than frozen samples were used for the EPR measurements 
to be able to gain an estimation of the ROS production rate, instead of a single 
level, well assuming that this procedure allowed us to attain more precise and 
reliable results (Figure 24-25). The experimental protocol was developed to 
measure ROS production in human blood and then adopted in all experiments 
carried out “in vivo” (Figure 20). EPR ROS determination by capillary blood 
samples can be well compared to a finger-prick blood sampling for glycemic test. 
Therefore the easy of the methods seems to be the dominant factor in the 
overwhelming use of blood measurement in human study.  
Unpaired electron(s) carrying species are, as such, EPR visible. However ROS 
half-life (superoxide [O2•-] t1/2 (s): 10-4; nitric oxide [NO•]: 0,4 at ambient 
temperature) is too short if compared to the EPR time scale. Therefore the species 
have to be ‘trapped’ and transformed in a more stable radical species to become 
EPR detectable. Among spin trapping or probe molecules, suitable for biological 
utilization, CMH was adopted, since it is a molecule capable of diffusion in all cell 
compartments, including mitochondria [114]. Indeed, due to its peculiar physical–
chemical properties, CMH probe is able to cross biological membranes, thereby 
detecting ROS both in plasma and intracellular compartments. In this way, EPR 
measurements allowed us to attain a overall quantitative determination of ROS 
production rate in human blood samples.  
In addition, owing to its high efficiency in radical detection, CMH probe can be 
used at very low concentrations (0.5 - 1 mM) compared to spin traps (10 – 50 mM), 
which minimizes side-effects of the probes on the biological samples. Moreover 
CMH rapidly reacts and allows radical detection in a single chemical reaction, while 
other probes require at least two reactions, which may cause artefacts [115]. 
 
 
Reproducibility measurement and limit of detection 
The high reproducibility of the measurement was demonstrated by performing the 
experiments two times on the same subject six hours apart. In fact the procedure 
itself makes impossible to repeat the same experiment several times on the same 
blood sample. Nevertheless the collected data suggested that repeated 
experiments from a resting subject gave almost super-imposable results: we can 
be observed an excellent correlation coefficient (R² = 0.9999) (Figure 25).  
The high sensibility EPR instrument was demonstrated by limit of detection (LOD) 
and quantification (LOQ) of 30 · 10-3 mM and 100 · 10-3 mM were calculated 
respectively.  
 
 
Starting measurement 
After checking the reproducibility of the EPR measurements from the collected 
data; we tested the ROS production rate in human blood in about one hundred, 
middle aged, healthy subjects. Different ROS concentrations were obtained when 
collecting data, on the same resting subject, from different blood fractions. These 
series of preliminary measurements on a homogeneous group of healthy subjects 
was firstly carried out for determined the mean measurements in blood. 
	   90	  
In peripheral blood ROS production levels were found about 18% greater (1.79 ± 
0.12 µmol · min-1 vs 1.48 ± 0.2 µmol · min-1) than in venous, owing to the different 
pO2 (100 mmHg vs 75 mmHg). An even greater level was found in erythrocytes 
samples (2.8 ± 0.3 µmol · min-1), due to the increased number of cells in the same 
volume. On the contrary, significantly lower results (0.16 ± 0.02 µmol · min-1) were 
found in plasma due to red cells absence, the main ROS producing elements in 
blood (Figure 26). The data well demonstrate the crucial role played by some 
parameters (e.g. temperature, PO2) on the results, suggesting that great care must 
be taken to keep all parameters at a constant level during the whole experimental 
procedure (Figure 27). 
	  
	  
Exercise: the transitory hypoxic state 
Considerable evidence has linked exhaustive exercise with extensive free radical 
formation. Davies et al. [116] were the firstly to establish exercise-induced free 
radical formation after exhaustive physical activity by demonstrating a heightened 
EPR signal (around g=2.004) in muscle and liver homogenates. Other studies [117, 
118] have also been able to demonstrate higher EPR signals with exercise. There 
are numerous reported that provide reasonable support to the notion that exercise 
increases the production of reactive oxygen species and that mitochondria are 
important sources of oxidants species [119, 27]. Other sources of oxidative stress 
during physical exercise are inflammatory responses mediated by neutrophils [120], 
the release of transition metals, such as iron, that supports Fenton chemistry with 
formation of hydroxyl radical, the interaction of met-Myoglobin and met-
Hemoglobin with lipid peroxides [121], and the activity of xanthine oxidase [122], 
possibly within an ischemia-reperfusion model [123]. As known, high-intensity 
physical exercise alters the fragile balance between oxidants and antioxidant 
defences and that the mitochondrial respiratory chain and other pathways 
contribute to free radical generation. As above reported, blood plays paramount 
importance in regulating redox status changes appearing during exercise. 
Using ESR spectroscopy, our studies clearly demonstrated in human capillary 
blood that a short-term constant-load submaximal exercise (CLE) at heavy-
intensity in hockey players, and/or incremental test (IT) in swimmers, induced 
oxidative injuries since a significant (p<0.01) increase: +7% and +16% 
respectability, in ROS production were detected (Figure 28 and 31).  
As reported elsewhere [124], professional athletes showed a rapid increase in 
ROS production at the starting of exercise. This was followed by a gradual 
decrease in the magnitude of the ROS production, reaching the initial value after 
20 min. This finding well accords with the idea that adaptive responses to aerobic 
training programs render athletes’ enzymes less responsive over time to further 
significant activation, and that increased ROS generation caused by physical 
exercise overwhelms the body capacity to detoxify from ROS. 
As expected when using a systemic determination the ROS detected levels are 
surely lower mainly because part of the produced ROS have been buffered by 
blood itself. Bailey et al. [125] showed, in typical EPR spectra, a positive veno-
arterial concentration of a-phenyl-tert-butylnitrone (PBN) adducts, detected in the 
arterial and venous circulation, at moderate intensity exercise. In the same article 
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the authors reported an increase in the EPR signal amplitude, according to the 
exercise intensity both in the arterial and venous circulation.  
Parenthetically we would like to underline that first aim of the present thesis was to 
evaluate the efficacy of ROS generation assessment by adopting a mini invasive 
procedure. Just for this reason we have been forced to use arterial capillary blood 
samples even if we are completely aware that arterial blood, because of circulatory 
system design, is very far from muscles that are the main ROS sources during 
exercise. 
However despite the moderate exercise levels adopted in these studies, the 
method was found suitable to detect significant differences so demonstrating its 
sensitivity even under the adopted experimental conditions. On the other side, 
under the adopted acquisition protocol, the ROS levels measured in the present 
study resulted in any case many times over the estimated limits of detection and 
quantification of a few nanomolar order.  
Furthermore, long-duration exercise effects were tested in two groups of athletes 
during Triathlon competition (swimming, cycling and running): the first group 
performed a short-competition (ShC 7.3): and the second group performed a long-
competition (Ironman). In both groups our study demonstrated that long-duration 
exercise induced a oxidative injuries since a significant (p<0.01) increase: +12.5% 
and +14% respectively, in ROS production were detected in human capillary blood 
(Figure 32).  
Increased production of reactive oxygen and nitrogen species may contribute to 
elevated levels of lipid and protein peroxidation markers also after the end of 
exercise (Figure 29A,B, 33 and 34). The measurement of these latter only in 
plasma is enough to describe the changes in erythrocyte and muscle redox status 
because of a strong communication between the different compartments [112]. 
Indeed results from the present study indicate that lipid peroxidation, as measured 
by TBARS, was elevated immediately and until 20 min after CLE (Figure 29A). 
Many studies have provided indications for substantial increase in plasma lipid-
peroxidation levels after aerobic exercise [126, 127,128].  
The delay in TBARS clearance, compared to more rapid ROS production kinetics, 
is in agreement with the observation of Echtay et al. [129] who proposed that lipid 
peroxidation products regulate mitochondrial ROS production by inducing the 
expression of proteins that inhibit mitochondrial O2• production by inducing 
uncoupling. 
Otherwise, removal of oxidized proteins from blood is, presumably, a time-
consuming process, also considering that oxidative modification in proteins can 
occur by the effect of ROS directly or indirectly through conjugation to lipoxidation 
end products. For this reasons protein carbonyls concentration remained elevated 
for a prolonged period (1 h) after CLE (Figure 29B). Other studies generally have 
reported increases similar to ours immediately after exercise, whereas the 
increases in protein carbonyls mostly disappeared after 0.5 to 6 h of recovery [126, 
130-132]. The different life response of protein carbonyls reported may be partly 
ascribed also to the different intensity and more or less muscle-damaging exercise 
mode used in the studies and to differences in the physical fitness of the 
participants [133]. 
Other aim of the study was to examine whether measuring blood oxidative stress 
markers, a currently common practice in biomedical research, is indicative of ROS 
production. Although almost all oxidative stress biomarkers have been criticized for 
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their reliability (including those used in the present thesis) [134, 135], it is apparent 
that, at rest, all changes suggesting increased oxidative stress are directly related 
to ROS production (Figure 30A - B). However the time-course changes of the 
used markers of oxidative stress were delayed (Figure 29A - B) than ROS 
production kinetics (Figure 28) and no correlation is possible in dynamic conditions. 
In other words it must be stressed that the good correlation found between EPR 
and enzymatic assays data do not represent a validation test for the here proposed 
EPR technique. By principle, the adopted enzymatic methods can quantitate the 
damage arising from ROS production, while EPR is the only technique capable, by 
using suitable probes, of quantitating the ROS production itself. These are the 
reasons why we could not hypothesize an ‘a priori’ existing relationship between 
these methods we cannot absolutely affirm that ROS production will at the same 
time produce damage. On the other hand the data collected in the present study 
seem to suggest that the practice of the vast majority of the studies to collect one 
blood sample immediately after exercise can potentially lead to inaccurate 
deductions [126]. 
Finally, as mentioned until now, the short and long-duration exercise invoke 
increased ROS production in human. In agreement with our data, Kanter et al, Liu 
et al [136, 137] reported significant increases in oxidative stress in response to 
marathon and ultra-marathon distance running races. Excessive ROS production 
and consequent oxidative damage induced by intense long-duration exercise, are 
mainly a response to increased oxygen utilization [138]. 
It should also be said that in long-exercise, defenses are often not sufficient to 
eliminate oxidative damage during and after exercise, as demonstrated by 
significant increased lipid (ShC +38%, Ironman +49%) (TBARS) and protein (ShC 
+92%, Ironman +128%) (PC) (Figure 33 and 34). The increase lipidic peroxidation 
is associated with the ROS production and that consequently leads to the 
breakdown of lipid; the PC content is the most general and widely used biomarker 
of severe oxidative protein damage.  
Triathlon is a multi-event sport (swimming, cycling and running). Although the 
physiological bases for success in a triathlon are not well understood, the ability to 
maintain minimal alterations in the homeostasis of cardiovascular, hemodynamic, 
thermal, metabolic and musculoskeletal functions seem to be a crucial point [139].  
Triathlon competition causing changes in biochemical parameters (Table 7), 
dehydration, oxidative stress, (Table 6) inflammation and the long-duration 
exercise is associated with an increased risk of infections in the upper respiratory 
tract [140].  
By laboratory analysis, we observed after competition, a significant increased 
production of leucocytes, neutrophils, lymphocytes and monocytes cells, probably 
results by inflammatory response (Table 7), our data are in accord with those 
reported by other authors [141]. 
As reported by YU et al. [142], HDL cholesterol increased significantly immediately 
after the race. We found a significantly increase of HDL in both triathletes group (+ 
13% and + 17% respectively) after competition too (Table 7). It could be assumed 
that HDL would constitute a primarily target for free radicals, thus delaying LDL 
deleterious oxidative modifications [143]. Furthermore, it has been hypothesized 
an efficient antioxidant function played by HDL, which could constitute an adaptive 
response to the increased oxidative stress [143].  
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Now, we want to examine the correlation between ROS production at rest (pre 
competition) and blood chemical laboratory test. Platelets, Iron, HDL, MCH, and 
Corpuscular Volume exhibited a significantly positive correlation with EPR ROS 
production (mean r2=0.50) (Figure 35A-E). Lymphocytes shows a minimal and not 
significantly correlation (r2=0.23) (Figure 35F) 
After competition, we found a good direct linear relationship between Hemoglobin, 
MCH and MCHC and ROS production (mean r2=0.63) (Figure 36A-C). 
Once again, these correlation data are important because they allow us to confirm 
that EPR measure follows the trend of other collected parameters. 
Thus, physical exercise and some pathological status can be seen as a typical 
example of an acute, intermittent or long-lasting/chronic hypoxic exposure or 
condition. 
The role of hypoxia was studied in the exercise [144]. It’s known that Hypoxia 
Inducible Factor 1 (HIF-1) play an important role during exercise. Almen et al, [145] 
reported that 45 minutes of one-leg knee-extension exercise elevated protein level 
and DNA binding activity of HIF-1α in human skeletal muscle. Furthermore, it was 
observed that 6 weeks of high and intensity bicycle training under normoxic 
condition increased HIF-1 and mRNA expression in human skeletal muscle [146] 
Endurance exercise-related angiogenesis, up to a significant degree, is regulated 
by ROS-mediated activation HIF-1α. 
 
Summarizing:  
• Confirms the increase of ROS production and oxidative stress after 
exercise 
• Data showed a direct correlation between EPR ROS production rate and 
markers of oxidative stress concentration (TBARS and PC) at rest 
 
 
Hypoxia: Acute Normobaric, Acute and Prolonged Hypobaric  
Hypoxia induces changes in blood composition: increases the concentration of red 
blood cells (RBC) because of an increase of erythropoietin secretion (EPO), a 
decrease of plasma volume (dehydration) and mobilization of erythrocytes from the 
spleen. 
The existence of hypoxia-induced ROS production remains controversial [150]. 
However a number of reports have provided evidence for ROS formation in acute 
conditions of hypoxia, but there is no general consensus regarding the 
physiological significance of these observations. ROS are more likely to be 
produced in hypoxia when there is both a high reductive capacity (e.g. high 
NADH/NAD+) and sufficient O2 available for reaction. Hypoxia exposure can lead to 
altitude mountain sickness (AMS) and sometime to high-altitude pulmonary or 
cerebral edema when the exposure is severe. There are indirect evidence from 
cells and tissue experiments that acute hypoxia induces accumulation of ROS 
[37,38]. As already said, the increase of ROS accumulation during exposure to 
hypoxia has important systemic implications [39] and more particularly at the brain 
level with damage of vascular endothelium, neurons, glia, and down-regulation of 
Na+-K+-ATPase, Ca2+-ATPase, Na+/Ca2+ exchanger activities. [37].  
Our present study was designed to investigate in healthy volunteers the role of 
high and middle altitude associated with hypoxia. This is because AMS is a more 
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common condition, which affects 40-50% of people who go up over 4200m. Typical 
symptoms are similar to that of a bad hangover: dizziness, headache, nausea, 
prolonged shortness of breath, prolonged fatigue, vomiting and exhaustion. In 
extreme cases, subject may experience agitation, anxiety or mental confusion, lack 
of coordination or imbalance. 
ROS production and oxidative stress in Hypoxia was studied in three conditions: i) 
Acute Normobaric Hypoxia, ii) Acute Hypobaric Hypoxia and iii) Prolonged 
Hypobaric Hypoxia.  
All the hypoxia-exposure procedures induced the increase in ROS production 
preceding the appearance of oxidative stress-induced damage (measured as 
increase in TBARS and PC). There are also other important factors, because in 
perfused systems local changes in blood flow associated with hypoxia or ischemia 
can induce a rise of the phenomenon [150]. Martinelli et all, [151] have shown that 
climbers who have been exposed for prolonged periods to extreme altitude exhibit 
evidence of oxidative stress in skeletal muscles as demonstrated by the presence 
of increased lipofuscin in muscle biopsy samples and muscle DNA oxidative 
damage [152]. Lipofuscin is a product of lipid peroxidation and is largely attributed 
to mitochondrial membrane oxidative break-down products associated with aging 
and disease. Similar oxidative changes in muscle biopsies have been observed in 
hypoxic chronic obstructive pulmonary disease [153].  
By contrast, our results show that:  
 
i) In healthy sedentary subjects, immediately after the start of the breathing of a 
normobaric hypoxic mixture (12.5% O2 in air, simulating about 4100m altitude) a 
significant (p<0.001) turning on of ROS (+38%) is formed because of the transition 
to low intracellular O2 tension (Figure 38) as attested by a significant (p< 0.001) 
reduction 88-90% (Figure 39) in arterialized blood oxygen. 
Figure 38 showed that an important, significant and fast elevation of ROS 
production occurs immediately after 2 minutes breathing of the mixture (+30%). In 
agreement with the present finding, Steiner et al, observed in isolated systemic 
vessels, that hypoxia alone can result in rapid elevations in ROS signalling in local 
vascular beds [154]. 
After 30 minutes of the return to normoxia, ROS production still showed +3.5%. 
During normobaric hypoxia, oxidative damage was observed too: TBARS 
underwent only a 10% increase at 4 hours of hypoxia. By contrast, 1 hour after 
hypoxia offset plasma concentration of TBARS it was significantly (p<0.05) 
increased returning back to pre-hypoxia control value in the subsequent 2 hours 
(Figure 40A). PC concentration significantly increased, attaining the highest value 
(p<0.059) at 4 hours. At hypoxia offset, PC decreased slowly, being still higher 
after 2 hours than at 0 hours (Figure 40B). 
The late onset of oxidative stress damage seems to give evidence that once again 
the imbalance between antioxidant capacity and antioxidant production, 
documented by some biomarkers of oxidative damage, is a time consuming 
process. 
 
ii) When reaching high altitudes, the decrease in barometric pressure results in a 
reduction in the partial pressure of oxygen in inhaled air. In acute hypobaric 
hypoxia, at 3480m s.l, ROS production significantly (p<0.01) increases at 6 (+42%) 
and 24 (+47%) hours respectively (Figure 41A) according to a reduction of SO2 (-
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11 and -10% respectively) (Figure 41B). One of the most detrimental effects of 
hypobaric hypoxia is oxidative stress, which could be the consequence of an 
increase in ROS, as demonstrated in our study, and a decrease in antioxidant and 
free radical-mediated reduction in pulmonary nitric oxide bioavailability [155, 156, 
157]. The passive ascent on the high mountain (Plateau Rosa) by cableway may 
have contributed to the rapid production of ROS, as the time for acclimation had 
been lacking. Because of this lack of acclimatization we also observed an increase 
in the ventilatory frequency (at 6 hours +43%: hyperventilation) (Figure 42A) and 
heart frequency (at 6 hours +30%) (Figure 42B). Moreover, three subjects showed 
typical AMS symptoms. 
 
iii) In prolonged hypobaric hypoxia, after two weeks exposure to moderate altitude 
(1860m sl), ROS production and lipid peroxidation product significantly  (p<0.01) 
increased: ROS +33%; (Figure 43) TBARS +9% (Figure 44A).  
Moreover, even if two weeks exposure to moderate hypoxia induced significant 
increase in both ROS and oxidative marker concentration, one week after return to 
s.l. both ROS production and TBARS concentration returned to pre-exposure 
values and even better, PC concentration significantly (p<0.01) reduced (-40%) 
(Figure 44B). 
 
From our results, we may conclude that ROS production and oxidative damage 
were: type (normobaric versus hypobaric) time and altitude dependent but always 
reversible.  
In fact, 30 minutes after the end of simulated normobaric hypoxia exposure, the 
ROS production returns to basal value (Figure 39).   
 
Summarizing: 
• The experimental conditions under investigation, even though very 
different for degree of hypoxia and duration, were both characterized by 
comparable trends of accumulation of ROS and oxidative damage.  
• Taken all together these results must be considered when altitude 
exposure is used as endurance training procedure to increase the oxygen 
transport capacity. 
• Our EPR methods can be applied as routinary procedure in mountain 
medicine for studying pathologies induced by hypoxia following high 
altitude acute and chronic staying. 
 
 
Training: Balance Restore 
Regular physical exercise increased the level of antioxidant defence and 
decreased the rate of ROS production [35]. Many data indicate that exercise with 
moderate intensity has systemic and complex health promoting effects, which 
undoubtedly involve regulation of redox homeostasis and signaling. 
Overload is a primary key of physical training required for peak performance, but 
overtraining can result in performance decrements, profound fatigue and oxidative 
damage. Margonis et al [147] examined whether progressively increasing and 
decreasing training volume and intensity induced oxidative damage to lipids and 
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proteins. They concluded that over-training induced changes in oxidative stress 
biomarkers proportional to training load. 
Otherwise good training, that is a moderate training, can have a positive effect on 
ROS production, leading to decrease ROS and increase the antioxidant capacity in 
whole body.  
In triathletes, we found a good linear relationship between ROS productions at rest 
and years of training (r2= 0.60) (Figure 37). Increasing years of training also 
increases the production of ROS, even if the ROS production values were always 
low compared to sedentary subjects. 
In master swimmers after a high-volume/low intensity training, moderate daily 
exercise for eight weeks, induces a significant (p = 0.0001) reduction of ROS 
production at rest (-20% in POST) and after incremental exhaustive exercise (-25% 
referred to end exercise in PRE) (Figure 45). 
Besides an inverse correlation between ROS production at the end of exercise and 
VO2max was found (r2=0.58) (Figure 46): a low index of ROS production 
corresponds to a higher VO2max. level  
Based on our data observed at rest in sedentary subjects, this phenomenon can 
also be interpreted in another way: physical inactivity decreases the adaptive 
subject oxidant capacity, including redox processes and the increase of ROS 
production, which can be transformed into high risk of diseases and into a 
worsening of life quality [148]. 
There is a great deal of evidence which indicates that higher VO2max is associated 
with a decreased risk in the incidence of a number of life-style related diseases, 
including breast, colon and prostate cancer, cardiovascular disease, type II 
diabetes and Alzheimer Disease [148, 149].  
 
Summarizing:  
• At rest, in trained versus untrained athletes a lower value of ROS 
production was found 
• “Over training” is dangerous! It increases ROS production 
•  “Good training” or regular physical exercise decreases ROS production 
and oxidative stress 
• An inverse correlation between ROS production, at the end of exercise, 
and VO2max 
• Our method was demonstrated rentable to be applied to sport medicine, as 
an effective /available help in sports centers to set up and adjust training 
protocols by monitoring training effects on oxidative stress.  
 
 
Antioxidant supply	  
Some starting considerations need to be expressed for the analysis of the effects 
of antioxidant supplementation. Thioctic acid (a-lipoic acid) was adopted as an 
endogenous antioxidant molecule which, in its reduced form, i.e. dihydrolipoic acid, 
forms a thiol-disulphide redoxing system [158, 159]. At the same time this moiety 
can also succeed in restoring intracellular GSH levels [160.] also resulting an 
essential cofactor in multienzyme complexes and pyruvate dehydrogenase activity. 
Indeed, in our study, the time corresponding to the peak activity of R-thioctic acid is 
delayed well after supplementation (Figure 47), as reported by other authors too 
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[161]. We found that after 90 minutes of supplementation of R-thioctic acid, ROS 
production level significantly decrease (p<0.01). 
Antioxidants may be defined as molecules preventing cell damage due to free 
radicals and are critical in maintaining health at its optimum, both in animals and 
humans. In living systems, cells require adequate antioxidant defences levels in 
order to avoid the harmful effect of an excessive ROS production, and so 
preventing the associated damage. Indeed excess of ROS production might play a 
role in pathophysiology of many disease conditions. Many basic researching as 
well as observational epidemiologic studies in humans suggest that antioxidants 
can prevent oxidative damage. However, this is still a controversial issue because 
clinical trials have often been produced conflicting results [163]. Indeed there is a 
need for the design of large multicentre randomized controlled trials to investigate 
the effects of different types and doses of antioxidant supplementation in selected 
groups of subjects.  
Nevertheless the here adopted methodological EPR approach was found an 
efficient and practical tool to respond to the question both in acute or chronic 
conditions. In particular, in the present study, the R-thioctic acid effects in type II 
diabetic /neuropathic patients were investigated. 
 
 
Under diseases: Unbalance of ROS production rate  
Oxidative stress is a very fashionable topic to take into account in defining etiology 
of pathologies since ROS play a major role in many diseases. Oxidative damage 
within cells has been linked to a wide range of diseases including arthritis, cancer, 
arteriosclerosis, AD, diabetes and ALS [163, 164, 165]. Unfortunately, many of 
these diseases have no treatment, show rapidly progressive disabilities, in some 
cases (depending on pathology) up to death. A significant ROS production 
increment was found in resting subjects affected by neurodegenerative pathologies, 
suffering of sure homeostasis unbalance condition: Mild Cognitive Impairment 
(MCI) +2%, sporadic Amyotrophic Lateral Sclerosis (sALS) +20% (Figure 48). As 
reported in the literature, neurodegenerative diseases (e.g. AD, and MCI frequently 
seen as a prodromal stage of Alzheimer's disease) are generally age-related 
disorders characterized by the deposition of abnormal form of a specific protein 
(e.g. the beta-amyloid in AD), while ALS patients displayed lipid and protein 
oxidative lesions. On the other side, there was substantial evidence to support the 
hypothesis that oxidative stress is one mechanism producing motor neuron death. 
This theory gained a better impact with the discovery that in few cases anti-oxidant 
enzyme, superoxide dismutase 1 (SOD1) mutation is at the basis of the diseases 
onset [165] 
The two here presented studies have to be taken as ‘in fieri’ and were carried out 
on two groups of patients: A) Type 2 diabetes mellitus neuropathic patients: 
antioxidant supply; B) sALS patients: exercise and training effects 
 
A) Type 2 diabetes mellitus neuropathic patients 
Diabetic neuropathies are diabetes mellitus associated disorders. Patients may 
develop nerve damage; symptoms such as pain, tingling or numbness, loss of 
feeling-in hands, arms, feet, and legs are reported. The causes are probably 
different and researchers are studying how prolonged exposure to high blood 
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glucose levels can produce nerve damage. Excessive ROS levels or reduction in 
the antioxidant defenses, such as SODs, Heme Oxygenase-1 (HO-1), NAD(P)H, 
Quinone Oxidoreductase-1 (NQO-1), catalase, causes oxidative stress, as it has 
been widely described in a number of various diseases, including type 2 diabetes 
mellitus. 
Major sources of oxidative stress in diabetes include glucose autooxidation, 
overproduction of ROS by mitochondria and non-enzymatic glycation process [166] 
Dietary supplementation with α-lipoic acid, evening primrose oil or sunflower oil 
was found to lower plasma lipids and risk factors [167]. 
Starting from these considerations, our study aimed at investigating the possible 
effects in diabetic neuropathy in this kind of patients as a consequence of 
antioxidant supplementation (1.6g/die R(+) Thyoctic acid): EPR detectable 
changes in formation of in-vivo ROS in capillary blood were calculated (Figure 49). 
Indeed ROS production significantly (p<0.01; -7%) decreased mainly after 1 hour 
from supplementation. These acute decremental effects of the supply persisted 
even after 15 days and 30 days of daily supplementation, inducing changes in 
oxidative markers’ levels: TBARS (Figure 50A) and PC significantly (p<0.01) 
decreased (-18% respectively) at 30 days (Figure 50B). In agreement with 
literature data, high levels of oxidative damage before antioxidant supply were 
found. Accordingly it was previously reported, even after diabetes pathology is 
established, TBARS increasing trend may be reversed by combined treatment with 
vitamins C, E, and ß-carotene [168] 
 
Summarizing: 
• R(+) Thyoctic acid) induced EPR detectable changes in formation of in-
vivo ROS in capillary blood 
• Changed in oxidative stress biomarker (TBARS and PC) 
• Effects of exogenously administered antioxidants have been observed until 
30 days  
• Necessary to assess the effects on neuropathy 
 
 
B) sALS patients: exercise and training effects 
sALS is as a neurodegenerative disorder whose cause, unfortunately, remains up 
to now unknown, characterized by rapidly progressive skeletal muscular paralysis 
reflecting selective death of both upper and lower motoneurons in the primary 
cortex, brainsterm and spinal cord.  Based on the region where motoneurons are 
primarily degenerated, strictly related to the afore mentioned symptoms, ALS is 
classified in two different forms: the bulbar-onset and the spinal-onset (25 and 75% 
of cases respectively). Bulbar onset firstly involves lip, tongue and throat muscles 
thereby resulting in progressive dysarthria and dysphagia. By contrast limbs and/or 
trunk muscles are firstly affected in the Spinal form together with muscular 
weakness and atrophy, cramps and fasciculation. The initial localization of the 
degenerative process is a known predictor of progression: indeed bulbar forms are 
characterized by a shorter life survival. 
All these observations led us to divide sALS patients in two groups according to 
symptoms: bulbar and spinal. Exercise (t0) and training (t1 – 20 weeks; 30 min/day 
cycling) effects has been tested in both of them. 
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In bulbars: at (t0) a significant decrease (p<0.05) of ROS production rate was 
found both immediately at the end (-17%) of an incremental test (IT) and 15 
minutes after the end of the exercise (recovery) (-17%). By contrast, at t1, no 
significant modification in the ROS production rate was found (Figure 51A).  
The t1 decrement can probably be attributed to an oxygen supply impaired 
(intermittent hypoxia). Otherwise other factors can possible produce episodic 
glucose deficit  (hypoglycemia). These hypotheses are supported by Zhang et al 
Hypoxia Inducible Factor-1 as a target for neurodegenerative diseases [169], who 
reported HIF-1 as a target for ALS and then hypoxia as a typical factor leading to 
intermittent and topical suppression of blood flow around motor neuron axon and at 
tissue levels. In addition age related hypoxia or other factors can produce either 
chronic or episodic deficits in glucose chronically-reducing vascular perfusion. 
Other authors focus their attention in the role of genetic expression of vascular 
endothelial growth factors (VEGF) reactive to hypoxia: VEGF is in fact known by 
the critical role playing in the growth and control of vascular permeability.  
At t0, the here reported oxidative damage results indicated lipid peroxidation: 
(TBARS) and Protein Carbonyl (PC) concentrations slightly decreased at the end 
the exercise. Conversely, at t1 TBARS and PC concentrations increased (+8% vs 
22%) at the exercise end (Figure 52A-B).  
By contrast in spinal patients: at t0 an increase (+7%, p>0.05) of ROS production 
rate was found immediately at the end of exercise followed by a progressive 
returning to the basal level after 15 minutes. 
At t1 an increase (+4%, p>0.05) of ROS production rate was observed 
progressively returning to the basal level after 15 minutes (Figure 51B).  
The observed trend was comparable to the exercise response found in healthy 
subject, characterized by an increase of ROS immediately after exercise. 
We can argue that in spinal patients antioxidant defenses are often not able to 
scavenge oxidative damage during and after exercise, as demonstrated by the 
significantly increased lipid (t0 and t1 +8%) (TBARS) and protein (t0 +14% and t1 
+13%) (PC) levels (Figure 53A-B). 
As reported in the literature [170] oxidative stress reflected by elevated lipid 
peroxidation is attributable to enzyme SOD1 mutation (in ALS familiar cases) or 
non SOD 1 (sporadic ALS cases). Our data confirmed the high oxidative damage 
by plasma TBARS and PC data, as previously reported [171]. 
No evidence of an improvement between t0 and t1 was found in ALS control group 
as concerning ROS production. 
Finally, the positive training effects are highlighted in Figures 54 and 55. Although 
preliminary data, once again, we have found a match between EPR data, oxidative 
markers (TBARS and PC) and data collected by NIRS. After training, the ability of 
O2 muscle extraction was found improved (+85%) in sALS patients versus Ctrl 
groups.  
Even if ALS studies of the exercise effects are very controversial [172] from our 
data exercise does not seem to play deleterious effects on the investigated 
patients. 
 
Summarizing: 
• In neurodegenerative disorders an over production of ROS was observed. 
• Spinal and bulbar sALS showed a different behavior as a consequence of 
 exercise 
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• The presence of oxidative damage (TBARS and PC) is confirmed 
• Regular moderate exercise can improve the performance in spinal sALS 
 patients, but not in bulbars. 
 
 
Myoglobin and NO 
Interest in human Mbs originated from the observation, in the literature, of different 
isoforms. Among them, 54K is the most expressed one in the skeletal muscle of 
populations born and living at low altitude. On the other hand, Mb over-expression 
has been reported for Tibet natives, totally attributable to the second main isoform 
54E, together with a better working and running efficiency [54, 169, 173]. 
Compared to lowlanders, Tibetans have been found to offset physiological hypoxia 
with more than double blood flow and more than six fold higher concentration of 
bioactive NO products, including plasma and red blood cell nitrate and nitroso 
proteins and plasma nitrite. [174, 175] Thus, a possible role for the latter in hypoxia 
adaptation of these high-altitude populations has been put forward, with particular 
emphasis on a different NO scavenging and/or nitrite reductase activity of the two 
human Mb isoforms. However, neither experimental nor computational data 
supporting this hypothesis are available so far, since, generally speaking, human 
Mb is rarely investigated when compared to those from other species  
As already indicated, NO is a highly diffusive and reactive molecule, produced, in 
the cells, by the NO synthases enzymes (NOS), using L-arginine and O2 as 
substrates. Among many different and fundamental roles as a signaling molecule, 
NO is a well-known inhibitor of the mitochondrial respiratory chain, having the 
cytochrome-c-oxidase as its primary target. Under hypoxia, the low O2 availability 
leads to NOS inactivation (being substrate limited). The NO produced by Mb down-
regulates mitochondria O2 consumption, contributing to elongate the intracellular 
oxygen gradient [176, 177] and limiting the formation of deleterious reactive 
oxygen species [63]. 
EPR was the other technique of choice, being considered particularly suitable to 
investigate NO binding to Mb. Indeed, nitrosyl-heme is characterized by an 
unpaired electron, such that, from the very beginning, NO was used as a spin-
labeled ligand for probing the electronic structure of the heme group and its 
environment, also in the light of the fact that the O2 Hb/Mb complex is diamagnetic, 
thus EPR invisible. [85] NO binding to the metallo-heme protein’s center can be 
directly measured in vitro and in vivo. In fact, by virtue of differences in the line 
shape and position of the magnetic field (g values) of the EPR absorption, spectra 
are sensitive to conformational changes of the protein’s moiety, which, in turn, 
produce geometrical changes at the metal site. The binding of NO to these 
proteins gives rise to a unique EPR spectrum, with characteristic symmetry and 
hyperfine coupling [178]. 
Under conditions as physiologic as possible, in the present study, the NO binding 
capacity of the two more expressed human Mb isoforms was compared, to the 
best of authors’ knowledge, for the first time in the literature. Our results suggest a 
different unpaired electron interaction with the axial base nitrogen for the two 
proteins, with, possibly, a stronger bond between the H93 and the iron for 54E than 
54K. In turn, these observations support the differences found in DP dynamics of 
the two isoforms with the MD simulations. Indeed, in the 54E, the distal histidine 
was found to move relatively far from the heme much more often than observed in 
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the 54K. This might be probably reflected by a slightly weaker coordination of the 
ligand bound to the iron at the heme distal side, leading, in turn, to a relatively 
stronger interaction between the iron and the proximal histdine. 
Particular attention was paid to establish the NO donor concentration to be 
adopted. The necessity of avoiding the use of a large excess of the NO (e.g. 10-
fold greater) has been previously pointed out as one of the main aspects to be 
taken into account to model, in vitro, a physiological environment. 
From the spectra, the two proteins showed a different super-hyperfine interaction, 
with the 54E showing an almost axial symmetry. The difference could be also 
observed when spectra were recorded under pO2 = 40 mmHg starting from the 
aquomet-form [Figure 58]. These results suggest a different unpaired electron 
interaction with the axial base nitrogen for the two proteins, with, possibly, a 
stronger bond between the H93 and the iron for 54E than 54K The pO2 levels were 
in turn chosen to mirror three well known physiological conditions: the extreme 
hypoxia (pO2 = 0), the resting O2 partial pressure in venous blood and interstitial 
space of peripheral tissues (pO2 = 40 mmHg) and the “maximum” O2 concentration 
reached on air-exposure, respectively. Moreover, it is important to stress here, that 
pO2 = 40 mmHg was also found to correspond to the maximum efficiency of the 
NO donor employed, when both NO generation and its oxidation to NO2- in the 
presence of O2 are taken into account. 
The NO binding of the two Mb isoforms is reported in Figure 59 as the intensity of 
the EPR signal due to the nitrosyl-Mb generated as a function of the oxygen 
concentration. A significantly larger NO binding capacity (more than double; p < 
0.01) was determined for 54E under deoxygenated conditions, while the two 
proteins became almost comparable in the presence of oxygen. An exponential 
decay of the bound NO as a function of pO2 (R2 = 0.99) was found by fitting a 
model curve to the experimental data: NO binding rate (amount of NO (a.u) · pO2-1) 
was higher for the 54E than 54K isoform. 
The results obtained by EPR showed a significantly larger NO binding capacity for 
the 54E isoform with respect to the 54K, but, very interestingly, this difference was 
circumscribed to the deoxygenate state 
 
Summarizing: 
• Very interesting differences emerged into 54 K and 54E.  
• The two isoforms resulted to have a intriguingly different behavior tuned 
by the presence of oxygen, such that their differences became strikingly 
evident at a very low pO2 level. 
• Presence of oxygen at a pO2 of both 40 and 200 mmHg, the binding 
capacity became significantly lower and almost comparable for the two 
proteins 	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5 CONCLUDING REMARKS 
The here presented study aimed at highlighting mechanisms involved in Oxidative 
Stress responses in man at both integrative and molecular levels. We believe we 
succeeded in elucidate some points in particular to underline the following: 
• The EPR method herein presented allowed reliable, rapid and non-
invasive absolute measurement of ROS production rate in human 
peripheral blood. Due to its simplicity coupled with the high sensitivity and 
specificity seems to us the most suitable, when compared to the other 
currently available methods, generally applied to evaluate ROS 
production/damage. Indeed the method was found suitable to be applied 
to a lot of physiological and pathological subjects and conditions. 
• The obtained results offered a contribute into different medical fields: 
sport and mountain medicine, clinical trials, helping in evaluating the 
efficiency of training protocols, in monitoring pathologies progression 
and/or therapies effects. Indeed some of the here presented studies, 
especially when concerning disease conditions, have to be considered ‘in 
progress’, nevertheless an extremely interesting road to be taken was 
marked, so calling for further investigation.  
• Also in ‘in vitro’ experiments EPR technique gave experimental evidence 
to the relevant role played by Mb isoforms as NO scavenger especially 
under hypoxic conditions also confirming MD simulation analysis data. 
• Finally we are confident that all these studies do provide a firm basis for 
future researching activity. 	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